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Part of this chapter is based on the following 
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Osteoarthritis (OA) is the most common joint disease among middle-aged and elderly 
in Western countries 1-4. Hip and knee joints are more frequently affected by OA than 
other joints. For example, 40% of the population aged 70 years and above suffers from 
knee OA 5. OA is a chronic disease that, because of its high prevalence, contributes 
most to impaired physical well-being and quality of life on a population level. In the 
year 2011, over 1.000.000 persons in The Netherlands visited their general practitioner 
because of symptomatic hip or knee OA 2, 3. Due to the ageing of the population in 
Western countries, the prevalence of OA is expected to increase further with another 
40% in the coming decades 3, 6. When increased rates of obesity in Western societies are 
additionally taken into consideration as an important risk factor for the development of 
OA, the prevalence is expected to increase by almost 50% in 2040 3, 6.
Besides impairment in physical well-being and quality of life, OA also results in more 
costs to society than other musculoskeletal diseases such as rheumatoid arthritis and 
osteoporosis 7-9. Due to the ageing population, this financial burden to society is also 
expected to increase over the coming decades. The economic burden of arthritis is esti-
mated at 1 to 2.5% of the gross national product of Western countries 8, 10. Symptomatic 
OA accounts for the majority of this burden because it is by far the most prevalent 
form of arthritis. The total medical costs for symptomatic OA in The Netherlands were 
estimated at €1.1 billion in 2011 3, 11. Most of the medical costs for OA are made in 
secondary care, mainly due to expensive joint replacement surgeries and associated 
costs for end-stage OA 12.
Given the absence of definitive treatment options other than joint replacement and 
the high burden of OA both in terms of health and costs, research in the OA field focuses 
on therapies that may modify the course of OA, e.g. disease-modifying osteoarthritis 
drugs (DMOADs) 13, 14, stem cell therapy 14, 15, joint distraction 16, 17 or more established 
intervention methods such as high tibial osteotomy 18. Especially the first two strategies 
aim at targeting OA at an early stage when they are expected to be most effective, 
thereby aiming at avoiding or delaying progression of the disease to its end-stage 
and reducing the large socio-economic impact of OA. In addition to these therapeutic 
interventions, high-risk populations for development of OA are being studied which 
might be a candidate for targeted OA prevention studies in the future 19-21. Successful 
application of the aforementioned therapeutic or preventive strategies could reduce 
the need for invasive and irreversible joint replacement, which is associated with com-
plications, high costs and limited lifetime of the prosthesis.
It is known from previous research that OA is not a disease of only bone and carti-
lage. OA is rather a disease of the whole joint in which bone, cartilage, menisci and 
synovium play a role in the development and progression of the disease 22. As cartilage 
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is an important tissue in the joint that is known to be affected by OA at early stages, 
research concerning DMOADs or preventive interventions focuses on articular cartilage 
as a target tissue in knee OA. These interventions can only be developed, assessed, 
improved and implemented successfully if their clinical and structural effect can be 
monitored and measured accurately, sensitively, and objectively in cross-sectional 
and longitudinal studies. Clinical efficacy of these interventions can be assessed by 
validated questionnaires that include patient’s clinical history and physical examina-
tion. However, these measurements, which represent clinical disease severity, are prone 
to subjectivity and poorly correlate with radiological disease severity 23, 24. Therefore, it 
is of utmost importance to also assess the structural efficacy of an intervention. The 
structural effects of a certain treatment on articular cartilage structure can be assessed 
non-invasively using radiological imaging 25, 26. Thus, radiological imaging can be used 
as an imaging biomarker to assess the structural efficacy of a certain treatment in the 
development of novel therapeutic strategies for OA, but also for assessment of disease 
status or progression.
TradITIonal ImaGInG TeChnIQues In osTeoarThrITIs
radiography
Radiography is the most commonly applied radiological technique to image OA and 
an accepted imaging biomarker to evaluate progression both in clinical practice and 
in research settings 27. A frequently used grading system for diagnosing and following 
OA was developed by Kellgren and Lawrence which allows the differentiation of radio-
graphic OA in 4 categories of severity: no OA (Figure 1A), mild or early OA (Figure 1B) and 
more advanced, e.g. moderate and severe OA (Figure 1C) 28. Radiography is a frequently 
used modality both in clinical and in OA research settings since it is relatively inexpen-
sive and is easily accessible for general physicians, medical specialists and researchers.
There are, however, major limitations of radiography applied as an imaging biomarker 
for OA. The most important limitation is its inability of directly visualizing cartilage and 
its weak correlation with cartilage damage on arthroscopy 29, 30. Instead, radiography 
can only detect joint space narrowing used as a representation of gross cartilage loss 
or meniscal damage in moderate to advanced stage OA 31, 32. Furthermore, radiographic 
assessment of early stage OA is associated with substantial inaccuracy and subjectivity 
33 and there is major disagreement concerning the definition and grading of OA using 
the Kellgren and Lawrence classification system 34. In addition, radiography is incapable 
of detecting disease progression with sufficient sensitivity within a reasonable time 
window, i.e. progression of OA on radiography is only detectable after years instead 
of months 35, 36. This makes large-scale studies, which use radiography as an outcome 
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1
measure less feasible since it would be necessary to have a follow-up period of several 
years, while a shorter follow-up period is desirable in clinical research. Another limita-
tion of radiography is its incapacity to depict any soft tissues in and around the joint 
Figure  1: Radiographic, conventional morphological MRI and schematic representation of articular cartilage in 
healthy (A, D, G), early stage osteoarthritic (B, E, H) and moderate (right side of the tibiofemoral compartment in C) or 
end stage osteoarthritic cartilage (left side of the tibiofemoral compartment in C, F, I). In healthy cartilage on radiog-
raphy and conventional MRI, no morphological abnormalities are present (A, D). In healthy cartilage the orientation 
and density of the collagen fibers varies by location within the cartilage layer and regionally within the joint. Relative 
to the articular surface, their prevailing orientation is parallel in the superficial layer, oblique in the transitional (middle) 
layer, and perpendicular in the deep radial zone (G). Similarly, the concentration of proteoglycans varies according to 
location and is highest in the middle layer (G). In the early phase of OA no morphological changes of the cartilage 
are visible on radiography and conventional MRI (B, E), but sulphated glycosaminoglycans leak from the cartilage 
and the collagen fibers change in size and orientation (H). In advanced stage OA, morphological changes (thinning 
and defects) of the cartilage appear on radiography or conventional MRI (C, F), while the whole original microscopic 
structure is destroyed (I).
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that are believed to play an important role in OA, e.g. synovium, menisci, ligaments, 
joint capsule and muscle 22. Finally, OA related findings derived from radiographs cor-
relate poorly with clinical OA symptoms, e.g. pain, stiffness and disability 37, 38.
magnetic resonance imaging
Because of the aforementioned limitations of radiography, magnetic resonance imag-
ing (MRI) is increasingly applied as an imaging biomarker to assess and follow-up OA, 
both in clinical trials and epidemiological studies. Unlike radiography, MRI is a three-
dimensional technique that can directly visualize cartilage and other soft tissues of 
the joint (Figure 1D), and is substantially more accurate than radiography in detecting 
cartilage damage 33. Therefore, several semi-quantitative MRI scoring systems for OA 
features in different tissues of the knee have been developed over the last decade 39. 
The Knee Osteoarthritis Scoring System (KOSS) 40, the Whole-Organ MRI Score (WORMS) 
41, the Boston Leeds Osteoarthritis Knee Score (BLOKS) 42, and MRI Osteoarthritis Knee 
Score (MOAKS) 43, 44 are commonly used scoring systems 25. In addition to these semi-
quantitative scoring systems for OA features on MRI, quantitative morphometric 
methods that involve cartilage segmentation followed by thickness and volume mea-
surements were developed to further increase sensitivity of MRI as an OA biomarker to 
determine and follow articular cartilage quality in OA 45, 46.
Despite these advantages of MRI over radiography, there are also limitations of MRI, 
especially if it is used as an outcome measure in early stage OA. Current “conventional 
MRI techniques” are usually aimed at assessing morphology alterations (thinning or 
defects) of cartilage in moderate or end stage OA (Figure 1F) 47, 48. These morphological 
cartilage changes are, however, not present in early stage OA (Figure 1E) and may not 
be manifest with subtle OA progression 49, 50. Moreover, morphological MRI assessment 
of cartilage is a subjective outcome measure for cartilage quality.
QuanTITaTIve ImaGInG BIomarKers of CarTIlaGe 
ComPosITIon and ITs BasIC PrInCIPles
To overcome the limitations of radiography and conventional MRI methods, there is 
increasing interest in novel imaging techniques that enable measurement of the bio-
chemical composition of cartilage rather than its morphology 51-53. These quantitative 
techniques offer a numeric outcome measure that can be used as an imaging biomarker 
for cartilage composition in cross-sectional studies, as well as in longitudinal research 
of OA in an early stage of the disease. In addition, they may enhance understanding of 
the pathogenesis of OA, much of which is still unknown.
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The basic principles of these novel quantitative imaging biomarkers are based on 
the microscopic changes in composition of cartilage during early stage OA. Articular 
cartilage which is also known as hyaline cartilage, is largely acellular as chondrocytes 
constitute only 4% of its wet weight 54. Instead, the main components of cartilage are 
water (65%-85% depending on depth from the articular surface) and the extracellular 
matrix (ECM). The ECM is synthesized and maintained by the chondrocytes and mainly 
consists of type II collagen (15-20%) and proteoglycans (PG) (3-10%) (Figure 1G) 55-57. PGs 
mainly consist of sulphated glycosaminoglycans (sGAG), which are negatively charged 
due to ionized sulfate and carboxyl groups. These strong negative electrostatic charges, 
collectively responsible for the so-called fixed-charge density (FCD), are important 
contributors to the structure and biomechanical properties of articular cartilage 55, 56. 
They allow sGAG molecules to be fixed to the collagen network of the extracellular 
matrix and attract positive counter-ions, mainly sodium, which lead to a firm increase 
of the cartilage osmotic pressure. As a consequence cartilage attracts water molecules 
resulting in a swelling of cartilage, which is counteracted by the surrounding collagen 
meshwork. This balance between swelling pressure and collagen tension contributes 
to a large extent to the tremendous tensile and compressive strength of cartilage 
under normal physiological conditions 55, 56, 58, 59. Articular cartilage can be subdivided in 
three layers: the superficial, middle and deep layer. In healthy cartilage, PG density and 
the orientation of the collagen fibers varies by location within the cartilage layer and 
regionally within the joint 55, 60-62 (Figure 1G).
In early stages of OA, the microstructure of the ECM breaks down and the tissue 
begins to lose its functional capacity. These early changes are indicated by a decreasing 
FCD due to loss of PGs, a decreased organization of the collagen matrix, and increased 
water content (Figure 1H) 56. These changes compromise the ability of cartilage to resist 
stress, resulting in further strain on the ECM and leaving cartilage prone to more ad-
vanced morphological degenerative changes 57, 63 that radiography and conventional 
MRI techniques are sensitive to (Figure 1I). Quantitative imaging biomarkers for cartilage 
composition are advocated to visualize and measure the microscopic biochemical 
changes during the early stage of OA, which are described above. In this thesis, the 
focus will be on the techniques that can measure the sGAG content present in the ECM 
of articular cartilage.
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QuanTITaTIve ImaGInG BIomarKers measure sulPhaTed 
GlyCosamInoGlyCan ConTenT of arTICular CarTIlaGe
delayed gadolinium-enhanced mrI of cartilage
Most quantitative imaging biomarkers for articular cartilage composition are MRI based. 
The most established method of these is delayed gadolinium-enhanced MRI of cartilage 
(dGEMRIC) 64, 65. The technique was introduced in 1996 and makes use of the repulsive 
force between a negatively charged contrast agent (gadopentetate dimeglumine) and 
the negative charge of the sGAG present in the extracellular matrix of cartilage. This results 
in contrast agent accumulation in cartilage inversely proportional to its sGAG content 64. 
The outcome parameter is the T1 relaxation time, usually averaged for the pixels in a region 
of interest and presented as the dGEMRIC index. T1 relaxation time is reduced by the con-
trast agent and consequently is lower in areas with decreased sGAG content compared 
to healthy cartilage with relative high and homogeneous sGAG distribution (Figure 2A). 
Because dGEMRIC is one of the first quantitative biomarkers for cartilage composition, it 
has become the standard biomarker in clinical research during the last decade 25, 26.
T1rho-mapping
Another quantitative MRI biomarker to measure cartilage composition is T1rho-mapping 
66, 67. T1rho-mapping, also described as relaxation in the rotating frame, uses a constant 
radiofrequency field referred to as a “spin lock” pulse to change relaxation rates of water 
associated with large macromolecules in cartilage. As T1rho relaxation time is proposed 
to be sensitive to protons associated with sGAG, several authors have suggested a direct 
relationship between T1rho relaxation time and sGAG concentration 66, 68, 69. Decreased 
sGAG content may lead to increased mobile proton density in bulk water and therefore 
Figure 2: dGEMRIC, T1rho-mapping and CT arthrography applied in healthy subjects and early and moderate stage 
knee OA patients. Sagittal slices through the center of the medial or lateral tibiofemoral compartment of knee OA 
patients and healthy volunteers (insets) acquired using different quantitative radiological techniques (all images ac-
quired in different subjects). None of the early OA patients showed clear abnormalities on the conventional MRI se-
quences (not shown). The dGEMRIC color map A shows a clear decrease in T1 relaxation times (purple/red) in early OA 
representing loss of sGAG. T1rho mapping (B) shows increased T1rho relaxation times (red) in a patient with moderate 
knee OA. CT arthrography color map C shows a clear increase in Hounsfield units (blue/white) in early OA representing 
loss of sGAG.
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increased T1rho relaxation times (Figure 2B). Since T1rho-mapping does not involve the 
use of a contrast agent, the technique has been advocated as a non-contrast-enhanced 
alternative to dGEMRIC and is therefore increasingly applied in clinical OA research 25, 26, 70.
other potential mrI based biomarkers for cartilage sulphated 
glycosaminoglycan content
Chemical exchange saturation transfer (CEST) is an MRI method to measure the dif-
ference in free water and water which has been bound by certain macromolecules 71. 
Applied to cartilage, CEST can be used to assess the amount of water, which has been 
bound by the sGAG molecules in the cartilage ECM to provide a direct measurement 
of cartilage sGAG content (referred to as gagCEST) 72. When less sGAG is present in the 
ECM, the free water signal increases as a result of the loss of sGAG from the cartilage.
Unlike previously discussed MRI biomarkers that rely on proton imaging, sodium 
MRI measures sodium signal 73. As positive sodium ions are associated with negatively 
charged sGAG of the cartilage ECM extracellular matrix 74, sodium MRI outcomes cor-
relate with sGAG content. GAG loss from cartilage in early cartilage degeneration is 
accompanied by reduced sodium concentration resulting in decreased sodium MRI 
signal 75.
GagCEST and sodium MRI are promising imaging biomarkers which are mainly ap-
plied in vitro 72, 74, but are also already applied in vivo in human research 76, 77. However, 
they mostly needs specific MRI equipment, coils and imaging post processing software 
which makes these techniques less feasible compared to dGEMRIC and T1rho-mapping.
Contrast-enhanced computed tomography
In addition to MRI based biomarkers for cartilage composition, there are also contrast-
enhanced computed tomography (CT) based quantitative imaging techniques, such 
as equilibrium partitioning of an ionic contrast agent using microCT (EPIC-µCT) 78, 79 
and µCT arthrography (µCTa) 80, 81. Like dGEMRIC, EPIC-µCT and µCTa use the inverse 
relation between a negatively charged contrast agent (ioxaglate) and the sGAG content 
of cartilage 80, 81. The quantitative outcome of contrast-enhanced CT is the X-ray at-
tenuation measured in Hounsfield units and is higher in sGAG depleted compared to 
healthy, non-sGAG-depleted, cartilage (Figure 2C). In µCTa, the contrast agent is injected 
intra-articularly and is also used for cartilage delineation and segmentation 80, 81. After 
contrast injection, the injected joint is passively or actively moved to promote contrast 
distribution throughout the joint cavity. Although CT arthrography has been used 
extensively in the past to assess cartilage morphology 82, 83, quantitative CT arthrogra-
phy is not yet applied as biomarker of cartilage biochemical composition in a clinical 
human research setting and is only used in in vitro research or in in vivo animal research.
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CurrenT use of QuanTITaTIve ImaGInG BIomarKers of 
CarTIlaGe sulPhaTed GlyCosamInoGlyCan ConTenT In 
human osTeoarThrITIs researCh
As previously mentioned, dGEMRIC and T1rho-mapping are already applied as imaging 
biomarkers for cartilage sGAG content in human OA research. To generate correct and 
reliable outcomes from quantitative MRI biomarkers, robust image processing tools are 
of great importance. Until now, only little research has been performed to develop such 
image processing tools 84-86. Therefore, future research is warranted to optimize image 
processing of quantitative MRI data. In addition to robust imaging processing tools, the 
reproducibility is also of importance when using a quantitative technique, i.e. dGEMRIC, 
as an outcome measure in cross-sectional or longitudinal research. dGEMRIC has been 
shown to be a reproducible measure for cartilage sGAG content in healthy human 
knees 87, 88, but the reproducibility in OA knee cartilage, which constitute an important 
target population for quantitative imaging techniques for cartilage composition, has 
not yet been determined.
T1rho-mapping has been shown to yield reproducible results in an OA population 89 
and could therefore possibly be a non-contrast-enhanced alternative for dGEMRIC to 
quantify sGAG content in OA cartilage, as advocated. Even though both dGEMRIC and 
T1rho-mapping are used as outcome measure for cartilage sGAG content in clinical 
OA research, no thorough validation studies have been performed that compare both 
techniques within the same OA patients using a reference standard for cartilage sGAG 
content. Both techniques were only validated in vivo in humans in one (dGEMRIC) or 
two (T1rho-mapping) studies with relatively small sample size 69, 90, 91.
Assuming that the aforementioned research shows that both dGEMRIC and T1rho-
mapping yield reproducible and valid outcomes in terms sGAG content of OA cartilage, 
the techniques could indeed be used as a quantitative imaging biomarker for cartilage 
composition, for example to assess the efficacy of a potential DMOAD. In addition, 
since MRI images multiple tissues in the knee joint, quantitative assessment of non-
cartilaginous tissues might be studied.
Unlike MRI based quantitative imaging biomarkers for cartilage sGAG content that are 
already applied in human OA research, contrast-enhanced CT or CT arthrography (CTa) 
have not yet been used for this purpose in human OA research. If properly translated 
and implemented in clinical setting, CT based techniques may be a potential valuable 
alternate to MRI based techniques for cartilage sGAG imaging in clinical OA research, 
for example in indications to undergo MRI.
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1
aIms and ouTlIne of ThIs ThesIs
The main aims of this thesis are divided between MRI and CT based quantitative im-
aging biomarkers of cartilage sGAG content, which relates to their different stage of 
application in research. MRI is already applied in human OA research, whereas CT is still 
to be translated and implemented in clinical research.
The first part of this thesis focuses on MRI based biomarkers for cartilage sGAG 
content and aims at optimization of image post processing, assessing reproducibil-
ity, comparison of different MRI sequences and application in clinical OA research. In 
chapter 2, the development of a sophisticated image processing algorithm to analyze 
quantitative MRI datasets is described. This algorithm is used in all following chapters in 
which MRI biomarkers are applied. In chapter 3, the reproducibility of dGEMRIC in early 
stage OA patients is assessed. In chapter 4 an in vivo validation and comparison study is 
performed for dGEMRIC and T1rho-mapping, which is advocated to be a non-contrast 
alternative to dGEMRIC in human knee OA patients. In chapter 5, dGEMRIC is used to 
investigate if improvement of cartilage sGAG content could be measured after treating 
early stage OA patients with hyaluronic acid and in chapter 6, the possibility to analyze 
both cartilage, as well as meniscus composition using dGEMRIC is assessed.
The second part of this thesis focuses on CT based imaging biomarkers and aims at 
translating CTa from a microscopic to a macroscopic setup and making it suitable to be 
used in clinical OA research. In chapter 7 µCT arthrography is translated to a clinically 
applicable protocol for CTa of human knee joints. The ability of this protocol to measure 
cartilage sGAG content using low radiation dose is assessed in chapter 8. In chapter 9, 
the CTa technique is validated in vivo in human patients with knee OA.
In chapter 10, the results of the research on which this thesis is based are discussed 
followed by the overall conclusions of this thesis and future perspectives towards 
quantitative imaging biomarkers in the human OA research. Chapter 11 summarizes all 
results and the conclusions in English and chapter 12 in Dutch.
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Chapter
2
Image registration improves human 
knee cartilage T1 mapping with 
delayed gadolinium-enhanced mrI 
of cartilage (dGemrIC)
e.e. Bron, J. van tiel, h. smit, d.h.J. Poot, W.J. niessen, 
g.P. krestin, h. Weinans, e.h. oei, g. kotek, s. klein.
eur radiol. 2013 Jan;23(1):246-52.




To evaluate the effect of automated registration in delayed gadolinium-enhanced MRI 
of cartilage (dGEMRIC) of the knee on the occurrence of movement artifacts on the T1 
map and the reproducibility of region of interest (ROI)-based measurements.
materials and methods
Eleven patients with early stage knee osteoarthritis and ten healthy controls under-
went dGEMRIC twice at 3-T. Controls underwent unenhanced imaging. ROIs were 
manually drawn on the femoral and tibial cartilage. T1 calculation was performed with 
and without registration of the T1-weighted images. Automated 3D rigid registration 
was performed on the femur and tibia cartilage separately. Registration quality was 
evaluated using the square root Cramér–Rao lower bound (CRLBσ). Additionally, the 
reproducibility of dGEMRIC was assessed by comparing automated registration with 
manual slice matching.
results
Automated registration of the T1-weighted images improved the T1 maps as the 90% 
percentile of the CRLBσ was significantly (P<0.05) reduced with a median reduction of 
55.8 ms (patients) and 112.9 ms (controls). Manual matching and automated registra-
tion of the reimaged T1 map gave comparable intraclass correlation coefficients of 
respectively 0.89/0.90 (patients) and 0.85/0.85 (controls).
Conclusion
Registration in dGEMRIC reduces movement artifacts on T1 maps and provides a good 
alternative to manual slice matching in longitudinal studies.




Osteoarthritis, the most common form of arthritis, is characterized by the degradation 
and loss of cartilage 92. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) has 
been introduced as a non-invasive quantitative technique to measure cartilage quality 
by evaluating its glycosaminoglycan content 64, 65, 93. Imaging is performed after admin-
istration of a negatively charged contrast agent that diffuses into cartilage in reverse 
relationship to the charge of glycosaminoglycan molecules. A quantitative T1 map is 
reconstructed from images acquired consecutively with different inversion times.
Automated image registration may improve dGEMRIC studies in two ways. First, T1 
map quality may be improved by registration of the T1-weighted images to correct 
for patient movement during the acquisition process. Only a few papers on dGEMRIC 
used image registration to correct for motion artifacts 84, 85. Moreover, registration of the 
T1-weighted images has not been evaluated before in patients with knee osteoarthritis. 
Second, automated image registration can be applied in longitudinal studies to com-
pare T1 maps acquired at different time points. Previous studies did not use registration 
for this purpose, but instead relied on manual matching of slices 87, 88, which is operator-
dependent and time-consuming. Automated image registration eliminates the subjec-
tive manual slice matching and manually outlined ROIs are required only once. This can 
be of value in follow-up studies evaluating for example the effect of a treatment.
The present study evaluates the effects of both image registration steps on the 
outcome of dGEMRIC in patients with knee osteoarthritis as well as in healthy controls.
maTerIals and meThods
subjects
This study was approved by the institutional review board of Erasmus MC, Rotterdam, 
The Netherlands. Informed consent was obtained from all subjects.
Two subject groups were included in this study. Group I consisted of 11 patients 
(age 52.2±11.0 years, 7 male) with early stage knee osteoarthritis (knee complaints > 3 
months, visual analogue pain scale > 20 mm and Kellgren–Lawrence grade I or II on 
radiography 28). Group II consisted of 10 healthy controls (age 26.7±8.6 years, 4 male).
Imaging protocol
Images were acquired on a 3-T MRI (Discovery MR750, General Electric Healthcare, 
Milwaukee, WI, USA). The 3D protocol for T1-weighted imaging consisted of an inver-
sion recovery fast spoiled gradient-recalled echo (FSPGR) sequence with five inversion 
times (TI = 100, 200, 400, 800, 2100 ms) 94. The repetition time (TR) was the inversion 
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time plus the time after read-out (TS = 3.9ms). Other parameters were: flip angle = 15º, 
echo time = 1.5 ms, field of view = 15x15 cm, slice thickness = 3 mm, slice spacing = 3 
mm, in-plane voxel size = 0.6x0.6 mm, number of slices in the sagittal plane = 36. The 
dGEMRIC MR protocol lasted approximately 15 min.
In patients, the dGEMRIC protocol 94 was performed twice with an interval of 7 days 
(range 5–14 days). A double dose (0.2 mmol/kg) of Magnevist® (Bayer, Berlin, Germany) 
was injected intravenously. Next, the patients were asked to cycle for 10 min on a 
home trainer to promote contrast agent distribution into and throughout the knee 
and the cartilage 95. After cycling, there was a delay of 80 min before the participants 
underwent MRI. An open design three-channel knee coil (Flick Engineering Solutions 
B.V., Winterswijk, The Netherlands) was used which enabled imaging of patients with 
a large knee diameter. Controls underwent MRI with the standard eight-channel knee 
coil (General Electric Healthcare) requiring a knee diameter less than 14 cm. For the 
controls no contrast agent was used and the second MR examination was acquired 
after a short break and repositioning of the knee.
definition of regions of interest
For each subject two regions of interest (ROIs) on the femoral and tibial cartilage were 
outlined by a trained researcher with a medical degree (JvT). The femoral cartilage ROI 
consisted of the adjacent trochlear, weight-bearing and posterior cartilage of the femur 
and the tibial cartilage ROI consisted of the weight-bearing tibial plateau cartilage. The 
ROI outlining was performed on the central slice through the medial and lateral tibio-
femoral joint, for both the first and second MR examination, resulting in eight cartilage 
ROIs per subject.
T1 calculation and uncertainty estimate
The T1 map was reconstructed by voxel wise fitting of the relation SI(TI)=S0·(1-A·exp(-TI/
T1)+exp(-TR/T1)) 94 to the T1-weighted images acquired at a range of inversion times. 
The fitting was performed with a maximum likelihood estimator of T1, S0 (fully relaxed 
signal) and A (inversion efficiency) which takes into account the Rician distribution of 
the data because, for magnitude MR images, this is more accurate than the commonly 
used normal distribution 96.
The uncertainty of the estimated parameters at each voxel can be expressed by the 
Cramér–Rao lower bound (CRLB), which gives a lower bound for the variance 96-98. The 
square root of the T1 CRLB (CRLB σ) can therefore be interpreted as a lower bound for 
the standard deviation of the T1 value, which quantifies how noise on the MR signal 
propagates to uncertainty of the estimated T1 value. In quantitative MRI, CRLB σ has 
previously been used for optimization of MR sequences 99-101, but it can also be used 
as an indicator of misalignment. Misalignment of the T1-weighted images, especially 
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at tissue boundaries, results in biologically implausible values of S0, A and T1, often as-
sociated with a high uncertainty, which is expressed by CRLB σ. The T1 calculations were 
performed using in-house developed Matlab software (R2008a, The MathWorks, Natick, 
MA, USA), which produces both the T1 map and the CRLBσ map. As a summary statistic 
for the CRLBσ values, we computed the 90% percentile (90%-CRLBσ) over all voxels in 
each annotated ROI; the lower this value, the better. We also computed the 90%-CRLBσ 
over all voxels in all ROIs together, to obtain a single measure per subject.
registration of T1-weighted images
All T1-weighted images were registered in 3D with respect to that T1-weighted im-
age showing the highest contrast between cartilage and surrounding synovial fluid, 
and between cartilage and bone cortex (FSPGRTI=2100). Registrations were performed 
using Elastix software 102 using a rigid transformation model (translations and rotations). 
Femoral and tibial regions were registered separately based on sub volumes containing 
only the specific bone and surrounding tissue to allow correction for motion of the 
knee joint (Figure 1). The registration was optimized over 1000 iterations with localized 
mutual information (LMI) as a similarity measure 103. Per iteration, LMI was calculated us-
ing 2048 random samples obtained from a sample region of size 50x50x50 mm. Cubic 
B-spline interpolation was used when applying the deformation to the moving image. 
The exact registration settings can be found on the parameter file database on the 
Elastix website: http://elastix.isi.uu.nl/wiki.php.
T1 maps were calculated with and without registration. A Wilcoxon signed rank test 
was used to test for a significant effect of registration on the 90%-CRLBσ values.
Figure 1: Registration is performed separately on the femoral (red) and tibial (blue) sub volumes to correct for motion 
of the knee joint. The background grayscale image is a T1-weighted image (FSPGRTI=2100)
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registration between the first and second mr examinations
To align the FSPGRTI=2100 images from the first and second MR examinations, registra-
tion was performed with the same method as in the previous section. Based on this 
registration, the T1 maps from the second MR examination were transformed to the 
T1 maps obtained at the initial study. The result of this alignment was compared with 
the reference standard of manually selecting matching slices, which was performed 
by a trained researcher (JvT.) visually inspecting FSPGRTI=2100 images from the first and 
second MR examinations for matching slices.
Analysis of the reproducibility between the first and second MR examinations was 
based on correlations of a weighted mean T1 value per ROI. A weighted mean was 
computed to reduce the effect of outliers which are for example caused by bone voxels 
accidently included in the cartilage ROIs. As outliers are expected to have a high CRLBσ, 
the reciprocal of the CRLB σ was used as the weight of each voxel to reduce their effect.
The reproducibility of the weighted mean T1 values was assessed using the intraclass 
correlation coefficient (ICC), Pearson’s correlation coefficient, and total least squares regres-
sion. In these analyses we treated the four ROIs on each image as independent measure-
ments. The ICC describes the resemblance of two sets of data with identical unit and an 
equal variance 104, 105 and can therefore be used to measure the agreement between the first 
and the registered second MR examination. A total least squares fit 106, 107 was performed to 
estimate a linear relation between measurements obtained at the two examinations. A fit 
with a slope significantly different from 1 would imply a systematic difference.
resulTs
registration of T1-weighted images
Registration of the T1-weighted images improved the T1 mapping, as CRLB σ was re-
duced and the homogeneity of the T1 maps was increased (Figure 2). Visual inspection 
of all ROIs showed an improvement in the alignment of the T1-weighted images due to 
registration. This effect was similar in the femoral and tibial cartilage ROIs. In only 3 out 
of 84 tibial cartilage ROIs, the severity of movement artifacts was increased by registra-
tion, which was caused by misalignment of the FSGPRTI=100 image in 2 of the cases.
Table 1 reports per subject the 90%-CRLBσ over all voxels in the eight ROIs, with and 
without registration. Table 2 shows the statistics for these measurements (first row) and 
for each ROI separately (rows 2–9). The 90%-CRLBσ decreased significantly in patients 
(P=0.003) and controls (P=0.005) owing to automated registration. The effect of regis-
tration was more pronounced in the femoral cartilage than in the tibial cartilage. With 
a Bonferroni correction for multiple testing, the registration effect in the femoral ROIs 
was still significant (P<0.05).
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registration between the first and second mr examinations
Figure 3 shows scatter plots of the weighted mean T1 measurements on the first versus 
the second MR examination. Table 3 summarizes the statistics. In patients, the ICC for 
the manual slice matching was 0.89 and with registration similar results were obtained 
(ICC=0.90). In controls, an ICC of 0.85 was found with both manual matching and regis-
tration. These ICC values indicate a similar reproducibility for both methods as the ICC 
values lie in each other’s 95% confidence interval. The Pearson correlation coefficients 
show the same pattern. Linear total least squares regression resulted in a slope of ap-
proximately 1 in patients and controls, with both manual matching and automated 
registration, which confirms that there are no systematic differences.
Figure 2: Comparison of T1 map and square root of Cramér–Rao lower bound (CRLB σ) map of a patient with and 
without automated registration to correct for patient movement (color overlay). The CRLB σ (ms) provides a lower 
bound for standard deviation of T1 (ms) and is a measure for registration quality. The background grayscale image 
is a T1-weighted image (FSPGRTI=2100). (a) T1 map without registration, (b) CRLB σ map without registration showing 
high uncertainty in the T1 estimates, (c) improved T1 map with registration, (d) CRLB σ map with registration showing 
reduced uncertainty in the T1 estimates












1 1753 177 260 244
2 43 34 >10000 605
3 142 84 443 298
4 96 74 410 360
5 765 152 176 164
6 178 120 >10000 712
7 111 74 456 385
8 >10000 762 441 267
9 128 105 >10000 2609
10 152 86 165 141
11 91 69 - -
Table 1: The 90%-CRLBσ calculated over all voxels in the eight cartilage ROIs. In 1 patient and 3 control subjects the 
90%-CRLBσ value without registration is over 10000 (ms). This resulted from voxels where the maximum likelihood fit 









All voxels in the eight ROIs 55.8 0.003 112.9 0.005
Femoral cartilage in the selected slice 
in the lateral compartment: Initial MRI
71.6 0.004 1561.6 0.005
Femoral cartilage in the selected slice 
in the medial compartment: Initial MRI
223.2 0.003 210.9 0.005
Lateral femoral cartilage on second MRI 73.8 0.003 677.6 0.005
Medial femoral cartilage on second MRI 104.8 0.003 72.8 0.009
Tibial cartilage in the selected slice in 
the lateral compartment: Initial MRI
-5.7 0.374 -63.1 0.647
Tibial cartilage in the selected slice in 
the medial compartment: Initial MRI
-7.4 0.350 -5.1 0.508
Lateral tibial cartilage on second MRI 3.0 0.424 -45.0 0.959
Medial tibial cartilage on second MRI -15.4 0.286 148.6 0.037
Table 2: The effect of registration on the 90%-CRLBσ of all voxels in the eight ROIs combined and of each ROI separately. 
1 Differences in the median of the 90%-CRLBσ for all subjects between no registration and automated registration. 2 P 
values of the Wilcoxon signed rank test
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Figure 3: Weighted mean T1 value per ROI for all patients (a, b) and controls (c, d). Subjects are represented by different 
colored markers. The weighted means of the T1 maps from the first and second MR examinations are plotted against 
each other with manual slice-matching (a, c) and automated registration (b, d). The black line represents y=x which 
is the expected result at perfect registration and reproducibility. The blue line is a linear total least squares fit through 
the points. r represents the Pearson’s correlation coefficient of the points and ICC the intraclass correlation coefficient
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Table 3: Comparison between first and second MR examinations: weighted mean T1 values of each ROI with manual 
slice-matching and automated registration. ICC(2,1) = Two-way random intraclass correlation coefficient based on 
single measures, r = Pearson’s correlation coefficient, slope = the slope obtained with a total least squares fit, CI = 95% 
confidence interval
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dIsCussIon
Our study demonstrates that automated registration can improve two aspects of 
dGEMRIC studies in the setting of knee osteoarthritis: the T1 map calculation and the 
reproducibility of T1 maps obtained at different MR examinations.
First, applying automated image registration in the calculation of T1 maps from T1-
weighted images improves the T1 maps and reduces the uncertainty in the estimated 
T1 value. In finger and hand arthritis, analysis by the coefficient of variation (CV) and 
visual grading analysis (VGA) showed that registration improves image quality and 
reduces variability 84. In knee dGEMRIC, this has only been investigated in five healthy 
volunteers 85 where the goodness of the T1 fit was evaluated using χ2 analysis. In our 
paper the CRLB σ was used to measure the effect of registration on the T1 map. Like 
χ2 analysis, CRLB σ provides a quantitative measure to express the quality of the T1 fit, 
which is not provided by CV or VGA. However, χ2 and CRLBσ express different properties 
of the quality of fit: χ2 quantifies the difference between the fit and the measurements, 
and CRLBσ quantifies how noise on the MR signal propagates to the fit. CRLB σ has the 
advantage over χ2 of being an absolute measure expressed in the same unit (ms) as 
T1. The results of our study show a reduction of CRLB σ due to registration, with a more 
pronounced effect in the femoral cartilage than in tibial cartilage. The 90%-CRLBσ did 
not show a significant effect of registration on the tibial ROIs (Table 2). This may be ex-
plained by the smaller signal intensity difference between cartilage and bone observed 
in the tibia compared with the femur. Misalignments in the tibial area will therefore 
have less effect on the CRLBσ than misalignments in the femoral region.
Second, automated image registration in evaluation of dGEMRIC reproducibility has 
been addressed. Using manual slice matching, Multanen et al 87 reported an ICC of 0.95 
in femoral cartilage and 0.87 in tibial cartilage of control subjects and Siversson et al 
88 found a femur ICC of approximately 0.68 in patients. We found an ICC of 0.89 with 
the manual slice-matching method in patients. For the control group, the manual ap-
proach resulted in an ICC of 0.85, which is comparable to the aforementioned studies. 
The automated registration method presented in our study requires only one manually 
drawn cartilage mask for evaluating the same ROI in two or more MR examinations. 
Therefore, analysis of dGEMRIC is less time consuming using the automated registra-
tion method. The actual amount of time that can be saved depends on the number of 
ROIs, slices and MR examinations to be analyzed. This is particularly of interest if two or 
more MR examinations need to be analyzed for large cohorts of patients. Automated 
registration yielded similar results to the manual method (ICC = 0.90 in patients and 
0.85 in controls). The reproducibility in patients was slightly higher than in controls, 
which could be explained by differences in signal-to-noise ratio (SNR) owing to dif-
ferent coils, or by the difference in T1 values as controls underwent unenhanced MR 
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imaging. The SNR was actually higher in controls than in patients (132±38 vs. 67±37), 
so the better reproducibility in patients is most likely explained by the presence of 
contrast agent leading to shorter T1 values. The range of inversion times in the FSPGR 
sequence is optimized for these typical T1 values in the presence of contrast agent. The 
lower 90%-CRLBσ values for patients reflect this (Table 1).
Although this paper focuses on dGEMRIC, the registration method used is not specifi-
cally developed for dGEMRIC. The method should therefore be applicable to other MR 
mapping methods as well, such as T1ρ and T2.
In conclusion, automated registration of dGEMRIC in knee cartilage improves the 
quality of T1 maps and provides a good alternative to manual slice-matching in longi-
tudinal studies as it leads to equal reproducibility and is operator-independent.
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To assess the reproducibility of 3D delayed Gadolinium Enhanced MRI of cartilage 
(dGEMRIC) at 3 T in early stage knee osteoarthritis (OA) patients.
materials and methods
In 20 patients, 3D dGEMRIC at 3 T was acquired twice within 7 days. To correct for patient 
motion during acquisition, all images were rigidly registered in 3D. Eight anatomical 
cartilage ROIs were analyzed on both images of each patient. Capability of dGEMRIC to 
yield T1 maps that reproducibly distinguish spatial differences in cartilage quality was 
assessed in two ROIs within a single slice in each patient. Reproducibility was assessed 
using ICCs and Bland–Altman plots.
results
ICCs ranged from 0.87 to 0.95, indicating good reproducibility. T1 maps revealed repro-
ducible spatial differences in cartilage quality (ICC 0.79). Based on the Bland–Altman 
plots, we defined a threshold of 95 ms to determine if a change in dGEMRIC outcome 
in longitudinal research was statistically significant.
Conclusion
3D knee dGEMRIC at 3 T combined with 3D image registration is a highly reproducible 
measure of cartilage quality in early stage OA. Therefore, dGEMRIC may be a valuable 
tool in the non-invasive evaluation of cartilage quality changes in longitudinal research 
in patients with early stage OA and focal cartilage defects.




Knee osteoarthritis (OA) is the most common joint disease in the middle-aged and 
elderly, causing serious morbidity and having a large socio-economic impact 7, 108, 109. 
As the current radiological reference standard for grading the severity of OA on radio-
graphs 28, is not sensitive enough to detect or follow structural changes in the cartilage 
present in early stage OA, sophisticated imaging techniques have been developed that 
can quantitatively measure cartilage quality 13, 33. An example of such a quantitative 
technique is delayed gadolinium enhanced magnetic resonance imaging of cartilage 
(dGEMRIC) which has been validated both in vitro and in vivo 65, 95. This technique has 
become a standard for the non-invasive assessment of articular cartilage quality in OA 
research and after articular cartilage repair techniques in the knee 110-114.
Potentially, dGEMRIC could also be an excellent technique for the follow-up of 
cartilage quality over time. However, both for quality assessment of the technique 
and especially before the dGEMRIC technique can be used in longitudinal research, 
its reproducibility must be evaluated. Since the introduction of dGEMRIC by Bashir et 
al. in 1996 65, only three small studies on the reproducibility of dGEMRIC have been 
published, reporting good reproducibility in healthy volunteers and patients with 
an anterior cruciate ligament tear (ACLT) with only limited changes related to OA on 
radiography 87, 88, 115. To our knowledge, for early stage OA patients, who might have 
a higher and possibly more variable penetration of contrast agent into the cartilage 
116, the reproducibility of dGEMRIC has not been reported. As the results of the previ-
ous reproducibility studies are not directly generalizable to the early stage OA patient 
population, the reproducibility of dGEMRIC needs to be reassessed accordingly.
The aim of this study was to assess the reproducibility of three-dimensional (3D) 
dGEMRIC at 3.0 Tesla (T) in patients with clinical and radiological signs of early stage OA 
of the knee. We also assessed whether the dGEMRIC protocol is capable of yielding T1 
maps that reproducibly distinguish spatial differences in cartilage quality within a single 
slice. This information is important for using dGEMRIC to follow both OA development 
and the repair of cartilage defects over time.
maTerIals and meThods
Participants
Between March and September 2011, 20 patients with early stage OA of the knee were 
recruited and included from the outpatient clinic of the Department of Orthopedic 
Surgery of Erasmus Medical Centre, Rotterdam, The Netherlands.
Jasper Tiel - Binnenwerk cp7.indd   39 30-09-15   10:33
40
The inclusion criteria were: age > 18 years, duration of knee pain > 3 months, severity 
of knee pain  >  2 out of 10 on a numeric rating scale 117, 118, and radiographic knee 
OA with a Kellgren and Lawrence grade of 1 or 2 28. Exclusion criteria were: absolute 
contra-indications to undergo magnetic resonance imaging (MRI), renal insufficiency 
(glomerular filtration rate < 60 ml/min), a history of previous reactions to contrast agent, 
significant co-morbidities in the lower extremity of the index knee joint, inflammatory 
arthritis in the index knee or knee surgery in the index knee < 1 year ago.
Written informed consent was obtained from all participants and the study was ap-
proved by the Institutional Review Board (protocol number MEC-2010-088).
mrI system and knee coil
Magnetic resonance imaging was performed on 3.0-T MRI (Discovery MR750, General 
Electric Healthcare, Milwaukee, WI, USA) using a custom made three-channel knee 
coil (Flick Engineering Solutions B.V., Winterswijk, the Netherlands) with a SNR compa-
rable to the dedicated knee coil, which was delivered with the MRI. The design of the 
custom-made knee coil allowed the imaging of participants with a knee diameter > 14 
cm which would not fit into the dedicated knee coil supplied by the manufacturer 
of the MRI system (Figure  1). From a previous study using identical selection criteria 
to ours 7, we estimated that approximately 30% of our patient population has a knee 
diameter  >  14 cm and exclusion of these patients from our study could potentially 
cause a selection bias.
study protocol
With an interval of 7 days two dGEMRIC MR images were acquired of the index knee of 
all participants. On both occasions, we tried to image patients at the same time of the 
day and asked them to not overload the index knee with sports or other activities the 
Figure 1: Example of a patient with a knee diameter of > 14 cm who does not fit in the dedicated knee coil (A) requiring 
the custom-made knee coil (B)
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day before and during the day of the examination. By doing so, we tried to minimize any 
possible impact of daily or sports activities on the sulphated glycosaminoglycan (sGAG) 
distribution in the cartilage, and hence the dGEMRIC results 119 which could negatively 
influence the reproducibility results. Before imaging, a double dose (0.2 mmol/kg) of 
gadopentetate dimeglumine (Magnevist®, Bayer Schering Ag, Berlin, Germany) was 
injected intravenously. After the injection, the participants were asked to cycle at a 
constant speed for 10 min on a home trainer to promote contrast distribution into the 
articular cartilage 95. After cycling and a delay of 80 min, dGEMRIC was acquired, i.e. 
approximately 90 min after contrast agent injection. The participants were imaged in 
the supine position with the index knee fixed into the knee coil.
We used a 3D dGEMRIC protocol which was published by McKenzie et al 94 and 
consisted of an inversion recovery fast spoiled gradient-echo sequence with five dif-
ferent inversion times (TI=2100, 800, 400, 200 and 100 ms). The other MR parameters 
were kept constant during imaging: matrix 256 x 230 pixels; field of view 150 mm; slice 
thickness 3 mm; flip angle 15º; echo time 1.5 ms and repetition time 3.9 ms. The total 
acquisition time was approximately 14 min, resulting in 36 sagittal slices with complete 
coverage of the knee joint.
region of interest selection
Using Matlab (R2007b, The MathWorks, Natick, MA, USA), four cartilage regions of inter-
est (ROIs) were drawn manually on three consecutive slices through the lateral and 
medial tibiofemoral joint (central slice and one adjacent slice on each side), resulting in 
Figure 2: Representation of the four anatomical cartilage 
ROIs in which the weighted mean T1 was calculated in 
three consecutive slices in each compartment of the tibio-
femoral joint (lateral side shown in this example). wbFCa 
and wbFCp: anterior and posterior weight-bearing carti-
lage of the femoral condyle. pFC: posterior non-weight-
bearing cartilage of the femoral condyle. wbTP: weight-
bearing cartilage of the tibial plateau.
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three ROIs in each anatomical location for each patient. This ROI selection was based 
on the scheme suggested by Eckstein et al 120. Tiderius et al 121 showed low inter- and 
intraobserver variability in anatomical landmark based ROI drawing independent from 
experience in reading MR images. Therefore, all ROIs in our study were drawn by a 
trained researcher with a medical degree. The anatomical landmark-based ROIs were 
drawn on the TI=2100 ms images of the first dGEMRIC and consisted of the anterior and 
posterior weight-bearing cartilage of the femoral condyles (wbFCa and wbFCp), the 
posterior non-weight-bearing cartilage of the femoral condyles (pFC) and the weight-
bearing cartilage of the tibial plateaus (wbTP) (Figure 2). The mean number of voxels in 
each anatomical cartilage ROI was: wbFCa 112 (± 28) voxels, wbFCp 200 (± 31) voxels, 
pFC 135 (± 31) voxels and wbTP 192 (± 60) voxels.
To assess if the 3D dGEMRIC protocol yields T1 maps that reproducibly distinguish 
spatial differences in cartilage quality within a single slice, we defined two additional 
ROIs on 28 slices of the first dGEMRIC examination of 20 patients. These ROIs (we will re-
fer to them as quality-based ROIs) were visually selected on the T1 maps of the cartilage 
in all first dGEMRIC examinations of every patient. On those maps, we identified slices 
with cartilage regions with a long T1 relaxation time, indicating a relatively high sGAG 
content and hence a relatively high cartilage quality compared with a cartilage region 
on the same slice with shorter T1 relaxation time which indicates a relatively low sGAG 
content and hence quality 65, 95, 122.
dGemrIC analysis
During acquisition of dGEMRIC, patient motion, which may cause errors in the T1 
calculation, might occur. However, such motion artifacts can be reduced by image 
registration and subsequent post-imaging compensations 84, 85. Therefore, we devel-
oped an automated registration algorithm that first aligns all images with different TI 
values to the TI=2100 ms images within the first and second dGEMRIC separately 123. 
The registration method consisted of two 3D rigid registrations (the femoral condyle 
and tibial plateau were registered separately) and was implemented using open source 
registration software (Elastix, http://elastix.isi.uu.nl/) 102. After the first step, the algorithm 
automatically registers the acquisition and the reacquisition. This eliminates subjective 
visual slice matching between acquisition and reacquisition and also eliminates the 
need to manually outline the cartilage ROIs in the reacquisition
After registration, T1 maps were created and further analyzed using a T1 fitting tool 
developed in-house using Matlab. In all ROIs, the weighted mean T1 relaxation time per 
ROI was calculated, where the estimated T1 relaxation time of each voxel was weighted 
by the reciprocal of its uncertainty. The uncertainty was measured by the square root 
of the Cramér-Rao Lower Bound, which gives a lower bound for the standard deviation 
of the estimated T1 96-98. Misalignment of the T1-weighted images, especially at tissue 
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boundaries, results in biologically implausible values of T1, often associated with great 
uncertainty. Using the weighted mean, these implausible T1 values will not heavily 
influence the calculated mean T1 values in the determined cartilage ROIs 123.
After calculating the T1 values in the anatomical ROIs, we calculated the average T1 of 
the three similar anatomical cartilage ROIs. By doing so, we use the 3D information we 
have available instead of only using a separate slice (2D analysis) in both the medial and 
lateral compartment of the knee which has been done in most previous studies using 
dGEMRIC. After calculating the average T1 values, there were eight weighted mean T1 
values of eight anatomical cartilage ROIs for each participant.
statistical analysis
We calculated the mean of all weighted mean T1 relaxation times in each anatomical 
cartilage ROI in the first and second acquisitions. We also calculated the standard error 
of mean of all anatomical ROIs.
To assess the reproducibility of dGEMRIC in each separate anatomical cartilage ROI, 
we used the intraclass correlation coefficient (ICC) measuring the absolute agreement 
in a two-way random effect model 124. We calculated eight ICC values for eight ana-
tomical cartilage ROIs in the medial and lateral tibiofemoral joint. In addition to the ICC 
values, according to the method suggested by Bland and Altman 125, we plotted the 
difference between the weighted mean T1 of the first and second dGEMRIC against the 
mean outcome in weighted mean T1 of both images of the anatomical ROIs separately. 
In these plots, the 95% limits of agreement were expected to be comparable to two 
standard deviations 125.
Finally, to analyze whether the 3D dGEMRIC protocol is capable of yielding T1 maps 
that reproducibly distinguish spatial differences in cartilage quality, we subtracted the 
T1 relaxation time of the low cartilage quality ROI from the T1 relaxation time of the 
high cartilage quality ROI resulting in the difference in T1 relaxation times of the two 
ROIs. We did this in both the first and the second acquisitions, resulting in 28 difference 
measurements of which we calculated the ICC value.
We interpreted ICC values > 0.75 as good, whereas ICC values between 0.74 and 0.40 
were interpreted as moderate and values < 0.40 were interpreted as poor reproduc-
ibility 87, 88, 124. All analyses were performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA) 
and all P values < 0.05 were considered to be statistically significant.




All included participants completed both dGEMRIC examinations. The median interval 
between the first and second acquisitions was 7 days (range 5–14 days).
Three participants were excluded from our statistical analysis because of technical 
errors during the acquisition of dGEMRIC (e.g. differences in pre-imaging settings 
between the first and second acquisitions). Therefore, we included 17 participants (7 
women and 5 left knee joints) in our data analysis. The mean age of the participants was 
50 (± 10) years and their mean body mass index was 30 (± 5) kg/m2.
dGemrIC reproducibility
The mean T1 relaxation times in the different anatomical cartilage ROIs ranged from 458 
to 574 ms with higher mean T1 values in the lateral compartment of the tibiofemoral 
joint (Figure 3). All mean T1 relaxation times of the anatomical cartilage ROIs and the 
associated standard error of the mean are displayed in Table 1. We pooled the mean and 
Figure 3: Sagittal central slices through the lateral (A) and medial (B) tibiofemoral compartment of an early stage 
medial OA knee. The T1 color map of the cartilage clearly shows lower T1 values (red arrows in B), indicating relatively 
lower sGAG content in the weight-bearing femoral cartilage in the medial compartment compared to the relatively 
higher T1 values (green arrows in A) in the same cartilage region in the lateral knee compartment.
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the standard error of the means of the first and the second MR examination, since those 
values were equal in all anatomical ROIs.
The reproducibility of dGEMRIC in the different anatomical cartilage ROIs, in terms of 
the ICC values together with the 95% confidence intervals (95% CI), are shown in Table 1. 
The reproducibility was good in all anatomical cartilage ROIs (n=17 for each ROI), as all 
ICC values were > 0.75 124. No large differences in ICC values were observed among the 
different anatomical ROIs. Scatter plots of weighted mean T1 values in acquisitions and 
reacquisitions are shown in Figure 4. In these plots, the range of observed T1 values was 
300 to 750 ms in the cartilage.
In agreement with the ICC values, the Bland–Altman plots of the different anatomical 
cartilage ROIs suggest the good reproducibility of dGEMRIC (Figure 5). In addition, based 
on the 95% limits of agreement of the Bland–Altman plots, we defined a threshold of 
95 ms to determine whether a change in dGEMRIC outcome is statistically significant 
or not.
The capability of the 3D dGEMRIC protocol to yield T1 maps that reproducibly dis-
tinguish spatial differences in cartilage quality within a single slice (n=25 because 3 
patients with three difference measurements were excluded from the analysis) was also 
considered good (ICC 0.79, 95% CI 0.57–0.90). A scatter plot of the difference measure-
ments is shown in Figure 6.
Cartilage roI mean T1 (s.e. mean) ICC (95% CI)
Medial tibiofemoral compartment
Anterior weight-bearing femoral 458 (17) ms 0.87 (0.69–0.95)
Posterior weight-bearing femoral 475 (17) ms 0.91 (0.78–0.97)
Posterior femoral 492 (22) ms 0.88 (0.69–0.96)
Weight-bearing tibia 489 (18) ms 0.90 (0.74–0.96)
Lateral tibiofemoral compartment
Anterior weight-bearing femoral 490 (14) ms 0.87 (0.68–0.95)
Posterior weight-bearing femoral 542 (14) ms 0.88 (0.70–0.96)
Posterior femoral 477 (16) ms 0.95 (0.85–0.98)
Weight-bearing tibia 574 (19) ms 0.91 (0.76–0.97)
Table 1: Mean T1 relaxation times in milliseconds, standard error of the mean in milliseconds and ICC value for re-
producibility between the first and second dGEMRIC in each anatomical cartilage ROI (n=17 for each ROI). S.E. mean: 
standard error of the mean. ICC: intraclass correlation coefficient. 95% CI: 95% confidence interval
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dIsCussIon
Reproducible outcome measures to follow cartilage quality non-invasively over time in 
longitudinal studies are important in OA research, as they might enhance understand-
ing of the pathogenesis of (early stage) OA. Furthermore, accurate, objective and repro-
ducible imaging techniques are essential to develop and monitor disease-modifying 
OA drugs and other novel OA therapies.
The first aim of the present study was to assess the reproducibility of dGEMRIC using 
a 3D sequence on 3.0-T MRI equipment in patients with early stage knee OA. The results 
of our study demonstrate that the reproducibility of individual anatomical cartilage 
Figure 4: Scatter plots of the first and second dGEMRIC of all patients. Every anatomical cartilage region (n=17) is 
represented by a blue dot (lateral) or red triangle (medial), depending on the location in the tibiofemoral joint. A: an-
terior weight-bearing cartilage of the femoral condyle. B: posterior weight-bearing cartilage of the femoral condyle. C: 
posterior non-weight-bearing cartilage of the femoral condyle. D: weight-bearing cartilage of the tibial plateau. The 
black line represents the relation x=y (perfect reproducibility). ICC: intraclass correlation coefficient.
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ROIs is good, regardless of the anatomical location within the knee joint (Table 1). The 
Bland–Altman plot of the anatomical cartilage ROIs (Figure 5) agrees with the calculated 
ICC values in the anatomical ROIs. However, the 95% limits of agreement indicate a 
relatively large variation between the first MR acquisition and reacquisition in the 
anatomical cartilage ROIs. This is also revealed by the relatively large standard error 
of the mean in all ROIs (Table 1) indicating a relatively large variation in the calculated 
weighted mean T1 values within a single MR examination, but also between the first 
and second dGEMRIC.
Figure 5: Bland–Altman plots of the difference in the weighted mean T1 values between the first and second dGEMRIC 
plotted against the weighted mean T1 values of both acquisitions in each separate anatomical ROI in the lateral (A) 
and medial (B) tibiofemoral compartment (n=17 participants x 8 ROIs for each participant = 136). The red lines indi-
cate the 95% limits of agreement of the anatomical cartilage ROIs. wbFCa (blue dots) and wbFCp (red triangles): an-
terior and posterior weight-bearing cartilage of the femoral condyle. pFC (green stars): posterior non-weight-bearing 
cartilage of the femoral condyle. wbTP (black squares): weight-bearing cartilage of the tibial plateau
Figure 6: Scatter plot of the difference measurements 
between weighted mean T1 in adherent cartilage with 
relatively high and low quality cartilage within one 
slice in the first and second dGEMRIC (n=25). Every dif-
ference measurement is represented by a blue dot. The 
black line represents the relation x=y (perfect repro-
ducibility). ICC: intraclass correlation coefficient, 95% 
CI: 95% confidence interval
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Our reproducibility results in terms of ICC values are similar to those of previous 
studies assessing the reproducibility of 2D and 3D dGEMRIC in healthy volunteers and 
patients with an ACLT 87, 88, 115. As this is the first study assessing the reproducibility of 
dGEMRIC in OA, we aimed to investigate whether the impaired cartilage quality, includ-
ing loss of sGAG, in early OA 56, 116 causes less reproducible results in comparison to 
studies conducted in healthy volunteers or patients with an ACLT without radiographi-
cal signs of OA 87, 88, 115. The use of an automated image registration method, which 
allowed us to analyze exactly the same voxels on the same slice in the first and the 
second acquisitions, might have been beneficial to the ICC values we observed in our 
study. It solves the issue of visual slice and ROI selection, which could have a negative 
influence on the reproducibility 88.
The second aim of our study was to analyze the capability of the 3D dGEMRIC protocol 
to yield T1 maps that distinguish spatial differences in cartilage quality within a single 
slice. This ability is important for longitudinal non-invasive follow-up measurement for 
(surgical) techniques to treat (focal) cartilage defects (e.g. microfracturing and autolo-
gous chondrocyte implantation 14, 126). The T1 maps generated revealed reproducible 
spatial differences in cartilage quality (ICC value of 0.79 with a 95% CI ranging from 0.57 
to 0.90). This ICC is lower than the anatomical ROIs (Table 1) and might be caused by 
using relatively small ROIs (mean number of voxels 115) compared with the anatomical 
cartilage ROIs (mean number of voxels 180). An outlier in the weighted mean T1 of one 
pixel in such an ROI might have a relatively large negative impact on the ICC value.
The clinical significance of this work is that, to our knowledge, this is the first study, 
which assesses the reproducibility of 3D dGEMRIC in early stage OA knees. Compared 
with previous research 87, 88, we used a higher field strength MR system and an auto-
mated registration method to analyze the dGEMRIC 123. In addition, our study popula-
tion (n=17) is two to three times larger than the populations of previous studies on 
dGEMRIC reproducibility. Based on the Bland–Altman plots, we determined a change 
of 95 ms in the weighted mean T1 relaxation time as a threshold to define a significant 
change in dGEMRIC outcome if a single person is followed over time in future studies, 
e.g. treatment efficacy studies, using our study protocol. Because of the differences in 
the dGEMRIC protocols, MRI equipment and post processing algorithms compared with 
other groups using dGEMRIC, we think that our threshold might not be generalizable to 
other centers. Therefore, we recommend that every group should calculate a threshold 
value as presented in this study for their own setup (dGEMRIC protocol, MRI system, 
etc.). We believe that establishing such a threshold value is absolutely essential in every 
longitudinal quantitative study, regardless of it being specific to the actual setup.
Despite the promising results, this study also has some limitations. We used a custom-
built knee coil to enable imaging of knees with a diameter > 14 cm. However, because 
of the open design, the SNR in the patellar cartilage region was insufficient. This may 
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have influenced the outcomes of the dGEMRIC analysis in the patellar cartilage and 
therefore, we decided not to analyze the patellar cartilage in our study. Another limi-
tation may be that we only analyzed the reproducibility of dGEMRIC in full thickness 
cartilage ROIs. This is contrary to Multanen et al 87, who described the reproducibility of 
dGEMRIC for each different zone (superficial, middle and deep) of the articular cartilage. 
However, because of the relatively low in-plane spatial resolution of the MR images in 
this study, we decided to analyze full thickness ROIs only.
Future research should focus on developing a pulse sequence for dGEMRIC with a 
higher in-plane resolution. Using such a sequence could enable an accurate visualiza-
tion and ROI selection of different zones within the cartilage as suggested recently 
127. Other future research should focus on developing an automated segmentation 
algorithm for articular cartilage. Combining such an auto-segmentation algorithm with 
an automated post processing pipeline, will enable analysis of all slices of the dGEMRIC 
procedure within a limited time instead of the laborious and time-consuming process 
of slice and ROI selection by hand.
In conclusion, the results of the present study show that in patients with early stage 
OA, 3D dGEMRIC of the knee at 3.0 T combined with 3D image registration is a highly 
reproducible measure of articular cartilage quality in anatomical ROIs. The technique 
also yields T1 maps that reproducibly distinguish spatial differences in cartilage quality 
over time. Finally, we defined a threshold of 95 ms to determine a significant change in 
dGEMRIC outcome if a single person is followed over time in future studies using our 
study protocol. Therefore, dGEMRIC may be a valuable tool to non-invasively evaluate 
cartilage quality changes in longitudinal research in patients with early stage OA and 
focal cartilage defects.
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validation and comparison of 
dGemrIC and T1rho-mapping 
as imaging biomarker in human 
osteoarthritis research
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T1rho-mapping has been proposed as a non-contrast-enhanced alternative to delayed 
gadolinium-enhanced MRI of cartilage (dGEMRIC) to quantify cartilage sulphated gly-
cosaminoglycan (sGAG) content. However, no thorough validation studies have been 
performed that compare both imaging biomarkers within the same osteoarthritis (OA) 
patients using reference standards for cartilage composition. We assessed if T1rho-
mapping can be used as an alternative to dGEMRIC for quantifying cartilage biochemi-
cal composition in vivo in human OA knees
materials and methods
Institutional review board study approval and written informed consent from partici-
pants was obtained. Twelve knee OA patients underwent dGEMRIC and T1rho-mapping 
at 3T before total knee replacement (TKR). Outcomes of dGEMRIC and T1rho-mapping 
were calculated in 6 cartilage regions of interest (ROI). Femoral and tibial cartilage 
were harvested during TKR. Cartilage sGAG and collagen content were assessed with 
dimethylmethylene blue and hydroxyproline assays, respectively. DGEMRIC and T1rho-
mapping were correlated with cartilage sGAG and collagen content.
results
dGEMRIC T1 relaxation times correlated strongly with cartilage sGAG (r=0.73, 95% con-
fidence interval (95%CI) 0.60-0.83) and weakly with cartilage collagen content (r=0.40, 
95%CI 0.18-0.58). T1rho relaxation times did not correlate with cartilage sGAG (r=0.04, 
95%CI -0.21-0.28), nor with cartilage collagen content (r=-0.05, 95%CI -0.31-0.20).
Conclusion
dGEMRIC can accurately measure cartilage sGAG content in vivo in human knee OA 
subjects whereas T1rho-mapping appears not suitable for this purpose. Although the 
technique is not completely sGAG specific and requires a contrast agent, dGEMRIC is 
a validated and robust method for quantifying cartilage sGAG content in human OA 
subjects in clinical research.




Knee osteoarthritis (OA) is the most common joint disease in middle-aged and elderly, 
causing serious morbidity and large socio-economic impact 8. Since no definitive treat-
ment options other than joint replacement surgery in end stage OA are available, 
research mainly focuses on novel interventions such as disease-modifying OA drugs. 
These should be effective in the early stages of OA by modifying the course of the 
disease, for example by improving cartilage biochemical composition 13, 128. To monitor 
the structural effectiveness of such novel interventions in early OA, accurate in vivo 
imaging biomarkers are essential. Therefore, quantitative biomarkers that measure 
cartilage biochemical composites, e.g. sulphated glycosaminoglycan (sGAG) content, 
have become of interest during the last decade 129.
An example of such a quantitative imaging biomarker to measure articular cartilage 
sGAG content is delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) 65. This 
technique utilizes the inverse relation between the amount of sGAG in cartilage and 
an intravenously administered negatively charged contrast agent. Although dGEMRIC 
is an established imaging biomarker for quantitative imaging of articular cartilage, the 
technique has disadvantages. These are mainly related to the contrast administration 
that increases costs and is potentially harmful for patients with impaired renal function, 
and the long delay between contrast administration and MR acquisition. Because of 
these drawbacks, T1rho-mapping was suggested as a non-contrast-enhanced alterna-
tive to dGEMRIC to measure cartilage sGAG content 128-130. T1rho-mapping quantifies 
the spin relaxation in the rotating frame by using a constant radiofrequency field 
referred to as a “spin lock” pulse to change relaxation rates of water associated with 
large macromolecules in cartilage such as sGAG 131, 132.
Although both dGEMRIC and T1rho-mapping are increasingly used as outcome 
measures for cartilage biochemical composition in clinical OA research, they have 
been validated mainly in vitro 67, 68 or ex vivo 133, 134 using bovine and cadaveric human 
cartilage. In vivo validation was performed in only one study for dGEMRIC 91 and only 
two studies for T1rho-mapping 69, 90. Besides, no study applied both imaging biomarkers 
in humans in vivo and compared the outcomes with a reference standard for cartilage 
sGAG content to validate and compare their performance. Finally, the influence of the 
cartilage extracellular matrix integrity, mainly provided by the collagen network, has 
not yet been studied in detail for dGEMRIC and T1rho-mapping.
The aim of this study was to assess if T1rho-mapping can be used as an alternative to 
dGEMRIC for quantifying cartilage biochemical composition in vivo in human OA knees.
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maTerIals and meThods
study design and participants
For this prospective observational study, conducted between October 2012 and De-
cember 2013, all consecutive patients scheduled for total knee replacement (TKR) at 
our institution were approached.
The inclusion criteria were: age  ≥  18 years and radiographic knee OA with asym-
metric distribution and a maximum of grade 1-2 (doubtful or definite osteophyte 
formation without definite joint space narrowing) according to Kellgren & Lawrence 
(KL) grading 28 in the least affected tibiofemoral compartment. Exclusion criteria were: 
renal insufficiency (glomerular filtration rate < 60 ml/min), history of previous reactions 
to contrast agent, or significant co-morbidities in the ipsilateral lower extremity (e.g. 
severe hip OA, neurologic or muscular diseases causing hip or knee disability), which 
prohibit exercising after contrast administration for dGEMRIC.
The study was approved by the Medical Ethical Committee of Erasmus MC (MEC-
2012-218) and written informed consent was obtained from all participants
mrI acquisition
One day before TKR, MRI was performed using a 3.0 Tesla MRI scanner (Discovery 
MR750, General Electric Healthcare, Milwaukee, USA) using a dedicated 8-channel knee 
coil (Invivo Inc., Gainesville, USA).
The MRI protocol included the following three pulse sequences, all acquired in the 
sagittal plane (specific imaging parameters shown in Table 1): (I) a 3D high resolution 
fat-saturated spoiled gradient-echo (SPGR) sequence, (II) a 3D fast spin-echo (FSE) 
T1rho-mapping sequence with five different spin lock times (TSL) 135 and (III) a 3D inver-
sion recovery (IR) non-fat-saturated SPGR sequence with five different inversion times 
(TI) for dGEMRIC 94.
Before dGEMRIC acquisition, a double dose (0.2 mmol per kg body weight) of gado-
pentetate dimeglumine (Magnevist®, Bayer Schering AG, Berlin, Germany) was injected 
intravenously as advocated previously 122. Subsequently, participants cycled for 10 
minutes on a home trainer at constant speed to promote contrast distribution into and 
throughout the knee. After a delay of 90 minutes, the IR SPGR sequence was acquired 95.
mrI analysis
Using Matlab (R2011a, The MathWorks, Natick, MA, USA), three cartilage regions of in-
terest (ROIs) in both tibiofemoral compartments were drawn: weight-bearing cartilage 
of the femoral condyles (wbFC), posterior non weight-bearing cartilage of the femoral 
condyles (pFC) and weight-bearing cartilage of the tibial plateaus (wbTP) (Figure 1). All 
ROIs consisted of 15 consecutive slices: the most central slice through the medial or 
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lateral tibiofemoral compartment (defined as the sagittal section depicting the most 
caudal point of the femoral condyle identified on multiplanar reconstructions of the 3D 
high resolution fat-saturated SPGR sequence) along with the neighboring seven slices 
medially and laterally. All ROIs were drawn on the high resolution SPGR images by a 
researcher with a medical degree and 4 years’ experience in musculoskeletal research 
(JvT).
sequence high resolution 
sPGr
T1rho-mapping dGemrIC
Plane Sagittal Sagittal Sagittal
Imaging mode 3D 3D 3D
Sequence SPGR FSE IR SPGR
Matrix (frequency) 512 288 288
Matrix (phase) 512 192 192
Number of slices 108 36 36
FOV (mm) 150 150 150
Slice thickness (mm) 1.0 3.0 3.0
TSL (ms) NA 1 / 16 / 32 / 64 / 125 NA
FSL (Hz) NA 500 NA
TI (ms) NA NA 2100 / 800 / 400 / 200 / 100
Flip angle (˚) 12 90 15
Bandwidth (Hz/pixel) 122 244 244
Number excitations averaged 0.75 0.5 1
Fat saturated Yes Yes No
Acquisition time (min) 05:37 05:43 14:18
Table 1: MRI protocol parameters. FOV: field of view; FSE: fast spin-echo; FSL: spin lock frequency; IR SPGR: inversion 
recovery spoiled gradient-echo; NA: not applicable; SPGR: spoiled gradient-echo; TI: inversion time; TSL: spin lock time
Figure 1: Representation of the three anatomical cartilage 
ROIs in which outcomes of dGEMRIC and T1rho-mapping 
were calculated in 15 consecutive slices in each compart-
ment of the tibiofemoral joint (lateral side shown in this ex-
ample). The posterior non-weight-bearing cartilage of the 
femoral condyle (pFC) is shown in red, the weight-bearing 
cartilage of the femoral condyle (wbFC) is shown in green 
and the weight-bearing cartilage of the tibial plateaus 
(wbTP) is shown in yellow.
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Image analysis was performed with Software for Post processing And Registration of 
Cartilage of the Knee 123, 136. The image analysis pipeline included registration to correct 
for patient motion and performed fitting of dGEMRIC post-contrast T1 (T1GD) and T1rho 
relaxation times. First, all images of the T1rho-mapping and dGEMRIC sequence with 
different TSL and TI values were registered to the TSL=1 ms and TI=2100 ms images. 
The femoral condyle and tibial plateau were registered separately. The images were 
registered using a 3D rigid transformation model by maximization of localized mutual 
information 103. To minimize the blurring of the registered images, cubic interpolation 
was used. All registrations were performed using open source registration software 
(Elastix, http://elastix.isi.uu.nl/) 144102. Second, both registered T1rho-mapping and 
dGEMRIC datasets were registered to the high resolution SPGR images. This registra-
tion was based on the TSL=1 ms and TI=2100 ms images; the other TSL and TI images 
were transformed accordingly. This second registration step allows analyzing matching 
cartilage ROIs on matching slices in both sequences.
After registration, T1rho- and dGEMRIC T1GD maps were estimated using a maximum 
likelihood fit. Before fitting, partial volume voxels for cortical bone within the cartilage 
ROIs were excluded by using a threshold. Next, weighted T1rho and T1GD relaxation 
times were calculated using the reciprocal of the uncertainty of the estimated T1rho 
and T1GD relaxation time in each voxel 123. This uncertainty was measured by the square 
root of the Cramér-Rao Lower Bound, which gives a lower bound for the standard de-
viation of the estimated T1rho or T1GD 96-98. If after registration T1rho- and T1GD-weighted 
images are not yet perfectly aligned, this might result in implausible T1rho and T1GD 
relaxation times especially at tissue boundaries. Using the weighted mean, these im-
plausible T1rho and T1GD relaxation times will not heavily influence the results of the 
analyses 123. Finally, as proposed by Tiderius et al., T1GD relaxation times were corrected 
for the participants’ body mass index (BMI) 137.
The weighted T1rho and T1GD relaxation times for each anatomical cartilage ROI were 
averaged over the 15 consecutive MR images. Thus, for each patient six mean T1rho 
and T1GD relaxation times from six cartilage ROIs were obtained.
harvesting of cartilage and biochemical cartilage analyses
During TKR, weight-bearing and non-weight-bearing femoral cartilage and weight-
bearing tibial cartilage were harvested and stored in saline for 30 minutes to one hour 
before further processing in the laboratory. Depending on size of the specimen, four 
(posterior femoral cartilage), six or eight (weight-bearing femoral and plateau cartilage, 
number of explants depending on specimen size) full thickness cartilage explants of 6 
mm diameter were taken using a biopsy punch, corresponding with cartilage of the 
ROIs analyzed with dGEMRIC and T1rho-mapping. All explants were cut in halves and 
stored separately in airtight tubes at -20 °C.
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Before biochemical analysis, explants were thawed at room temperature. One half 
was digested in a papain solution overnight and used to quantify sGAG content with 
the dimethylmethylene blue (DMMB) assay as described by Farndale et al. 138. The other 
half of each explant was not digested and used to quantify collagen content based 
on the hydroxyproline content as described by Bank et al. 139. This assay quantifies the 
degraded as well as the intact collagen content. The outcomes of both measures were 
summed together resulting in the total collagen content per explant. For each cartilage 
ROI, the mean sGAG or collagen content was calculated by adding up the sGAG or 
collagen content of each explant analyzed and dividing this by the numbers of explants 
taken from that specific ROI.
statistical analysis
To assess the correlation between T1GD and T1rho relaxation times and the reference 
tests (sGAG and collagen content) simultaneously, a multivariate mixed-effects model 
was applied. To take into account the potential intrinsic correlation between outcomes 
of different anatomical ROIs within one participant, a random intercept was included 
in the model. The Pearson’s correlation coefficient of dGEMRIC or T1rho-mapping and 
each reference test were extracted from the results of this model. The analysis was per-
formed using a Bayesian approach with Markov chain Monte Carlo (McMC) sampling 
using WinBugs 140. For all Pearson’s correlation coefficients the 95% confidence interval 




Fourteen patients participated in the study. Two participants were excluded because 
their TKR was postponed after inclusion. Therefore, 12 participants (6 women and 6 left 
knee joints) were analyzed. In one participant T1rho-mapping data were unavailable 
since its acquisition failed. Three cartilage specimens (one posterior non weight-bearing 
cartilage specimen of the lateral femoral condyle and two weight-bearing cartilage 
specimens of the medial tibial plateau) were severely damaged during surgery and 
were excluded from the analysis. Mean age of the participants was 64 (standard devia-
tion ± 6) years and their mean body mass index was 33 (± 6) kg/m2. The KL grades in 
the medial tibiofemoral compartments were 3 or 4 in 7 participants and 1 or 2 in 4 
participants. The KL grades in the lateral tibiofemoral compartments were 1 or 2 in 9 
participants and 3 in 2 participants.
Jasper Tiel - Binnenwerk cp7.indd   59 30-09-15   10:34
60
Correlation of dGemrIC and T1rho-mapping with biochemical cartilage 
analyses
T1GD relaxation times for all femoral and tibial cartilage ROIs correlated strongly with 
cartilage sGAG content measured using the DMMB assay (n=69, r=0.73, 95% confidence 
interval (95%CI) 0.60 to 0.83; Figure 2A) and weakly with cartilage collagen content mea-
sured using the hydroxyproline assay (n=69, r=0.40, 95%CI 0.18 to 0.58; Figure 2B). When 
each ROI was analyzed separately, the correlation coefficients between outcomes of 
dGEMRIC and sGAG content ranged from 0.70 to 0.80. For the correlation between 
dGEMRIC and collagen content, the range of correlation coefficients was 0.30 to 0.49.
T1rho relaxation times for all femoral and tibial cartilage ROIs did neither correlate 
with cartilage sGAG content (n=63, r=0.04, 95%CI -0.21 to 0.28; Figure  3A), nor with 
cartilage collagen content (n=63, r=-0.05, 95%CI -0.31 to 0.20; Figure  3B). A range of 
-0.07 to 0.06 was observed for the correlation coefficients between T1rho relaxation 
Figure 2: Correlation plots of mean T1GD relaxation times in all anatomical ROIs with sGAG content of the cartilage 
measured and DMMB assay (A) and outcomes of dGEMRIC and collagen content of the cartilage measured with hy-
droxyproline assay (B). The dashed lines indicate the 95% confidence interval of the Pearson’s correlation coefficient.
Figure 3: Correlation plots of mean T1rho relaxation times in all anatomical ROIs with sGAG content of the cartilage 
measured and DMMB assay (A) and outcomes of T1rho-mapping and collagen content of the cartilage measured 
with hydroxyproline assay (B). The dashed lines indicate the 95% confidence interval of the Pearson’s correlation coef-
ficient.
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times and sGAG content for all separate cartilage ROIs in both knee compartments. 
This range was -0.18 to 0.10 for the correlation between T1rho-mapping and collagen 
content.
Figure 4 shows images representative for cartilage with relatively high and low sGAG 
content measured using dGEMRIC, T1rho-mapping, equilibrium partitioning of an ionic 
contrast agent using micro-CT (EPIC-μCT: visual representation of sGAG content) and 
histology (visual representation of sGAG content using Safranin-O staining). These im-
ages confirm the strong correlation between dGEMRIC and cartilage sGAG.
Figure 4: Spatial agreement between MRI, EPIC-μCT and histology. Representative images of matching sagittal slides 
of dGEMRIC and T1rho-mapping, EPIC-μCT and histology. The relaxation time and/or attenuation of cartilage are vi-
sualized in color and representative for sGAG content. In dGEMRIC high T1GD represent high sGAG content and low T1GD 
represent low sGAG content. In T1rho mapping the opposite is true for T1rho relaxation times. In EPIC-μCT high attenu-
ation represents a low sGAG content of cartilage and a low attenuation represents high sGAG content. The intensity 
of the sGAG staining in histology is representative for sGAG content. A high intensity represents high sGAG content 
and a low intensity or discoloration represents a low or absent sGAG content. The top row shows visual agreement for 
dGEMRIC and disagreement for T1rho-mapping in relative high cartilage sGAG content and the bottom row shows 
the same for a relative low cartilage sGAG content in the superficial and partially mid zone of the cartilage. Visual slice 
matching was performed for the histological slices.
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dIsCussIon
Quantitative imaging biomarkers that measure cartilage biochemical composition 
non-invasively are needed for development and monitoring of new treatments for 
osteoarthritis. For this purpose, dGEMRIC is increasingly used to measure cartilage 
sGAG content, but the technique has drawbacks related to the use of a contrast agent. 
Therefore, T1rho-mapping was proposed as a non-contrast-enhanced alternative. 
Since, to our knowledge, a thorough in vivo comparison and validation study was lack-
ing, our aim was to assess if T1rho-mapping can be used as an alternative to dGEMRIC 
for quantifying cartilage biochemical composition in vivo in human OA knees.
Our results showed that outcomes of in vivo dGEMRIC in OA patients correlated 
strongly with cartilage sGAG content measured using the DMMB assay. This indicates 
that dGEMRIC acquired in vivo accurately measures sGAG content in OA patients. These 
results are consistent with previous research showing a strong correlation between 
T1GD relaxation times acquired in vitro and ex vivo in cadaveric animal cartilage post 
microfracture treatment and human OA cartilage 65, 141. The results are also in agree-
ment with the only in vivo validation study of dGEMRIC performed by Watanabe et al. 
in 2006 reporting a strong correlation (r=0.82) between outcomes of dGEMRIC after 
treatment of focal cartilage defects and cartilage sGAG content measured using high-
performance liquid chromatography in nine cartilage explants 91.
We found a weak correlation between outcomes of dGEMRIC and the amount of 
collagen in the articular cartilage (correlation with intact collagen content measured 
using the hydroxyproline assay was comparable, no correlation between dGEMRIC and 
degraded collagen content: data not shown). Despite the weak correlation, this finding 
suggests that in addition to sGAG content, the integrity of cartilage extracellular matrix 
also influences contrast influx into cartilage. Therefore, dGEMRIC outcomes appear 
not only dependent on sGAG content, which was recently also suggested by others 
142, 143. The difference between the strength in correlation between the outcomes of 
dGEMRIC and cartilage sGAG and collagen content, however, suggests that sGAG is 
the composite that influences contrast distribution throughout articular cartilage most.
We did not observe any correlation between T1rho relaxation times and cartilage 
sGAG content. These results are surprising when compared to previous in vitro and ex 
vivo research in which T1rho relaxation times correlated moderately to strongly with 
sGAG amount in bovine and human cartilage 68, 69. Our results, however, are more 
consistent with one of the two previous in vivo validation studies of T1rho-mapping 
which showed only a weak correlation (r=0.44) between T1rho relaxation times and 
sGAG content in the lateral tibial plateau cartilage of 20 OA patients 90. A possible 
explanation for the difference in strength of reported correlation values between in 
vivo and in vitro or ex vivo acquired T1rho-mapping and cartilage sGAG content may be 
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the differences in specific acquisition parameters. For example, number and duration 
of TSLs, field of view and in-plane image matrix are usually different for in vitro or ex vivo 
67, 68, 133 compared to in vivo experiments 69, 90, 131. Optimizing these parameters might 
improve the ability of T1rho-mapping to assess cartilage sGAG content, but will likely 
increase acquisition time. Moreover, the spin lock frequency (FSL) was usually higher in 
vitro or ex vivo 67, 132 compared to in vivo 69, 90. Higher FSL causes less B0 inhomogeneity, 
possibly improving accuracy of T1rho-mapping, but increased FSL is a limiting factor in 
vivo since it induces higher specific absorption rate 129. T1rho-mapping acquired with 
an FSL higher than 500 Hz has been described to be safe 132, but we applied a 500 Hz 
FSL since this is most commonly used in vivo, enabling us to compare our results with 
previous literature. Another option to improve T1rho-mapping would be to acquire a 
B0 map to correct for B0 inhomogeneity. Thus, different results may be obtained if the 
acquisition is optimized in future research.
T1rho relaxation times also did not correlate with cartilage collagen content (also no 
correlation with intact and degraded collagen content measured using the hydroxy-
proline assay: data not shown). While this finding is consistent with previous research in 
human cartilage after TKR 134, it suggests that T1rho-mapping measures other elements 
of cartilage, e.g. water content or a combination of composites of the cartilage extracel-
lular matrix.
The results of our study suggest that, despite the need of contrast agent and rela-
tively long delay between contrast administration and MR acquisition, dGEMRIC can 
still be regarded a good method to quantify cartilage sGAG content in human knee OA. 
T1rho-mapping appears less suitable for this purpose. However, because of its ability 
to discriminate between healthy subjects, mild and moderate OA patients 89, relatively 
short acquisition time and the fact that T1rho-mapping does not require a contrast 
agent, it may still be a valuable imaging biomarker in large clinical or population based 
OA research studies.
A potential drawback of our study is the use of OA patients undergoing TKR, whereas 
dGEMRIC and T1rho-mapping are advocated as imaging biomarkers in early stage OA 
13, 128. However, in our opinion this is the only human study population that allows com-
parison of in vivo acquired imaging biomarkers against ex vivo references standards per-
formed on cartilage specimens. To minimize the potential of bias we included patients 
with asymmetrical radiographic OA distribution who nevertheless were indicated for 
TKR. This way we ended up analyzing cartilage with a relatively wide range in quality 
and sGAG content.
Furthermore, it is important to note that the dGEMRIC sequence we used consisted 
of an IR SPGR protocol, while dGEMRIC can also be acquired using IR FSE or gradient 
echo sequences with variable flip angles or a Look-Locker method 129. Likewise, our 
T1rho-mapping protocol consisted of a 3D FSE pulse sequence while others may have 
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used different approaches. Therefore, our results may not be directly generalizable to 
other research institutes applying other acquisition protocols for dGEMRIC and T1rho-
mapping. However, the T1GD and T1rho relaxation times obtained in our study are 
within the same range as those reported by others using different dGEMRIC and T1rho-
mapping protocols at 3.0 T 129. Future research may compare the outcomes of different 
protocols for dGEMRIC and T1rho-mapping in patients with knee OA. Such studies may 
also compare dGEMRIC and T1rho-mapping with other recently introduced biomarkers 
to measure cartilage sGAG content, e.g. gagCEST or sodium MRI 129.
In conclusion, our results show that dGEMRIC can accurately measure cartilage 
sGAG content in vivo in human knee OA subjects whereas T1rho-mapping appears not 
suitable for this purpose. Although the technique is not completely sGAG specific and 
requires a contrast agent, dGEMRIC is a validated and robust method for quantifying 
cartilage sGAG content in human OA subjects in clinical research.
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viscosupplementation in patients 
with early stage knee osteoarthritis
J. van tiel, M. reijman, P.k. Bos, J. hermans, 
g.M. van Buul, e.e. Bron, s. klein, J.a. verhaar, 
g.P. krestin, s.M. Bierma - Zeinstra, h. Weinans, 
g. kotek, e.h. oei.
Plos one. 2013 nov;8(11):e79785.




Viscosupplementation with hyaluronic acid (HA) of osteoarthritic (OA) knee joints has 
a well-established positive effect on clinical symptoms. This effect, however, is only 
temporary and the working mechanism of HA injections is not clear. It was suggested 
that HA might have disease-modifying properties because of its beneficial effect on 
cartilage sulphated glycosaminoglycan (sGAG) content. Delayed gadolinium-enhanced 
MRI of cartilage (dGEMRIC) is a highly reproducible, non-invasive surrogate measure for 
sGAG content and hence composition of cartilage. The aim of this study was to assess 
whether improvement in cartilage structural composition is detected using dGEMRIC 
14 weeks after 3 weekly injections with HA in patients with early stage knee OA.
materials and methods
In 20 early stage knee OA patients (KLG I-II), 3D dGEMRIC at 3T was acquired before and 
14 weeks after 3 weekly injections with HA. To evaluate patient symptoms, the knee 
injury and osteoarthritis outcome score (KOOS) and a numeric rating scale (NRS) for 
pain were recorded. To evaluate cartilage composition, six cartilage regions in the knee 
were analyzed on dGEMRIC. Outcomes of dGEMRIC, KOOS and NRS before and after HA 
were compared using paired t-testing. Since we performed multiple t-tests, we applied 
a Bonferroni-Holm correction to determine statistical significance for these analyses.
results
All KOOS subscales (‘pain’, ‘symptoms’, ‘daily activities’, ‘sports’ and ’quality of life’) and 
the NRS pain improved significantly 14 weeks after viscosupplementation with HA. 
Outcomes of dGEMRIC did not change significantly after HA compared to baseline in 
any of the cartilage regions analyzed in the knee.
Conclusion
Our results confirm previous findings reported in the literature, showing persisting 
improvement in symptomatic outcome measures in early stage knee OA patients 14 
weeks after viscosupplementation. Outcomes of dGEMRIC, however, did not change 
after viscosupplementation, indicating no change in cartilage structural composition 
as an explanation for the improvement of clinical symptoms.




Knee osteoarthritis (OA) is the most common joint disease in middle-aged and elderly, 
causing serious morbidity and large socio-economic impact 7, 108, 109. The current treat-
ment strategies for OA, however, are limited and end-stage OA is treated with invasive 
joint replacement surgery. An important drawback of this surgery is the limited durabil-
ity of joint prostheses and hence the need for revision if implanted in relatively young 
patients. Therefore, OA research focuses on the development of disease-modifying 
osteoarthritic drugs (DMOADs) which may allow treatment before OA reaches its end-
stage 13. Hyaluronic acid (HA) improves the viscoelastic properties of synovial fluid 144 
and intra-articular injections with HA are nowadays frequently used as a viscosupple-
ment in the treatment of knee OA 145. Recently, a Cochrane review on the efficacy of 
viscosupplementation with HA in knee OA reported significantly good, but temporary 
clinical effects on pain, function and patient global assessment with the highest effect 
sizes between 5 and 14 weeks after viscosupplementation if high-molecular-weight HA 
derivatives are used 146.
The working mechanism of HA injections, however, is not yet clear. It has been sug-
gested that viscosupplementation, in addition to symptomatic benefits, may also have 
disease-modifying properties in OA 147, 148. As a possible pathway for disease modifica-
tion, previous in vitro research showed that HA has a beneficial effect on chondrocytes 
that are stimulated to produce proteoglycans (PG) 149-152. PGs, which mainly consist of 
sulphated glycosaminoglycan (sGAG), are one of the main components of the extracel-
lular matrix of articular cartilage 56, 153. It is known that PGs are depleted in the early 
stages of OA, long before cartilage degeneration is visible as joint space narrowing 
on radiography 116. Therefore, radiography is considered an inappropriate imaging tool 
for detection and follow-up of early stage OA in clinical research 33. Moreover, com-
mon magnetic resonance imaging (MRI) techniques that assess cartilage morphology 
alterations have also shown to be insensitive to detect subtle changes in biochemical 
cartilage composition 49, 50. In order to diagnose OA in early stage disease and detect 
intervention-caused biochemical changes sensitively during follow up, sophisticated 
MRI techniques have been developed during the last decade. These techniques provide 
a quantitative measure of the amount of sGAG, collagen or sodium of articular cartilage 
and therefore are a measure for cartilage structural composition 154, 155.
An example of such a MRI technique to measure cartilage structural composition 
is delayed gadolinium-enhanced MRI of cartilage (dGEMRIC). The technique uses the 
inverse relation between a negatively charged contrast agent and the sGAG content of 
cartilage and therefore provides an indirect quantitative outcome measure for cartilage 
sGAG content 65, 93. Because of its ability to serve as a non-invasive indirect measure for 
cartilage structural composition, dGEMRIC has become a standard for assessment of 
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articular cartilage sGAG content in OA research. Recently, dGEMRIC was also shown to 
be a highly reproducible surrogate outcome measure of cartilage sGAG content over 
time in early stage OA knees 136. Since other direct outcome measures such as cartilage 
biopsies are usually not ethically accepted, dGEMRIC is considered a suitable tool to 
non-invasively evaluate potential structure modification in terms of sGAG content 
improvement in articular cartilage.
Based on the aforementioned literature, we hypothesize that the improvement in 
clinical symptoms after HA injections will be corroborated by an improvement in sGAG 
content in the articular cartilage. Therefore, the aim of this study was to assess whether 
improvement in structural composition of cartilage is detected using dGEMRIC 14 
weeks after 3 weekly injections with HA in patients with early stage knee OA.
maTerIals and meThods
study design and participants
For this prospective follow-up study conducted between March and September 2011, 
we recruited and included 20 participants with early stage OA of the knee from the 
outpatient clinic of the Department of Orthopedic Surgery of our institution. This 
sample size was based on an expected difference in T1 relaxation time of at least 95 
ms which has been shown to represent a clinically relevant improvement in cartilage 
sGAG content as measured by 3D dGEMRIC of early stage OA knees acquired at 3.0 
Tesla 136, a standard deviation of 100 ms of T1 relaxation times with 3D dGEMRIC of early 
stage OA knees acquired at 3.0 Tesla, an α of 0.008 (corrected for multiple testing using 
Bonferroni-Holm method: see statistical analysis), a power of 0.8 and a maximum lost to 
follow-up of 10% of the included participants.
We were not able to include a control group in this study, because this was con-
sidered unethical by the Institutional Review Board (IRB). However, this was not a 
problem because it was not our aim to assess the potential clinical improvement of 
HA injections compared to a placebo or non-treated participant group. Such studies 
have already been performed and have shown a clinical improvement of HA injections 
compared to placebo 145, 146. Moreover, OA is generally a slow progressing disease in 
which no significant change in dGEMRIC outcomes was found at 14, 24 and 48 weeks 
follow-up compared to baseline in the control groups (n=15 and n=10 respectively) of 
two randomized controlled trials consisting of mild to moderate knee OA patients 156, 
157. Thus, the absence of a control group was not considered a limitation to address our 
study aim, i.e. the assessment of potential sGAG increase in an index group treated with 
viscosupplementation. Based on the aforementioned results we expect that dGEMRIC 
would have detected minor and non-significant changes in sGAG content of the car-
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tilage in a control group of non-treated early stage OA patients between the baseline 
and follow-up measurement 14 weeks later.
The inclusion criteria for our study were: participants age > 18 years, knee pain dura-
tion > 3 months, severity of knee pain > 2 out of 10 on a numeric rating scale (NRS) for 
pain (score from 0 - 10: the higher the score, the more knee pain) 117, and radiographic 
knee OA with a Kellgren and Lawrence grade of 1 or 2 28. Exclusion criteria were: visco-
supplementation in the index knee within the last year, glucocorticoid injection(s) in 
the index knee within the last three months, absolute contra-indications to undergo 
MRI, renal insufficiency (glomerular filtration rate  <  60 ml/min), a history of contrast 
medium allergy, significant co-morbidities in the lower extremity containing the index 
knee joint, knee surgery in the index knee within the last year or knee surgery sched-
uled in the index knee within the next half year.
Written informed consent was obtained from all participants and the study was ap-
proved by the IRB (Medical Ethical committee of the Erasmus MC, protocol number 
MEC-2010-088).
study protocol
Within two weeks before viscosupplementation of the index knee, a baseline dGEMRIC 
examination and routine MRI sequences of the index knee were acquired in all partici-
pants. Participants were also asked to rate their knee complaints on the Knee injury and 
Osteoarthritis Outcome Score (KOOS) 158. The KOOS consists of 5 subscales (score from 
0-100, the lower the score, the more knee symptoms in that subscale): ‘pain’, ‘symptoms’, 
‘activities of daily living’ (ADL), ‘sport and function’ (sport), and ‘knee-related quality of 
life’ (QoL) and was validated in Dutch for early stage OA patients by De Groot et al. in 
2008 159. In addition to the KOOS, all participants were asked to rate their knee pain on 
a NRS for pain. The NRS is a numeric rating scale for pain (score from 0 – 10: the higher 
the score, the more knee pain) comparable with the visual analogue scale for pain, but 
is easier to use for patients because pain can be expressed as a number 117.
After obtaining the baseline measurements, viscosupplementation was performed 
using an intra-articular injection with Hylan G-F 20 (Synvisc®, Genzyme Corp, Cam-
bridge, USA). With a time interval of one week between the injections, three injections 
with Hylan G-F 20 were provided by an experienced orthopedic surgeon according to 
a standardized protocol using a superolateral approach 160.
Follow-up measurements (dGEMRIC examination and routine MRI sequences, KOOS 
questionnaire, and NRS for pain) were obtained 14 weeks after viscosupplementation 
with HA. We chose a 14 weeks interval between viscosupplementation and follow-up 
measurements because the highest clinical effect sizes of intra-articular injections with 
HA have been reported between 5 and 14 weeks after treatment 146.
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acquisition of dGemrIC and routine mrI sequences
Before MR imaging, a double dose (0.2 mmol/kg) of gadopentetate dimeglumine 
(Magnevist®, Bayer Schering AG, Berlin, Germany) was injected intravenously based on 
the participants’ weight 122. For the follow-up dGEMRIC examination, we used the same 
amount of contrast agent as we used for the baseline dGEMRIC examination. This way, 
the outcomes of the follow-up dGEMRIC are not biased by the participants’ body mass 
index (BMI) 137. After contrast administration, the participants were asked to cycle for 
10 minutes on a home trainer at constant speed to promote contrast distribution into 
and throughout the knee and the articular cartilage 95. After cycling and a delay of 80 
minutes, the dGEMRIC images were acquired.
MR imaging was performed on a 3.0 Tesla MRI scanner (Discovery MR750, General 
Electric Healthcare, Milwaukee, WI, USA) using a custom made 3 channel knee coil 
(Flick Engineering Solutions B.V., Winterswijk, The Netherlands) 123, 136. We used a three-
dimensional (3D) dGEMRIC protocol, which was acquired in the sagittal plane and was 
previously published by McKenzie et al. 94. The dGEMRIC protocol consisted of an inver-
sion recovery fast spoiled gradient-echo sequence, which was acquired for five times 
with different inversion times (TI=2100; 800; 400; 200 and 100 ms). The other scanning 
parameters were constant during scanning: matrix 256 x 232 pixels; field of view 150 
mm; slice thickness 3 mm; flip angle 15º; echo time 1.5 ms and repetition time (TR) 
3.9 ms, pixel bandwidth 488 Hz/voxel and number of averages 1. The total acquisition 
time was approximately 14 minutes, resulting in 36 sagittal MR images with complete 
coverage of the knee joint.
In addition to dGEMRIC scans, three routine sequences consisting of a fast spin echo 
(FSE) proton density weighted sequence (sagittal and axial plane) and a coronal FSE 
T2-weighted sequence with fat suppression were acquired to allow morphological 
evaluation of the cartilage and incidental findings (e.g., chondroid tumors, bone tumors, 
etc.) in the knee. The scanning time of the additional sequences was approximately 11 
minutes, resulting in a total scanning time of approximately 25 minutes for the entire 
MRI protocol.
dGemrIC analysis
Using Matlab (R2011a, The MathWorks, Natick, MA, USA), three cartilage regions of 
interest (ROIs) were drawn manually on three consecutive images through the lateral 
and medial tibiofemoral joint (central image and one adjacent image on each side) by 
a researcher with a medical degree and 4 years of experience in this research field (JvT). 
These qualifications were considered sufficient, especially since Tiderius and colleagues 
showed that the experience of the investigator does not affect the variability of manual 
ROI selection in dGEMRIC 121.
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ROI selection was standardized and based on the scheme suggested by Eckstein et 
al. 120. These anatomical landmark based ROIs were drawn on the TI=2100 ms images 
of the first dGEMRIC examination and consisted of the weight-bearing cartilage of the 
femoral condyles (wbFC), the posterior non weight-bearing cartilage of the femoral 
condyles (pFC) and the weight-bearing cartilage of the tibial plateaus (wbTP) (Figure 1).
During acquisition of dGEMRIC, patient motion might occur. This patient motion 
may cause errors and imprecision in the outcomes of dGEMRIC, but image registration 
can correct for patient motion within dGEMRIC 85. To correct for patient motion, we 
used an in-house developed registration and T1-fitting algorithm (Software for Post 
processing And Registration of Cartilage of the Knee: SPARCK) that was previously 
published 123. In the registration part of the algorithm, first all images with different TI 
values were aligned to the TI=2100 ms images. The femoral condyle and tibial plateau 
were registered separately. The images were registered using a 3D rigid transformation 
model by maximization of localized mutual information. To minimize the blurring of 
the registered images, cubic interpolation was used 103. The registration was performed 
separately for the baseline and follow-up dGEMRIC acquisitions. All registrations were 
performed using open source registration software (Elastix, http://elastix.isi.uu.nl/) 102. 
After the first step, the follow-up examination is registered to the baseline examination 
based on the images with TI=2100 ms, the other TI images of the follow-up acquisition 
are transformed accordingly. Automated registration of baseline and follow-up scans 
eliminates subjective visual slice matching and also eliminates the need to manually 
outline the cartilage ROIs in the follow-up scan.
For the registered dGEMRIC baseline and follow-up datasets, T1 maps were estimated 
using a maximum likelihood fit 123. After injection with Magnevist®, cartilage regions with 
long T1 relaxation time have relatively high sGAG content compared to cartilage regions 
Figure 1: Central sagittal MR image through the lateral tib-
iofemoral joint. The three anatomical cartilage ROIs which 
were drawn and analyzed on three consecutive images in 
each compartment of the tibiofemoral joint are shown. 
wbFC (green): weight-bearing cartilage of the femoral con-
dyle. pFC (yellow): posterior non weight-bearing cartilage 
of the femoral condyle. wbTP (red): weight-bearing carti-
lage of the tibial plateau.
Jasper Tiel - Binnenwerk cp7.indd   75 30-09-15   10:34
76
with short T1 relaxation time which indicates reduced sGAG content 65, 95. All possible par-
tial volume pixels for the cortical bone in the cartilage ROIs were automatically excluded 
for the ROIs using a patient specific bone-cartilage threshold which removed bone pixels 
for the manually drawn ROI before calculating the T1 relaxation time in all ROIs. Finally, 
in all cartilage ROIs, the weighted T1 relaxation time per ROI was calculated, where the 
estimated T1 relaxation time of each  voxel was weighted by the reciprocal of its un-
certainty. The uncertainty was measured by the square root of the Cramér-Rao Lower 
Bound, which gives a lower bound for the standard deviation of the estimated T1 96-98. Re-
sidual misalignment of the T1-weighted images, especially at tissue boundaries, results 
in biologically implausible values of T1, often associated with great uncertainty. Using 
the weighted mean, these implausible T1 relaxation times will not heavily influence the 
calculated mean T1 relaxation times in the determined cartilage ROIs 123.
The weighted T1 relaxation times for each anatomical cartilage ROI were averaged 
over the three consecutive MR images. This way we used the available 3D informa-
tion instead of only using a single MR slice (2D analysis) in both the medial and lateral 
compartment of the knee as in most previous studies using dGEMRIC. Thus, for each 
patient in each dGEMRIC examination, six weighted average T1 relaxation times from 
six anatomical cartilage ROIs were obtained.
morphological cartilage analysis
On the routine MRI sequences, the articular cartilage was scored for cartilage defects 
according to the MRI Osteoarthritis Knee Score (MOAKS) as described by Hunter et al. 43. 
Both the baseline and the follow-up MRI were read by an experienced musculoskeletal 
radiologist (EO).
statistical analysis
We tested our data for normality and equal variance using the Kolmogorov-Smirnov 
and Levene’s test. The outcomes of these tests showed normality and equal variance 
of our data. We used paired t-tests to compare the outcomes of dGEMRIC in each 
anatomically defined cartilage ROI between follow-up and baseline. The same tests 
were used to compare the outcomes of each KOOS subscale and the NRS for pain 14 
weeks after HA injections with the baseline outcomes. Since six cartilage ROIs and six 
subscales of questionnaires (KOOS and NRS were analyzed together) were compared 
between baseline and follow-up using six paired t-tests, we applied a Bonferroni-Holm 
correction 161 to define statistically significant p-values for these analyses. We present 
both the crude, as well as the adjusted p-values to determine whether a particular 
test result is statistically significant after Holm’s adjustment of the p -values 162. P-values 
of  <  0.05 were considered statistically significant. All analyses were performed using 
SPSS 20.0 (SPSS Inc., Chicago, IL, USA).





We included 20 participants (eight female) with early stage OA of the knee (seven left 
knee joints). Their mean age at the time of inclusion was 48 ± 11 years and their mean 
BMI was 29 ± 5 kg/m2.
On radiography, 11 participants had early stage OA in the medial tibiofemoral com-
partment. Two participants only had OA in the lateral tibiofemoral and 7 participants had 
OA in both knee compartments. No incidental findings were observed on routine MRI.
All baseline measurements were obtained two weeks (range 8  –  16 days) before 
viscosupplementation of the index knee with HA. The mean time between the first 
and second and second and third HA injection was 7 ± 0 days for all participants. All 
follow-up measurements were obtained 14 weeks (range 14 - 16 weeks) after visco-
supplementation. All included patients completed both the baseline and the follow-up 
measurements.
dGemrIC outcomes
At baseline, mean T1 relaxation times ranged from 461 to 491 ms in the three differ-
ent cartilage regions in the medial tibiofemoral compartment. The mean T1 relaxation 
times in the lateral compartment were higher than those in the medial compartment 
and ranged from 475 to 581 ms in the different regions (p-value  =  0.0006) (Table  1). 
At 14 weeks follow-up, the mean T1 relaxation times in the medial compartment of 
the knee ranged from 456 to 520 ms and in the lateral compartment from 498 to 579 
(p-value = 0.04) (Table 1).
We did not observe a statistically significant change in T1 relaxation times in any of 
the analyzed cartilage regions between the baseline measurements and the follow-up 
measurements (all adjusted p-values > 0.05) (Table 1). In Figure 2, an example of a partici-
pant without change in cartilage T1 relaxation times and hence cartilage composition 
after HA injections is shown.
In two ROIs (wbFC and wbTP) in the lateral knee compartment and one ROI in the me-
dial compartment (wbFC), a trend towards a decrease in indirectly measured cartilage 
sGAG content in terms of lower mean T1 relaxation times was observed (Figure 3). In 
one ROI in the lateral compartment (pFC) and in two ROIs in the medial compartment 
(pFC and wbTP), mean T1 relaxation times after viscosupplementation showed a trend 
towards improvement compared to baseline (Figure  3). These trends were, however, 
neither statistically significant, nor exceeded a previously determined threshold of 
95 ms for clinically relevant improvement in cartilage sGAG content measured using 
dGEMRIC 136.
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Differences in T1 relaxation times at follow-up reached this threshold only in seven 
participants in a single cartilage ROI (3 times lateral pFC, 3 times medial pFC and 1 time 
lateral wbTP: data for each individual participant not shown). In the other ROIs in these 
participants, this 95 ms threshold was not reached. In the remaining 13 participants, the 
threshold for T1 improvement was not reached in any of the analyzed cartilage ROIs.
morphological cartilage analysis
On the routine MRI sequences, a total of 240 cartilage regions were assessed for car-
tilage lesions using the MOAKS criteria. A total of 21 regions were diagnosed with a 
Cartilage roI
mean T1 at 
baseline
(95% CI)











Weight-bearing femoral 512 (478 – 546) ms 510 (482 – 538) ms 0.89 0.89
Posterior femoral 475 (434 – 516) ms 487 (450 – 524) ms 0.42 > 0.99
Weight-bearing tibia 581 (529 – 633) ms 579 (526 – 630) ms 0.85 > 0.99
Medial tibiofemoral 
compartment
Weight-bearing femoral 461 (417 – 505) ms 456 (411 – 500) ms 0.64 > 0.99
Posterior femoral 488 (432 – 544) ms 520 (470 – 569) ms 0.04 0.24
Weight-bearing tibia 491 (441 – 541) ms 512 (466 – 558) ms 0.09 0.45
Table 1: Mean T1 relaxation times with 95% confidence interval for the mean in milliseconds at baseline and at 14 
weeks follow-up after HA injections (n=20 for each anatomical cartilage ROI). 95% CI: 95% confidence interval.
Figure 2: Representative sagittal central MR image through the medial tibiofemoral compartment of an early stage 
OA knee before (A) and after (B) viscosupplementation with HA. The T1 color map of the cartilage clearly shows a re-
gion with relatively lower T1 relaxation times (grey arrows in A), indicating relatively lower sGAG content in the weight-
bearing femoral cartilage before viscosupplementation (A). After HA injections (B), however, the region with relatively 
low T1 relaxation times is still present (grey arrows in B).
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cartilage lesion (6 in the lateral and 15 in the medial compartment) and 219 regions 
showed normal cartilage morphology. Eight full thickness cartilage defects were ob-
served at baseline in 3 participants. Thirteen partial cartilage lesions were observed in 
11 participants. All cartilage lesions had a size of either <10% or 10-75% of the region 
of cartilage surface area. No progression in any partial and full thickness size or progres-
sion from partial to full thickness cartilage lesions was observed at 14 weeks follow-up.
Koos and nrs outcomes
All KOOS subscales, ‘pain’ (mean at baseline: 48, mean at follow-up: 66, crude p-
value = 0.0003, adjusted p-value = 0.002), ‘symptoms’ (mean at baseline: 49, mean at 
follow-up: 56, crude p-value = 0.03, adjusted p-value = 0.03), ‘ADL’ (mean at baseline: 55, 
mean at follow-up: 72, crude p-value = 0.0007, adjusted p-value = 0.003), ‘sports’ (mean 
at baseline: 20, mean at follow-up: 35, crude p-value = 0.004, adjusted p-value = 0.01), 
and ‘QoL’ (mean at baseline: 28, mean at follow-up: 38, crude p-value = 0.01, adjusted 
p-value = 0.02), improved significantly 14 weeks after HA injections in the knee (Fig-
ure 4). The mean NRS pain score at baseline was 7 and improved significantly (crude 
p-value < 0.0001, adjusted p-value < 0.0001) to a mean of 4 14 weeks after HA injections 
(Figure 4).
Figure 3: Bar graphs showing the differences in dGEMRIC T1 relaxation times in each anatomical cartilage ROI at 
follow-up, 14 weeks after HA injections compared to baseline. The bar represents the mean and the whiskers represent 
the 95% confidence interval for the mean. +95 ms: clinically relevant threshold for improvement in cartilage sGAG 
content if a single patient is followed over time using dGEMRIC. -85 ms: clinically relevant threshold for impairment of 
cartilage sGAG content if a single patient is followed over time using dGEMRIC. wbFC: weight-bearing cartilage of the 
femoral condyle. pFC: posterior non weight-bearing cartilage of the femoral condyle. wbTP: weight-bearing cartilage 
of the tibial plateau.
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dIsCussIon
Because of the lack of established DMOADs for early stage knee OA, intra-articular 
viscosupplementation with HA has become a frequently used treatment for reducing 
symptoms and pain in early stage knee OA 145, 146. Since it was suggested in previous 
in vitro research that HA injections might also have disease-modifying properties by 
increasing cartilage sGAG content 149-152, the aim of this study was to assess whether 
improvement in cartilage structural composition is detected using dGEMRIC 14 weeks 
after 3 weekly injections with HA in patients with early stage knee OA.
Outcomes of dGEMRIC in the medial compartment of the knee were lower compared 
to the lateral compartment at baseline, indicating more structural damage in the me-
dial knee compartment. T1 relaxation times in both knee compartments were lower 
compared to previously published dGEMRIC T1 relaxation times acquired at 3.0 Tesla in 
healthy subjects 94, 163, 164, indicating sGAG loss from the cartilage in our early stage OA 
patients. The outcomes of dGEMRIC are consistent with radiographic findings and our 
morphological cartilage assessment on MRI with MOAKS and reflect the early stage OA 
population in which sGAG loss occurs before morphological changes are detectable on 
radiography or MRI (e.g. using MOAKS). We observed early stage OA in the medial com-
partment of the knee in 18 of the 20 participants, which is defined as mild to moderate 
osteophyte formation as the only features on radiography, and only a few participants 
with partial cartilage damage according to MOAKS, without definite joint space nar-
rowing or bone on bone contact which are signs of advanced or end-stage OA. Based 
Figure 4: Bar graphs showing the KOOS subscales and NRS pain at baseline (light blue box) and at follow-up, 14 weeks 
after HA injections (dark blue box). The bar represents the mean and the whiskers represent the 95% confidence interval 
for the mean. HA: hyaluronic acid injections. ADL: activities of daily living, sports: sport and function, and QoL: knee-
related quality of life. *: p-values adjusted using Holm’s method <0.05.
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on these characteristics, we consider our study population suitable to evaluate the 
potential structural effects of viscosupplementation as a potential DMOAD, since this 
should be tested in early stages of OA in which disease modification is still possible 13.
At follow-up, 14 weeks after viscosupplementation with HA, no statistically significant 
change in cartilage sGAG content was detected on dGEMRIC in any of the analyzed ana-
tomical cartilage ROIs compared to the baseline measurements. Outcomes of dGEMRIC 
showed a trend towards improvement in three of the analyzed cartilage ROIs two of 
which were the medial and lateral non-weight-bearing cartilage regions of the femoral 
condyles. This is somewhat unexpected, as one would expect an improvement in car-
tilage structural composition in the weight-bearing femoral condyles and/or plateaus 
since those ROIs had lower T1 relaxation times and hence more structural damage at 
baseline. Moreover, the improvement in T1 relaxation times did not exceed a previously 
determined threshold of 95 ms which has been shown to represent a clinically relevant 
improvement in cartilage sGAG content as measured by 3D dGEMRIC of early stage 
OA knees acquired at 3.0 Tesla 136. It may be that there are non-significant changes 
between baseline and follow-up T1 relaxation times which means that the measure-
ments were not the same between the two time points. However, we hypothesized 
that if the reported clinical effect of viscosupplementation, confirmed by our study, 
would act through an improvement of sGAG content, this would have been detectable 
using dGEMRIC with the sample size of our study.
We believe there are several possible explanations why we did not observe an in-
crease in cartilage sGAG content by dGEMRIC 14 weeks after viscosupplementation of 
early stage OA knees. First, cartilage sGAG content and therefore dGEMRIC outcomes 
might not improve after viscosupplementation if the treatment does not have any 
disease-modifying effects on articular cartilage. Instead, viscosupplementation may 
have a primary positive effect on pain and other clinical symptoms of OA. This working 
mechanism was suggested for HA injections in a recent OARSI review by Zhang et al. 
in which the evidence for available therapies in the treatment of hip and knee OA was 
re-evaluated and discussed 165.
A second explanation why T1 relaxation times did not increase is that viscosupple-
mentation may slow down the progression of OA by preventing the loss of sGAG content 
rather than improving the sGAG content of cartilage (the latter was our hypothesis in 
this study). This working mechanism of HA was suggested in several in vitro studies 
166-168, and is supported by the results of recent animal and human studies in which 
the structural efficacy of HA treatment over time was compared to a control group 
(non-treatment and placebo) using another quantitative MRI technique (T2 mapping) 
169 and cartilage thickness and volume measurements on MRI 170. However, as it was 
considered unethical to include a control group by the IRB, we could not compare the 
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sGAG content 14 weeks after viscosupplementation with the sGAG content of cartilage 
without viscosupplementation.
A third possible reason that T1 relaxation times may not increase after HA injections 
is the detection limit and specificity of dGEMRIC to detect (change) in sGAG content 
of articular cartilage. Minimal changes in sGAG content of cartilage following HA 
treatment may not be detected using dGEMRIC T1 because, although the technique 
is highly reproducible in knee OA 136, it is currently unknown to which extent minimal 
change in sGAG content are detectable using dGEMRIC in humans. dGEMRIC is an 
indirect measure for cartilage sGAG content and there are no in vivo studies, which 
investigated the sensitivity and specificity of dGEMRIC to measure (small) changes in 
sGAG content of the extracellular matrix of cartilage. Other drawbacks of dGEMRIC are 
the long acquisition protocol because of the delay between the contrast administra-
tion and MR acquisition and the risk of nephrogenic systemic fibrosis due to contrast 
administration. In addition to these drawbacks, a recent publication shows that dGEM-
RIC outcomes might not only represent sGAG content of cartilage, but may also be 
influenced by collagen orientation which influences diffusion of contrast agent into the 
extracellular matrix of the cartilage 142 and therefore concluded that dGEMRIC may not 
be considered sGAG specific. Despite these shortcomings of dGEMRIC, the technique is 
still considered the best tool available that provides a quantitative measure for cartilage 
sGAG content in human knee joints.
Finally, the timing of the follow-up measurement in our study could be an explana-
tion why dGEMRIC T1 relaxation times did not improve after viscosupplementation. 
It may be that the follow-up measurement was either too early or too late after vis-
cosupplementation to detect any changes in cartilage sGAG content caused by the 
treatment. We chose a 14 weeks follow-up period after viscosupplementation based on 
a Cochrane review on the efficacy of HA injections as treatment in knee OA 146, in which 
the maximum clinical benefit of HA injections was reached between 5 and 14 weeks 
after treatment. It is known that sGAGs are being synthesized within days instead of 
weeks 171. Moreover, previous in vivo animal research has shown that newly synthesized 
sGAGs have a turnover time over 100 days 172, 173 and therefore should be still detectable 
14 weeks after viscosupplementation. Therefore, we considered our follow-up period 
of 14 weeks appropriate in relation to our hypothesis. Future research with earlier or 
extended follow-up measurements might give better insight whether our findings are 
consistent over time.
In contrast to the results of dGEMRIC, all KOOS subscales (‘pain’, ‘symptoms’, ‘daily 
activities’, ‘sports’ and ’quality of life’) and the NRS for pain improved significantly 14 
weeks after viscosupplementation with HA. These results are in agreement with afore-
mentioned studies 145, 146 in which a significant reduction in patient complaints was 
observed after HA injections. The relief in patient complaints without an improvement 
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in cartilage sGAG content might be due to the placebo effect of viscosupplementa-
tion 165. However, the clinical efficacy of HA may also be attributed to a positive effect 
of viscosupplementation on the viscoelastic properties of the synovial fluid 144 and a 
positive effect on the synovial membrane, which has been observed histologically in 
previous clinical studies in OA patients 174-176. It has been suggested in previous work 
that this might have anti-inflammatory effects causing less synovitis and therefore less 
knee complaints since pain and synovitis were recently shown to be closely related in 
OA patients 22, 177, 178.
In conclusion, the results of this study confirm earlier findings reported in the litera-
ture, showing a persisting efficacy of viscosupplementation on symptomatic outcome 
measures of early stage OA knees 14 weeks after treatment. Outcomes of dGEMRIC, 
however, did not change after viscosupplementation, indicating no change in cartilage 
structural composition as an explanation for the improvement of clinical symptoms.
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To assess (I) if normal and degenerated menisci exhibit different T1GD on delayed 
gadolinium-enhanced MRI of the meniscus (dGEMRIM), (II) the reproducibility of dGEM-
RIM and (III) the correlation between meniscus and cartilage T1GD in knee osteoarthritis 
(OA) patients.
materials and methods
In 17 OA patients who underwent dGEMRIM twice within 7 days, meniscus and carti-
lage T1GD was calculated. Meniscus pathology was evaluated on conventional MRI. T1GD 
in normal and degenerated menisci were compared using a student’s t-test. Reproduc-
ibility was assessed using ICCs. Pearson’s correlation was calculated between meniscus 
and cartilage T1GD.
results
A trend towards lower T1GD in degenerated menisci (mean: 402 ms; 95% CI: 359 - 444ms) 
compared to normal menisci (mean: 448 ms; 95% CI: 423 - 473ms) was observed 
(p=0.05). Meniscus T1GD ICCs were 0.85-0.90. The correlation between meniscus and 
cartilage T1GD was moderate in the lateral (r=0.52-0.75) and strong in the medial com-
partment (r=0.78-0.94).
Conclusion
Our results show that degenerated menisci have a clear trend towards lower T1GD com-
pared to normal menisci. Since these results are highly reproducible, meniscus degen-
eration may be assessed within one delayed gadolinium-enhanced MRI simultaneously 
with cartilage. The strong correlation between meniscus and cartilage T1GD suggests 
concomitant degeneration in both tissues in OA, but also suggests that dGEMRIC may 
not be regarded entirely sulphated glycosaminoglycan specific.




Knee osteoarthritis (OA) is the most common joint disease in middle-aged and elderly, 
causing serious morbidity and large socio-economic impact 8, 9, 179, 180. The disease af-
fects many tissues of the joint, such as subchondral bone, synovium, joint capsule, 
articular cartilage and the menisci 22. It has been shown that pathologic changes in the 
meniscus such as degeneration and tears play an important role in the development of 
cartilage degeneration in knee OA because pathologic menisci fail to perform their role 
as shock absorbing tissues in the knee, resulting in more load on the articular cartilage 
which gives rise to faster degeneration 181, 182. Conversely, knee OA also leads to damage 
of the meniscus due to the release of degenerative enzymes and chemokines in the 
entire OA knee joint 183.
The extracellular matrix of articular cartilage is mainly composed of collagen and 
proteoglycans (PG) 56, 153, 184. PGs primarily consist of sulphated glycosaminoglycans 
(sGAG) 56, 153, 184. Delayed gadolinium-enhanced magnetic resonance imaging of carti-
lage (dGEMRIC) is an established quantitative imaging technique that uses the inverse 
relation between an ionic contrast agent and the amount of sGAG in articular cartilage 
to measure its biochemical composition and its degradation 93, 95. Based on the inverse 
relation of cartilage sGAG content and the contrast agent, cartilage with relatively low 
sGAG content will have low T1GD relaxation times 65. Since the extracellular matrix of 
the meniscus also contains PGs and hence sGAG 184, 185, quantitative analysis of delayed 
gadolinium-enhanced magnetic resonance imaging of the meniscus (dGEMRIM) has 
also been proposed as a tool to give insight in the composition of the meniscus in terms 
of its sGAG content 186, 187. However, no previous study has assessed if degenerated 
menisci, similar to articular cartilage in dGEMRIC, exhibit lower T1GD relaxation times 
compared to morphologically normal menisci. In addition, no previous study has inves-
tigated the reproducibility of T1GD of the meniscus in dGEMRIM. The aforementioned 
information is important to know whether meniscus and articular cartilage degenera-
tion may be analyzed within one gadolinium-enhanced magnetic resonance imaging 
(MRI) examination and if gadolinium-enhanced MRI provides a robust outcome which 
can be used in both cross-sectional, as well as longitudinal study designs.
Despite the absolute difference in sGAG content between the meniscus and articular 
cartilage - the meniscus only contains 10-15% of the amount of sGAG present in the 
cartilage 55, 153, 184, 188 - Krishnan et al. showed that there is a moderate relation between 
T1GD of the meniscus and of articular cartilage in healthy volunteers and patients with 
knee complaints who were not diagnosed with OA by their physician 186. However, the 
relationship between T1GD of the menisci and articular cartilage has not yet been estab-
lished in knee OA patients. In OA patients the amount of sGAG in both tissues is known 
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to be diminished during disease progression 56, 181, 185, which may cause a difference in 
contrast uptake in both tissues compared to non-OA subjects.
The aims of the current study were: (I) to assess if menisci, identified as normal or 
degenerated on conventional MRI, also exhibit different T1GD relaxation times on dGEM-
RIM, (II) to assess the reproducibility of T1GD of the meniscus in dGEMRIM and (III) to 




For this study we used delayed gadolinium-enhanced MRI data of patients included 
in a prospective study in which the reproducibility of dGEMRIC was assessed. The 17 
patients included in this study underwent dGEMRIC twice (test and retest) within a 
seven day interval. All analyses of this study, except for the reproducibility analysis of 
the meniscus, were performed on the datasets from the first dGEMRIC examination. The 
data were acquired between March and September 2011. Written informed consent 
was obtained from all participants and the study was approved by the IRB (Medical 
Ethical committee of the Erasmus MC, protocol number MEC-2010-088).
The inclusion criteria were: participants > 18 years, knee pain > 3 months, severity 
of knee pain > 2 out of 10 on a numeric rating scale at the time of inclusion 117, and 
radiographic knee OA with a Kellgren and Lawrence grade of 1 or 2 (doubtful or definite 
osteophyte formation without joint space narrowing) 28. Exclusion criteria were: abso-
lute and relative contra-indications to undergo MRI, a glomerular filtration rate  <  60 
ml/min, a history of previous reactions to contrast agent, significant co-morbidities in 
the lower extremity of the index knee joint (e.g. severe hip OA, neurologic diseases or 
muscular diseases causing a disability of the joint) which preclude exercising after the 
contrast administration, or knee surgery in the index knee < 1 year ago.
acquisition of delayed gadolinium-enhanced and conventional mrI
Before acquisition of the delayed gadolinium-enhanced and conventional MR images, 
a double dose (0.2 mmol/kg) of Magnevist® (Bayer Schering Ag, Berlin, Germany) was 
administered intravenously. After injection of the contrast agent, the participants 
cycled for 10 minutes on a home trainer with a constant speed to promote contrast 
distribution into the articular cartilage 95. Approximately 90 minutes after the contrast 
injection, the delayed gadolinium-enhanced scan was acquired first, followed by the 
conventional MR images.
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MR imaging was performed on a 3.0 Tesla MRI scanner (Discovery MR750, General 
Electric Healthcare, Milwaukee, USA) using a custom-made 3-channel knee coil (Flick 
Engineering Solutions B.V., Winterswijk, The Netherlands). The delayed gadolinium-
enhanced MR scanning protocol consisted of a 3D inversion recovery fast spoiled 
gradient-echo sequence which was acquired with five different inversion times (TI): 
2100; 800; 400; 200 and 100 ms 94. The other scanning parameters were the same for all 
five acquisitions and are shown in (Table 1).
Additionally, three conventional MR sequences were acquired consisting of a sagittal 
and axial fast spin echo (FSE) proton-density-weighted and a coronal FSE T2-weighted 
sequence with fat suppression (Table 1). On these images, evaluation of the morphol-
ogy and signal intensity of the meniscus was performed.
analysis of delayed gadolinium-enhanced mrI
Using Matlab (R2011a, The MathWorks, Natick, USA), two regions of interest (ROIs) in the 







Plane Sagittal Sagittal Axial Coronal
Imaging mode 3D 2D 2D 2D
Sequence IR SPGR FSE FSE FSE
Matrix (frequency) 256 416 416 320
Matrix (phase) 230 256 352 256
FOV (mm) 150 150 150 150
Slice thickness/gap 
(mm/mm)
3.0/0.0 3.0/0.0 2.0/0.0 3.0/0.0
TI (ms) 2100 / 800 / 400 / 200 
/ 100
N.a. N.a. N.a.
TE (ms) 1.5 27 27 70
TR (ms) 3.9 2250 2250 5000
Flip angle (˚) 15 90 90 90
Bandwidth (Hz/pixel) 244 244 244 244
Number excitations 
averaged
1 1 1 1
Fat saturation N.a. N.a. N.a. Yes
Number of slices 36 36 32 20
Acquisition time (min) 14 2 2 4
Table 1: MRI protocol parameters. FOV: field of view. FSE: fast spin-echo. IR SPGR: inversion recovery spoiled gradient-
echo. N.a.: not applicable. TE: echo time. TI: inversion time. TR: repetition time
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delayed gadolinium-enhanced MR exam acquired with TI=2100 ms by a musculoskel-
etal imaging researcher with four years of experience. The ROIs were drawn on three 
consecutive images through the lateral and medial tibiofemoral joint (central slice and 
one adjacent slice on each side) (Figure  1). We chose to use the three central slices 
since these represent approximately 1 cm of the weight-bearing tibiofemoral joint 
which is mostly affected by OA. The most central slices through the medial and lateral 
tibiofemoral compartment was selected using co-localization on the sagittal, coronal 
and axial conventional MR images by identifying the sagittal slice with the most caudal 
point of the femoral condyle on it. Because of the use of our dedicated knee coil, all 
knees were positioned in the same way (10 degrees of flexion in the knee joint) and by 
acquiring two sets of localizer images we were able to angulate all planes to achieve a 
consistent slice selection in all participants. The meniscus ROIs were drawn on the same 
slices as the cartilage ROIs and consisted of the anterior horn of the meniscus (aMEN) 
and the posterior horn of the meniscus (pMEN) (Figure 1).
During MR acquisition, patient motion might occur which may cause errors in the 
outcomes of quantitative analyses. Image registration, however, can correct for patient 
motion 85, 123. To correct for patient motion, we used an in-house developed registration 
and T1GD-fitting algorithm that was published and used previously 123, 136, 189. With this 
tool, first, all images with different TI values were registered to the TI=2100 ms images 
for both scans (test and retest) of each patient. Next, the retest examination was reg-
istered to the test examination based on the images with TI=2100 ms, and the images 
with other TIs of the retest examination were transformed accordingly. Automated 
registration of the retest to the test scan eliminates subjective visual slice matching and 
Figure  1: Representation of the two cartilage and two 
meniscus ROIs in which the T1GD relaxation time was cal-
culated in three consecutive slices in each compartment 
of the tibiofemoral joint (lateral side shown in this exam-
ple). wbFC (blue): weight-bearing cartilage of the femoral 
condyle. wbTP (green): weight-bearing cartilage of the 
tibial plateau. aMEN (red): anterior horn of the meniscus. 
pMEN (yellow): posterior horn of the meniscus.
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also eliminates the need to manually outline the meniscus ROIs on the retest scan. All 
Details on the registration settings can be found in 123.
For the registered datasets, T1GD maps were estimated using a maximum likelihood fit 
in each meniscus (T1GD maps of the registered tibia plateau) and cartilage (T1GD maps 
of registered femoral condyle and tibial plateau) ROIs, the weighted T1GD for each ROI 
was calculated. By using the weighted T1GD the outcomes are less affected by possible 
outlier T1GD within the ROIs 123. Finally, as proposed by Tiderius et al., T1GD was corrected 
for the participants’ body mass index (BMI) since this is a potential source of dose bias 
of the administered contrast agent 137.
The weighted, BMI-corrected, T1GD relaxation times for each ROI (meniscus and car-
tilage) were averaged over the three consecutive MR images. Thus, for each patient, 
eight T1GD measurements from 4 meniscus and 4 cartilage ROIs were obtained for the 
test and retest examination.
analysis of meniscus pathology
On the conventional proton-density and T2-weighted MRI sequences, we evaluated 
four different meniscal regions (anterior and posterior half or the medial and lateral 
meniscus, each including a part of the meniscal body) for the presence or absence 
of meniscal pathology. This analysis included all slices on which the specific meniscal 
region was visible (i.e. more than the three central slices on which dGEMRIM analysis 
was performed).
If no pathology was observed (Figure 2A), menisci were classified as normal. Menisci 
were evaluated for meniscal degeneration indicated by intrameniscal signal abnormali-
Figure 2: Top layer (A-C): examples of proton-density images of a normal, degenerated and torn meniscus. A: morpho-
logically normal, B: degenerated (intrameniscal signal abnormalities, white arrow) and C: torn (gray arrow) meniscus 
on sagittal conventional proton-density-weighted MR images. Bottom layer (D,E): proton-density images with T1GD 
color overlay of the morphologically normal and degenerated menisci (D, E). No T1GD color overlay of a torn meniscus 
is presented because those were excluded for all analysis for reasons stated in the materials and methods section.
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ties not reaching the articular surface 190, 191 and the presence of tears indicated by signal 
abnormalities extending to the articular surface (Figure 2BC).
Because we aimed to study early degeneration of the meniscus, we excluded me-
niscus ROIs with tears from our analysis since we consider meniscal tears either an 
advanced stage of meniscus pathology or of traumatic etiology. In addition, meniscal 
tears might fill with contrast agent directly from the joint cavity, causing erroneously 
low T1GD relaxation times.
All MR examinations were read by an experienced musculoskeletal radiologist (EO).
statistical analysis
We tested our data for normality and equal variance using the Kolmogorov-Smirnov 
and Levene’s test. The outcomes of these tests showed normality and equal variance of 
our data. For each cartilage and meniscus ROI, we calculated the mean T1GD and its 95% 
confidence interval (95%CI) in the first MR examination.
To assess if T1GD differs between menisci identified as morphologically normal or 
degenerated on conventional MRI, we compared the T1GD of normal and degenerated 
menisci using a student’s t-test.
To examine the reproducibility of T1GD of the meniscus, we calculated the intraclass 
correlation coefficient (ICC) measuring the absolute agreement in a two-way random 
effects model in each meniscus ROI 124. We did not investigate the reproducibility of 
cartilage T1GD, since this was already shown to be excellent in early stage OA patients 136.
To study the relation between T1GD in the meniscus and the articular cartilage, we 
calculated the Pearson’s correlation coefficients between aMEN and pMEN and wbFC 
and wbTP T1GD in both tibiofemoral compartments.
All analyses were performed using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). P-val-
ues <0.05 were considered to be statistically significant.
resulTs
Participants
The mean age of the 17 participants (seven women, five left knee joints) was 50 (± 10) 
years and their mean BMI was 30 (± 5) kg/m2. There were no differences in age (p=0.85) 
and BMI (p=0.20) between the participants with morphologically normal and degener-
ated menisci. Two participants had previous meniscal surgery in their index knee. In 
both cases the posterior meniscal horn (one lateral and one medial) was repaired and 
partially removed because of a tear. Two patients had their anterior cruciate ligament 
reconstructed and one patient had a high tibial osteotomy more than one year before 
inclusion.
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On radiography, 11 participants had early stage OA (Kellgren and Lawrence grade 1 
or 2) in the medial tibiofemoral compartment 28. Six participants had early OA in both 
the medial and lateral knee compartments. No isolated lateral OA was observed on 
radiography in any of the included participants.
analysis of meniscus pathology
A total of 68 meniscus ROIs were evaluated for degeneration and tears on the routine 
MRI sequences (4 meniscus ROIs in 17 patients). A total of 15 meniscus regions in 9 
participants were diagnosed with degenerative signal abnormalities: 4 aMEN and 6 
pMEN ROIs in the lateral compartment and 5 pMEN ROIs in the medial compartment. A 
total of 42 menisci were scored as normal on conventional MRI.
Meniscal tears were observed in 11 meniscal regions in 9 participants. 10 of which 
were located in the medial compartment (9 in the pMEN and one in the aMEN) and 
one was present in the pMEN in the lateral compartment. These menisci were excluded 
from all analyses as mentioned before.
analysis of delayed gadolinium-enhanced mrI
T1GD relaxation time in the meniscus ROIs ranged from 421 to 432 ms and from 489 
to 607 ms in the cartilage ROIs (Table 2). The T1GD in the medial tibiofemoral compart-
ment of the cartilage was significantly lower than in the lateral compartment (p=0.004), 
whereas there was no such regional difference observed for the meniscal ROIs (p=0.77) 
(Table 2).
Cartilage / meniscus roI (n) T1Gd (95% CI)
Medial tibiofemoral compartment
Weight-bearing femoral condyle (n=17) 489 (443 - 536) ms
Weight-bearing tibial plateau (n=17) 520 (466 - 574) ms
Anterior meniscus (n=16) 423 (372 - 475) ms
Posterior meniscus (n=8) 430 (355 - 506) ms
Lateral tibiofemoral compartment
Weight-bearing femoral condyle (n=17) 542 (508 - 578) ms
Weight-bearing tibial plateau (n=17) 607 (551 - 662) ms
Anterior meniscus (n=17) 432 (402 - 462) ms
Posterior meniscus (n=16) 421 (394 - 449) ms
Table 2: Mean T1GD relaxation times in the meniscus and articular cartilage. n: number of regions analyzed (torn 
menisci were excluded from our analyses). 95% CI : 95% confidence interval
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analysis of T1Gd in normal and degenerated menisci
T1GD relaxation time of morphologically normal menisci on conventional MRI (n=42) 
was 448 ms with a 95%CI ranging from 423 – 473 ms. We observed a trend towards 
lower T1GD relaxation time in degenerated menisci (n=15, mean: 402 ms, 95%CI ranging 
from 359 – 444 ms) (p=0.05) (Figure 2DE and Figure 3).
Figure  3: Boxplots showing T1GD relaxation time of mor-
phologically normal (n=42) versus degenerated menisci 
(n=15) as visualized on conventional MRI. Whisker repre-
sents the 5th - 95th percentile. The + represents the mean 
T1GD.
Figure 4: Scatter plots of the first and second dGEMRIM of all patients. Red circles represent anterior menisci and blue 
triangles represent posterior menisci. A: lateral menisci. B: medial menisci. The black line represents the relation x=y 
(perfect reproducibility). n: number of regions analyzed (torn menisci were excluded from our analyses). ICC: intraclass 
correlation coefficient. 95% CI: 95% confidence interval.
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reproducibility of meniscus T1Gd
The reproducibility of meniscus T1GD relaxation times of dGEMRIM, expressed as ICCs 
together with the 95%CIs, is shown in Figure 4. The reproducibility was good with ICC 
values > 0.80 124 in all meniscus ROIs (n=17 for the aMEN and n=16 for the pMEN in the 
lateral compartment, n=16 for aMEN and n=8 for pMEN in the medial compartment).
Correlation between T1Gd of meniscus and cartilage
T1GD relaxation times of the meniscus correlated moderately to strongly with the T1GD 
relaxation times of the articular cartilage (range of Pearson’s correlation coefficients: 
0.52 - 0.94, Table 3). The correlation in the medial tibiofemoral compartment was stron-
ger (range of correlation coefficients: 0.78 - 0.94, Table 3) compared to the lateral com-
partment of the knee (range of correlation coefficients: 0.52 - 0.75, Table 3). Examples of 
a meniscus and articular cartilage with high and low T1GD relaxation times in the medial 
knee compartment are shown in Figure 5.
dIsCussIon
dGEMRIC is a frequently used technique to measure cartilage biochemical composition 
based on the amount of sGAG in the cartilage 93, 95. Since the extracellular matrix of the 
meniscus also contains sGAG, dGEMRIM could give insight in biochemical composition 
of the meniscus tissue 186, 187. Little research on dGEMRIM in healthy and pathologic 
menisci, however, has been performed yet.
The first aim of our study was to assess if menisci, identified as normal or degener-
ated on conventional MRI, also exhibit different T1GD relaxation times on dGEMRIM. 
We observed a clear trend towards lower T1GD in menisci identified as degenerated 
on conventional MRI compared to morphologically normal menisci, indicating more 
r (95% CI)
Cartilage roI meniscus roI
Medial compartment Anterior (n=16) Posterior (n= 8)
Weight-bearing femoral condyle 0.94 (0.84 - 0.98) 0.78 (0.17 - 0.96)
Weight-bearing tibial plateau 0.87 (0.66 - 0.95) 0.78 (0.18 - 0.96)
Lateral compartment Anterior (n=17) Posterior (n=17)
Weight-bearing femoral condyle 0.75 (0.43 - 0.91) 0.66 (0.27 - 0.87)
Weight-bearing tibial plateau 0.52 (0.05 - 0.80) 0.67 (0.27 - 0.87)
Table 3: Correlation between meniscus and articular cartilage T1GD relaxation times. n: number of regions analyzed 
(torn menisci were excluded from our analyses). r: Pearson’s correlation coefficients. 95% CI: 95% confidence interval.
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gadolinium-enhancement in degenerated menisci on dGEMRIM. This result suggests 
that, similar to dGEMRIC, low T1GD in dGEMRIM may possibly be used as an indicator 
of meniscal degeneration, for example if no conventional MR images are available to 
identify meniscus degeneration in a research or clinical setting. In addition, it may be 
useful to assess both articular cartilage as well as meniscus degeneration within one 
delayed gadolinium-enhanced MR examination. This complementary information 
about both tissues might be useful for orthopedic surgeons to decide which treatment 
is indicated for individual patients since it has been shown that meniscus and cartilage 
quality are important predictors of clinical outcome after treatment of intra-articular 
pathology in the knee 192, 193.
The second aim of our study was to assess the reproducibility of T1GD of the meniscus 
in dGEMRIM. The results of our study demonstrate that the reproducibility of individual 
meniscus ROIs is good, regardless of the anatomical location within the knee joint. Our 
reproducibility results are similar to those of a previous study assessing the reproduc-
ibility 3D dGEMRIC at 3T in early stage OA (ICCs ranging between 0.87 – 0.95) 136, and 
indicates that dGEMRIM yields robust T1GD relaxation times of the meniscus and can 
thus be used in longitudinal study designs.
The third aim of our study was to assess the correlation between T1GD of the meniscus 
and the articular cartilage in patients with early stage knee OA. T1GD of the meniscus and 
cartilage were moderately to strongly correlated, indicating concurrent degeneration 
of both tissues in knee OA. The correlation in the medial compartment was stronger 
compared to the lateral compartment, which might be caused by the absence of lateral 
Figure 5. Representative images with a meniscus and cartilage color maps showing relatively high T1GD (left: 55 year 
old male, Kellgren and Lawrence grade 1 and a morphologically normal meniscus on conventional MRI) and rela-
tively low T1GD (right: 61 year old female, Kellgren and Lawrence grade 2 and a degenerated medial meniscus on con-
ventional MRI) relaxation times in both tissues. wbFC: weight-bearing cartilage of the femoral condyle. wbTP: weight-
bearing cartilage of the tibial plateau. aMEN: anterior horn of the meniscus. pMEN: posterior horn of the meniscus.
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OA in 11 of the 17 included participants. The strong correlation between meniscus 
and cartilage tissues we observed in our study is in agreement with previous research 
in which semi-quantitatively analyzed whole joint assessment of the knee showed an 
association between meniscal degeneration and cartilage loss in OA patients with 
a Kellgren and Lawrence grade  >  2 181. In addition, Zarins et al. also found a strong 
correlation between quantitatively analyzed T1rho- (MRI measure for PG content 68) 
and T2- (MRI measure for collagen content 194) maps of meniscus and cartilage in OA 
patients 195. Concurrent degeneration of the meniscus and cartilage in knee OA might 
also explain that the strength of the correlation we found between meniscal and carti-
lage T1GD is stronger (Pearson’s correlation coefficients > 0.78 in the medial tibiofemoral 
knee compartment) than reported by Krishnan et al. who evaluated the correlation 
between T1GD in menisci and cartilage of healthy volunteers and patients with knee 
complaints who were not diagnosed with OA by their physician (Pearson’s correlation 
coefficients ranging from 0.37 - 0.57 in the medial compartment) 186.
Since the sGAG constitutes only 1-2% of the total weight of the meniscus compared 
to 5-10% for articular cartilage 55, 153, 184, 188, it is questionable if sGAG is the only composite 
of the meniscus determining contrast influx into the meniscus. Li et al. analyzed delayed 
gadolinium-enhanced MRI acquired using both an ionic (inversely related to the sGAG 
content) and a non-ionic (no known interaction with sGAG content) contrast agent 
in the meniscus in patients with knee OA and healthy volunteers 196. They observed 
significant differences in meniscus T1GD between OA patients and healthy volunteers 
for both ionic and non-ionic contrast agents, suggesting that sGAG content does not 
dominate contrast influx into the meniscus. Therefore, they concluded that contrast 
influx into the meniscus is rather based on the integrity of the collagen network of 
the meniscus. This result, combined with the strong correlation between T1GD in the 
meniscus and cartilage we found in the current study, leads to the hypothesis that 
the amount of sGAG is not the only composite of articular cartilage that determines 
ionic contrast influx into it in dGEMRIC. In another study, Li et al. also performed the 
aforementioned comparison between ionic and non-ionic contrast influx into OA carti-
lage and healthy cartilage 197. They concluded that, in addition to the amount of sGAG, 
integrity of the cartilage collagen network also partially influences contrast influx into 
cartilage in dGEMRIC. This conclusion is supported by recent in vitro studies investigat-
ing ionic contrast diffusion into articular cartilage in dGEMRIC 142, 198, 199. Furthermore, 
in a recent ex vivo study in which diffusion of an ionic CT contrast agent into cartilage 
(inverse relation between contrast agent and sGAG content of cartilage, thus similar 
to dGEMRIC) was investigated, it was also shown that the composition of the cartilage 
extracellular matrix influences ionic contrast influx into articular cartilage 200. Therefore, 
the results of our current study, as well as those of others indicate that dGEMRIC should 
be regarded sGAG sensitive as advocated by Bashir et al. 65 and Watanabe et al. 91, but 
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that its specificity for sGAG is questionable. Therefore, outcomes of dGEMRIC must be 
interpreted with caution until future studies have evaluated the sGAG sensitivity and 
specificity of in vivo dGEMRIC.
The lack of a significant difference between normal and degenerated menisci may 
be caused by the design of our study. We analyzed delayed gadolinium-enhanced MR 
data of 17 early stage OA patients of which not all turned out to have meniscus degen-
eration, which may have caused insufficient statistical power in our analyses. Another 
limitation of our study is that conventional MR was acquired after intravenous contrast 
administration. However, we expect that this did not interact with the morphological 
evaluation of the menisci that was performed exclusively on proton-density and T2-
weighted images, which are typically not, influenced by contrast agent. In addition, 
it is theoretically possible to divide the meniscus into a peripheral and central region. 
However, because of the relatively low in-plane spatial resolution of the MR images on 
which the ROI segmentation was performed, we considered differentiating between 
peripheral and central ROIs of the meniscus unreliable. Finally, we used dGEMRIC data 
in which some of the parameters of the MRI (e.g. contrast agent dose, delay between 
contrast administration and MR acquisition, and acquired TIs) were optimized for 
cartilage imaging and may therefore not be optimal for analysis of the meniscus. Espe-
cially the delay between contrast administration and MR acquisition is relatively short 
compared to Mayerhoefer et al. who suggest a delay of 2,5 – 4,5 hours 187. However, we 
consider it more practical to use a single MRI protocol which can be used to analyze 
both meniscus and cartilage tissue within one MR examination since both are known 
to play a role in the development of knee OA 183.
Future studies using dGEMRIM should be conducted to further investigate its ac-
curacy to detect meniscus degeneration before morphological or signal changes 
appear on conventional MRI. Although our results are promising, the relation between 
low T1GD as measure of meniscus compositional change should be validated against 
biochemical analyses and histology of meniscus composition. In addition, including a 
wider range of Kellgren and Lawrence grades (0 – 4 instead of only grade 1 and 2 as in 
the current study) could provide valuable information regarding the degree of degen-
eration of the meniscus in various stages of OA. Such studies could also investigate if 
torn menisci can be assessed for compositional changes using dGEMRIM by comparing 
T1GD outcomes of torn menisci against normal and degenerated menisci as well as to 
biochemical assays and histology. Future research might also benefit from using a com-
bination of quantitative MRI techniques, e.g. delayed gadolinium-enhanced MRI and 
T2-, T1rho- and T2*-mapping which have been previously used to analyze meniscus 
composition 201, 202 since this might offer additional perspectives on the development 
of meniscus degeneration in knee OA in particular using MRI techniques that do not 
require a contrast agent.
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In conclusion, the results of the current study show that degenerated menisci have a 
clear trend towards lower T1GD on dGEMRIM compared to normal menisci. Since these 
results are highly reproducible, meniscus degeneration may be assessed within one 
delayed gadolinium-enhanced MR examination simultaneously with articular cartilage. 
The strong correlation between meniscus and cartilage T1GD suggests concomitant de-
generation in both tissues in OA, but also suggests that dGEMRIC may not be regarded 
entirely sGAG.
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Similar to delayed gadolinium enhanced MRI of cartilage, it might be possible to im-
age cartilage quality using CT arthrography (CTa). This study assessed the potential of 
CT arthrography as a clinically applicable tool to evaluate cartilage quality in terms of 
sulphated glycosaminoglycan content (sGAG) and structural composition of the extra-
cellular matrix (ECM).
materials and methods
Eleven human cadaveric knee joints were scanned on a clinical CT scanner. Of each 
knee joint, a regular non-contrast CT (ncCT) and an ioxaglate injected CTa scan were 
performed. Mean X-ray attenuation of both scans were compared to identify contrast 
influx in seven anatomical regions of interest (ROI). All ROIs were rescanned with 
contrast-enhanced μCT, which served as the reference standard for sGAG content. 
Mean X-ray attenuation from both ncCT and CTa were correlated with μCT results and 
analyzed with linear regression. Additionally, residual values from the linear fit between 
ncCT and μCT were used as a covariate measure to identify the influence of structural 
composition of cartilage ECM on contrast diffusion into cartilage in CTa scans.
results
CTa resulted in higher X-ray attenuation in cartilage compared to ncCT scans for all 
anatomical regions. Furthermore, CTa correlated excellent with reference μCT values 
(sGAG) (R=0.86; R2=0.73; p<0.0001). When corrected for structural composition of carti-
lage ECM, this correlation improved substantially (R=0.95; R2= 0.90; p<0.0001).
Conclusion
Contrast diffusion into articular cartilage detected with CTa correlates with sulphated 
glycosaminoglycan content and to a lesser extent with structural composition of car-
tilage ECM. CTa may be clinically applicable to quantitatively measure the quality of 
articular cartilage.




The current reference standard for osteoarthritis (OA) staging is the Kellgren and 
Lawrence score based on knee radiography 28. However, this technique is not sensitive 
enough to detect OA at an early stage. Sulphated glycosaminoglycan (sGAG) is a key 
molecule in articular cartilage and its content is an indicator of cartilage health 153. Loss 
of sGAG from the articular cartilage is a hallmark of early OA and occurs well before OA 
is detected radiographically 56, 116.
Micro computed tomography (μCT) used together with a negatively charged 
contrast agent (ioxaglate) is a well-established technique to image sGAG-distribution 
in cartilage 78, 203, 204. The technique is comparable to delayed gadolinium enhanced 
magnetic resonance imaging of cartilage (dGEMRIC) 64, 65, 93, 205, 206. Previous in vitro work 
has shown that there is a clear inversed relationship between the amount of ioxaglate 
in the cartilage measured with μCT and the negatively charged sGAG content of the 
cartilage measured with biochemical essays (R2 = 91-94%) 78, 203, and histology (R2 = 77%) 
79. In vivo research in small animals has also demonstrated that µCT arthrography is able 
to accurately measure changes in cartilage quality 80, 81.
In humans, CT arthrography (CTa) using intra-articularly injected contrast agent is 
an established clinical technique for imaging of knee abnormalities 82, 83. However, it 
is solely used for detection of morphologic derangements rather than assessment of 
cartilage sGAG content. In this cadaver study we determined whether it is possible to 
quantitatively measure the sGAG content of human articular cartilage with a clinical CT 
system, after intra-articular injection of a contrast agent. We also investigated to what 
extent the contrast influx into cartilage is influenced by the structural composition of 
the extra-cellular matrix (ECM).
maTerIals and meThods
Cadaver specimens
Thirteen cadaveric lower extremities from eleven individuals who had donated their 
bodies to science (seven female, four male; mean age at death 74 years, age range at 
death 30 - 96 years) were available. All extremities were freshly frozen at -20ºC until 
start of the experiment. Prior to first imaging, all specimens were slowly defrosted in a 
cooled environment (7ºC) for 5 days. All extremities were at room temperature during 
imaging.
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acquisition and post processing of non-contrast CT and CT arthrography 
data
Non-contrast CT (ncCT) was performed of all knee joints using a second generation dual 
source multidetector spiral CT scanner (SOMATOM Definition Flash, Siemens Health-
care AG, Erlangen, Germany) with a tube voltage of 80kV and an effective mAs-value of 
3140. Scan time per ncCT was approximately 30 seconds per scan. All specimens were 
scanned in the standard anatomic axial plane. All scans were reconstructed with an ef-
fective slice thickness of 0.75 mm and a sharp reconstruction kernel (B75s). Multiplanar 
reconstruction was performed (image pixel size 0.265mm) (Figure 1A-C).
Immediately after ncCT, 20ml of 30% ioxaglate solution (diluted in saline) (Hexabrix 
320, Mallinckrodt, Hazelwood, MO, USA) 83 was injected intra-articularly using a 18 
gauge needle. All knees were flexed (~120°) and extended (~0°) for 5 minutes in order 
to achieve optimal distribution of the contrast agent throughout the joint. Ten minutes 
after contrast injection, all knees were rescanned using the same CT scanner, scanning 
parameters (30 seconds/scan), and reconstruction methods (Figure 1D-F).
Figure 1: Representative sagittally reconstructed images of a knee joint from non-contrast CT (ncCT) (A-C) and after 
intra-articular contrast injection for CT arthrography (CTa) (D-F), after segmentation into a binary dataset showing the 
definition of the regions of interest. (G-I), and a 3D representation of all seven analyzed ROIs (J-M): weight-bearing me-
dial and lateral condyle (wbMC/wbLC; posterior medial and lateral condyle of the femur (pMC/pLC); weight-bearing 
medial and lateral plateau of the tibia (wbMP/wbLP); mid portion of patellar cartilage (mpP).
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All scans were converted into binary datasets using one fixed attenuation threshold 
(430 Hounsfield units) that was selected visually to render the best possible segmenta-
tion of cartilage in all datasets (Figure 1G-I, Figure 2) 80. Using analysis software (Skyscan, 
Kontich, Belgium), per knee seven regions of interest (ROIs) were manually defined. Each 
cartilage ROI extended over 40 contiguous sagittal slices. These cartilage ROIs consisted 
of the central weight-bearing area of both medial and lateral femoral condyles (wbMC 
and wbLC), the posterior non-weight bearing area of both femoral condyles (pMC and 
pLC), both weight-bearing medial and lateral tibial plateaus (wbMP and wbLP) and the 
mid-portion of patellar cartilage (mpP) (Figure 1G-M). Anterior margins of the weight-
bearing femoral condyles and tibial plateaus were defined at the level of the posterior 
aspect of the anterior meniscal horn. The posterior margins were defined at the level of 
the anterior aspect of the posterior meniscal horn. The posterior non-weight bearing 
femoral condyle ROI extended backward from the level of the dorsal margin of the 
posterior meniscal horn. We calculated the mean X-ray attenuation of cartilage in these 
ROIs on non-contrast and contrast-enhanced clinical CT scans.
equilibrium partitioning of an ionic contrast agent using (ePIC-)µCT
Because EPIC-μCT has shown strong correlation with cartilage sGAG content, we 
selected this as our reference test for sGAG content of cartilage 78, 79, 203. In EPIC-μCT 
an equilibrium-state exists between sGAG and contrast agent after a long incubation 
period. Due to the equilibrium, structural composition of the cartilage ECM 199 does not 
influence the interaction between contrast and sGAG content of cartilage 79.
After CTa, the knee joints were dissected into five parts: both medial and lateral 
femoral condyles, both medial and lateral tibial plateaus and the patella. Soft tissue was 
Figure 2: Profile line through different structures (red line in insert) of both CT arthrography (A) and EPIC-microCT (B). 
On the x-axis subsequent pixels in the profile line are represented, the y-axis indicates the attenuation values of these 
pixels. With the red dotted line, we have visualized the level of our selected thresholds per technique (CT arthrogra-
phy <430 Hounsfield units; EPIC-microCT >25 and <125 gray values).
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removed to a maximal extent, without harming cartilage integrity. In order to achieve 
equilibrium between the contrast agent and sGAG in cartilage, all dissected specimens 
were incubated in an ioxaglate contrast solution for 24 hours at room temperature 207-
209. It is advocated to use the highest possible concentration of contrast, allowing best 
cartilage segmentation to achieve highest sensitivity for changes in sGAG content 79, 204. 
We used a 20% solution of ioxaglate, which resulted in the best cartilage segmentation 
at the air/cartilage and bone/cartilage interfaces.
EPIC-μCT was performed on a μCT scanner (Skyscan1076, Skyscan, Kontich, Belgium). 
The following scan settings were used: isotropic voxel size of 35 μm; a voltage of 55 
kV; a current of 181 mA; field of view 68 mm; a 0.5 mm aluminum filter; 198o with a 0.4 
degree rotation step. Scanning time per specimen was 6 - 10 hours, depending on the 
size of the specimen (condyle, plateau or patella) which was scanned. A plastic foil was 
wrapped around the specimen to avoid dehydration. All scans were performed using 
the same settings and all data were reconstructed identically.
Using Skyscan analysis software, these datasets were segmented using a fixed 
attenuation threshold between air (25 gray value) and subchondral bone (120 gray 
value) that was selected visually for the best segmentation result in all datasets. In all 
segmented μCT datasets, similar ROIs of the cartilage regions corresponding with ROIs 
of the clinical CTa were drawn and the mean X-ray attenuation was calculated again. 
These μCT based mean attenuation values were used as the reference for sGAG content 
against which the attenuation values on ncCT and CTa were compared.
Contrast diffusion influenced by structural composition of cartilage eCm
An important difference between the μCT and CTa scans is that with μCT scanning, 
the contrast agent and sGAG are partitioned at equilibrium. However, the principle of 
CTa is dependent on a diffusion process before equilibrium, which is influenced by the 
electrostatic interaction between sGAG and ioxaglate 81. Therefore, measurements from 
non-equilibrium CTa are also influenced by other factors than sGAG content alone207-209. 
In particular, so-called tissue dragging influences the interaction between contrast and 
sGAG 210, 211. A high tissue drag results from an intact collagen network and is predomi-
nantly present in the top layers of healthy cartilage where collagen is densely packed 
parallel to the cartilage surface and acts as a barrier membrane 212, 213. Consequently, 
contrast diffusion goes slowly in regions with high tissue drag. When collagen is struc-
turally impaired, e.g. in OA, tissue dragging diminishes and more contrast penetrates in 
comparison to healthy cartilage due to a higher diffusion rate.
In non-contrast CT, X-ray attenuation of cartilage results only from initial dissimilari-
ties in cartilage composition (e.g. collagen, sGAG and water content). Together with the 
information on sGAG content from μCT, the influence of this structural composition of 
the cartilage on CTa outcome was further investigated using statistical models.




To assess if the influx of contrast agent into the cartilage could be detected, we com-
pared the attenuation values per anatomical region between ncCT and CTa scans with 
paired student’s t-tests. To evaluate to what extent the attenuation values represented 
sGAG content, we fitted linear regression models of the mean X-ray attenuation values 
of both the ncCT and CTa to the results of μCT scans for each knee compartment, of 
which we report the Pearson’s correlation coefficients. To test if the correlation with μCT 
was different between ncCT and CTa, we compared the slopes of both models. These 
analyses were performed using GraphPad (GraphPad Software Inc., San Diego, USA).
In this study we used thirteen knees from eleven individuals. The use of two knees 
from one individual could potentially lead to an overestimation of the correlation 
between μCT and CTa measurements 214, 215. Exclusion of either one of the knees in the 
two patients that were scanned bilaterally did, however, not influence the results of our 
study. Therefore, we did not apply a statistical correction.
Next, we investigated to what extent the influx of contrast was influenced by struc-
tural composition of cartilage ECM itself. The spatial variation in X-ray attenuation inside 
cartilage from ncCT scans is related to both structural composition of cartilage ECM 
and its sGAG content. Thus, when ncCT attenuation values are fitted to μCT values 
(representing sGAG content) using linear regression, the residuals, which is that part 
of the ncCT values which is not explained by μCT, contain information on structural 
composition independent of sGAG content. When these residuals are subsequently 
added as a covariable to the linear regression model that relates CTa to μCT values, the 
contribution of these residuals to the model represent the extent to which the influx of 
the contrast is influenced by structural composition of the cartilage ECM, independent 
of sGAG content. These analyses were performed using SPSS (SPSS Inc., Chicago, USA). 
All p-values < 0.05 were considered to be statistically significant.
resulTs
Cadaver subjects
After CT scanning, three extremities were excluded from the study due to clearly visible 
calcifications inside the cartilage. Thus, a total of ten cadaveric knee joints from nine 
individuals were included in the analysis (six female, three male; mean age at death 
69 years; age range at death 30 – 94 years). ). Furthermore, 12 cartilage ROIs were not 
included in our data analysis because of (motion) artifacts during µCT scanning and 
segmentation errors because of severe cartilage loss 81.
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sGaG correlation in ncCT and CTa
Mean X-ray attenuation results showed clear differences between the anatomical 
cartilage locations and between ncCT and CTa outcomes. In all locations, cartilage at-
tenuation increased significantly after injection of contrast agent (Figure 3A).
Cartilage X-ray attenuation in ncCT correlated moderately with μCT (n=57, R=0.45; 
R2=0.20; p=0.0003). The correlation between cartilage X-ray attenuation from CTa scans 
and μCT was strong (n=57, R=0.86; R2=0.73; p<0.0001) (Figure 3B). The slopes of both 
regression lines were significantly different (p < 0.0001).
sGaG content per anatomical location
The cartilage attenuation derived from CTa for all separate anatomical compartments 
correlated strongly with attenuation from μCT (wbMP, wbLP: n=17, R=0.89, R2=0.79, 
p<0.0001; wbMC, wbLC, pMC, pLC: n=33, R=0.87, R2=0.75, p<0.0001; patella: n=8, 
R=0.89 R2=0.7P, p=0.003; Figure 4A-C). There was a clear trend for all posterior condyle 
regions to have lower mean attenuation values, indicating that less contrast penetrated 
this less weight-bearing cartilage. The patellar values were clustered in a different loca-
tion than the values for the other anatomical regions. When the data was analyzed for 
the tibiofemoral cartilage, the correlation coefficient was 0.92 (n=49, R2=0.85, p<0.0001, 
Figure  4D). When all regions (including mpP cartilage) were pooled, the correlation 
diminished slightly (n=57, R=0.86, R2=0.73, p<0.0001, Figure 4E).
To display the spatial agreement of both techniques, Figure 5 shows representative 
images for cartilage attenuation for both CTa and μCT.
Figure 3: Contrast diffusion into cartilage. Comparison of cartilage attenuation between non-contrast CT (ncCT) and 
CT arthrography (CTa) scans. A: Box plot of mean attenuation in cartilage from CT and CTa scans per anatomical 
region. Boxes range from 25th to 75th percentile, whiskers run from min to max, the horizontal line in the box represents 
the median and the plus sign shows the mean. B: Correlated results of mean attenuation from EPIC-μCT and clinical CT 
scans with and without injected contrast for all anatomical regions combined (n = 57). ***: p < 0.0001
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CTa corrected for structural composition of cartilage eCm
Figure  6 shows the results of the additional analysis into the role of structural com-
position of cartilage ECM for non-equilibrium CTa scans. When residual values from 
the model that fits μCT to ncCT, which represents structural composition of the ECM 
independent of sGAG, were added as a covariate to the model that fits μCT to CTa, the 
correlation coefficient was 0.95 (n=57, R2=0.90; p<0.0001).
Figure 4: Correlation plots of mean attenuation from EPIC-μCT and CT arthrography. A: weight-bearing cartilage of me-
dial and lateral plateaus (n=17). B: weight-bearing and posterior cartilage of medial and lateral condyles (n=17). C: mid-
portion of patellar cartilage (n=8). D: pooled results for both tibial and femoral compartments (n=49). E: pooled results 
for all regions of interest (n=57). The dashed lines indicate the 95% confidence interval of the best fit regression line. wbMP: 
weight-bearing medial plateau, wbMC: weight-bearing medial condyle, pMC: posterior medial condyle, mpP: mid-por-
tion patella, wbLP: weight-bearing lateral plateau, wbLC: weight-bearing lateral condyle, pLC: posterior lateral condyle.
Figure 5: Images of both EPIC-μCT and CT arthrography. The attenuation of cartilage regions is visualized in color and 
representative for sGAG content. High levels of attenuation represent a low sGAG-distribution.
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dIsCussIon
Quantitative imaging techniques are of the utmost necessity for development and 
monitoring of treatment strategies targeted at early OA. Therefore, imaging techniques 
(e.g. like dGEMRIC) are extensively studied for their capability to measure sGAG content. 
This cadaver study demonstrates that cartilage attenuation from CTa is influenced by 
ioxaglate diffusion. And intra-articular injection of ionic ioxaglate significantly improved 
the correlation with the outcome of μCT. These results are similar to previous non-
clinical reports 78, 208, 216, supporting our hypothesis that CTa can be used as a quantita-
tive surrogate measure of the cartilage sulphated-glycosaminoglycan content.
Patellar cartilage is known to have a different structural ECM composition 217, 218. 
In the μCT and CTa scatter plot the patellar values were located differently than the 
other anatomical locations. Exclusion of patellar cartilage from our analysis improved 
the predictive value of CTa for sGAG content (R2 from 73% to 85%), indicating that 
structural composition of cartilage ECM influences the outcome of non-equilibrium 
CTa. When residual ncCT values representing structural composition of cartilage ECM 
were combined with μCT (sGAG content) as a predictive value for CTa, the R2 values 
from the model fit to CTa increased from 73% to 90%. This improvement indicates to 
what extent contrast diffusion into cartilage is influenced by structural composition 
of cartilage ECM. In clinical practice, a correction for different contrast diffusion rates 
Figure 6: Predictive CT arthrography value (horizontal axis) based best fitted model from EPIC-μCT (sGAG) and non-
contrast CT residuals (cartilage ECM composition) correlated with mean attenuation of CT arthrography (vertical axis) 
(n=57). The dashed lines indicate the 95% confidence interval of the best fit regression line. wbMP: weight-bearing me-
dial plateau, wbMC: weight-bearing medial condyle, pMC: posterior medial condyle, mpP: mid-portion patella, wbLP: 
weight-bearing lateral plateau, wbLC: weight-bearing lateral condyle, pLC: posterior lateral condyle.
Jasper Tiel - Binnenwerk cp7.indd   114 30-09-15   10:34
115
7
cannot be calculated, since a reference standard for sGAG like EPIC-μCT is not avail-
able in clinical practice. Therefore, cartilage X-ray attenuation from CTa does not solely 
resemble sGAG content, but reflects a quality measure of cartilage, which also concerns 
the structural integrity of the ECM.
Despite these encouraging results, there are limitations of CTa that need to be ad-
dressed. For example, the intra-articular injection introduces the risk of infection and 
also increases the risk of patient complaint of knee pain after injection. Furthermore, 
the high concentrations of ioxaglate used in this study, could influence cartilage 
electro-mechanical properties 219.
CTa is best applied in early stages of OA, because with severe sGAG loss in advanced 
stages of OA segmentation errors will occur 81. Usually, early OA progression develops in 
relatively young patients and obviously the main concern with (repetitive) CT scans at a 
younger age is radiation exposure. The total dose of the scanning protocol in this study 
(~2 mSv) was ten times higher in comparison to previously defined radiation doses of 
routine knee CT scans (~0.2 mSv) 220. More research is needed to determine whether 
the same correlation with sGAG content can be measured if radiation dose is reduced.
MRI uses no ionizing radiation and during the last years, has seen a rapid improve-
ment with several newly developed MR-based imaging techniques to measure articular 
cartilage quality (e.g. dGEMRIC, Na23 mapping, T2 mapping, and T1rho 154, 221. Thanks to 
the more widespread availability of 3.0 Tesla MR systems and the development of novel 
MRI sequences (e.g. Ultrashort TE 222, SSFP 223, UTE T2* 224, and DENSE-FSE 225), relatively 
fast MR scans can be acquired with high in plane resolution for (semi)quantitative car-
tilage imaging in OA research. However, these techniques still have several limitations: 
relative (e.g. claustrophobia) or absolute (e.g. pacemaker) contraindications for patients 
to undergo MRI, relatively low spatial resolution, and costs 226).
Given our results in relation to previously reported outcomes of in vivo μCT arthrog-
raphy studies in small animals with an intact circulation 80, 81, we believe that CTa may 
be able to measure cartilage quality in human patients in a clinical setting. CT has a 
short scanning time (~30 seconds), generates images with a high isotropic resolution. 
Therefore, CT techniques may be a valuable alternative to MR techniques, but more 
research is needed for this technique to find its place in clinics and research.
In our opinion, research should first focus on optimizing the CTa protocol for clinical 
use. The reproducibility of CTa measurements should be evaluated in an in vivo environ-
ment in which all factors that influence CTa outcomes are present (intact circulation, 
muscle tension, joint capsule strength, etc.). Future studies could also focus on the 
fact that recent in vitro studies indicate that X-ray attenuation of cartilage can predict 
certain biomechanical properties such as compressive stiffness 216. Our finding that CTa 
outcome is influenced by sGAG and structural composition of cartilage ECM could be 
used to predict the biomechanical function of articular cartilage with CT.
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In conclusion, the results of this cadaver study demonstrate the proof-of-principle 
that CTa is able to measure cartilage quality in human knee joints. A wide implementa-
tion of this quantitative analysis of articular cartilage may detect early changes in OA 
patients and may contribute to the development of new treatment strategies.
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Recently, CT arthrography (CTa) was introduced as a possible technique to quantita-
tively measure cartilage quality in human knees. This study investigated whether this 
is also possible using lower radiation dose CT protocols. Furthermore, we studied the 
ability of (lower radiation) CTa to distinguish between local sGAG content differences.
materials and methods
Of ten human cadaveric knee joints, six CT scans using different radiation doses (81.33-
8.13mGy) were acquired after intra-articular ioxaglate injection. The capability of CTa to 
measure overall cartilage quality was determined in seven anatomical regions of inter-
est (ROIs), using EPIC-μCT as reference standard for sGAG content. To test the capability 
of CTa to spatially distinguish between local differences in sGAG content, we calculated 
the percentage of pixels incorrectly predicted as having high or low sGAG content by 
the different CTa protocols.
results
Low radiation dose CTa correlated well with EPIC-μCT in large ROIs 
(R=0.78;R2=0.61;p<0.0001). CTa can also distinguish between high and low sGAG 
content within a single slice. However, the percentage of incorrectly predicted quality 
pixels increases (from 35% to 41%) when less radiation is used. This makes is hard or 
even impossible to differentiate between spatial differences in sGAG content in the 
lowest radiation scans.
Conclusion
CTa acquired using low radiation exposure, comparable to a regular knee CT, is able 
to measure overall cartilage quality. Spatial sGAG distribution can also be determined 
using CTa, however for this purpose a higher radiation dose is necessary. Nevertheless, 
radiation dose reduction makes CTa suitable for quantitative analysis of cartilage in 
clinical research.




The current reference standard for grading the severity of osteoarthritis (OA) in the knee 
is the radiography based Kellgren and Lawrence score 28. This technique is, however, 
not sensitive enough to detect or follow OA at an early stage of the disease because it 
only indirectly visualizes the cartilage and is not able to (semi)quantitatively measure 
cartilage quality 33. Therefore, sophisticated magnetic resonance imaging (MRI) imag-
ing techniques have been developed which can qualitatively measure cartilage quality 
in terms of the sulphated glycosaminoglycan (sGAG), collagen or sodium content of 
articular cartilage 116, 154, 155.
Recently, it has been shown that CT arthrography of the knee (CTa) is able to measure 
overall cartilage quality in large anatomical cartilage regions in human cadaveric knees 
200. Similar to micro CT (µCT) arthrography in small animals 80, 81 and delayed gadolinium 
enhanced MRI of cartilage (dGEMRIC) in humans 65, 95, 227, this technique uses the in-
versed relationship between a negatively charged contrast agent (ioxaglate) and the 
sGAG content of cartilage.
The reported CTa protocol has a CT-Dose Index (CTDIvol) of 81.33 mGy per CTa scan, 
which poses a limitation on this technique 220. Therefore, the radiation dose must be 
reduced before CTa can be used in clinical research. The use of less radiation to acquire 
CT scans results however, in an increase of noise in the reconstructed CT images. This 
increase of noise may influence the measured X-ray attenuation values and therefore 
interfere with the capability of measuring quality of cartilage using CTa.
Therefore, we designed a cadaver study with the purpose to investigate the effect 
of radiation dose reduction of CTa on its ability to measure articular cartilage quality in 
large cartilage regions. We also assessed the capability of CTa to distinguish between 
spatial high and low sGAG content of cartilage on a single slice and the influence of 
radiation dose reduction on this capability. The latter is of interest because it could 
enable the use of CTa as a tool to diagnose (focal) cartilage defects and follow the repair 
in these defects over time.
maTerIals and meThods
Cadaveric knee joints
For this study, we used ten randomly selected cadaveric lower extremities from eight 
individuals who had donated their bodies to science. All extremities were frozen at 
-20ºC directly after death. Before the start of the experiment, the specimens were de-
frosted slowly in a cooled environment (7ºC) for five days. All extremities were at room 
temperature during imaging procedures.
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acquisition and post processing of CT arthrography data
We injected 20 milliliters of 30% ioxaglate dilution (Hexabrix 320, Mallinckrodt, Hazel-
wood, MO, USA and saline) intra-articularly in all knee joints, using an 18 gauge needle. 
After the injection, we flexed (~120°) and extended (~0°) the knee joints for five minutes 
in order to achieve optimal distribution of the contrast agent throughout the joint cav-
ity. Ten minutes after contrast injection, CTa scans of all knee joints were acquired using 
a second generation dual source multidetector spiral CT scanner (SOMATOM Definition 
Flash, Siemens Healthcare AG, Erlangen, Germany) with a tube voltage of 80 kV, an effec-
tive mAs value of 3140 mAs, a pitch of 0.35 and a collimation of 32 x 0.6 mm, resulting 
in a CTDIvol of 81.33 mGy 200. This protocol will be referred to as maximum dose in this 
paper. Directly after the first scan, five additional scans were acquired using the same 
tube voltage (80kV), but with reduced radiation exposures: 1570 mAs (50%), 1256 mAs 
(40%), 942 mAs (30%), 628 mAs (20%) and 314 mAs (10%) per scan. All knee joints were 
scanned in the axial plane with a scanning time of 30 seconds per scan. All CT datasets 
were reconstructed with an effective slice thickness of 0.75 mm and a sharp reconstruc-
tion kernel. Multiplanar reconstruction was performed (image pixel size 0.265mm).
Using Skyscan analysis software (Skyscan, Kontich, Belgium), we segmented all CT 
datasets into binary datasets using one fixed attenuation threshold of 500 Hounsfield 
units (HU) that was selected because it resulted in the best segmentation of the carti-
lage 200 . Next, we manually defined seven anatomical cartilage regions of interest (ROIs) 
in all CT datasets based on the nomenclature and scheme as suggested by Eckstein et 
al. 120. Each ROI consisted of 40 consecutive slices covering the central weight bearing 
area of the cartilage of both the medial and lateral femoral condyles (wbMC and wbLC), 
the posterior non-weight bearing cartilage area of both femoral condyles (pMC and 
pLC), both weight bearing medial and lateral tibial plateaus (wbMP and wbLP) and 
Figure 1: 3D representation of the seven analyzed large cartilage ROIs per knee joint: (A) posterior medial and lateral 
condyle of the femur (pMC/pLC); (B) weight-bearing medial and lateral femoral condyle (wbMC/wbLC); (C) weight-
bearing medial and lateral plateau of the tibia (wbMP/wbLP) and mid portion of patellar cartilage (mpP).
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the mid-portion of the patellar cartilage (mpP) (Figure 1A-C). After defining all ROIs, we 
calculated the mean X-ray attenuation per cartilage ROI on the CTa scans.
equilibrium partitioning of an ionic contrast agent using µCT
Mean X-ray attenuation values of equilibrium partitioning of an ionic contrast agent 
using (EPIC)-μCT have a good correlation with the sGAG content of articular cartilage 
measured with a dimethylmethylene blue essay or quantified with optical density 
measurements 78, 79, 203. Therefore, we selected the outcomes of EPIC-μCT in mean X-ray 
attenuation values as our reference test of sGAG content of articular cartilage.
After CTa, all knee joints were dissected into five parts: the medial and lateral femoral 
condyles, the medial and lateral tibial plateaus and the patella. Soft tissue was removed 
to a maximal extent, without harming the integrity of the cartilage. In order to achieve 
equilibrium between the contrast agent and the sGAG content of the cartilage, all dis-
sected specimens were incubated in an ioxaglate dilution (Hexabrix 320, Mallinckrodt, 
Hazelwood, MO, USA and saline) for 24 hours at room temperature 207-209. We used a 
20% dilution of ioxaglate, which resulted in the best cartilage segmentation at the air/
cartilage and bone/cartilage interfaces 200 .
μCT scans were performed on a Skyscan 1076 in vivo μCT scanner (Skyscan, Kontich, 
Belgium). The following scan settings were used: isotropic voxel size of 35 μm; a voltage 
of 55 kV; a current of 181 mA; field of view 68 mm; a 0.5 mm aluminum filter; 198o with 
a 0.4 degree rotation step 200 . Scanning time per specimen was 6 - 10 hours, depending 
on the size of the specimen (patella, plateau or condyle). A plastic foil was wrapped 
around the specimen to avoid dehydration during scanning. All scans were performed 
using the same settings and all data were reconstructed identically.
Using Skyscan analysis software, we segmented the μCT datasets using a fixed at-
tenuation threshold between air and subchondral bone that was selected visually for 
the best segmentation result in all datasets 200. In all segmented μCT datasets, seven 
anatomical ROIs of the cartilage corresponding with ROIs of the CTa were drawn manu-
ally and the mean X-ray attenuation per ROI was calculated.
spatial analysis of cartilage quality
Using commercially available software (Matlab version 7.1, MathWorks, Natick, MA, USA 
and Multimodality Image Registration using Information Theory (MIRIT), Laboratory 
for Medical Imaging Research, Leuven, Belgium 228), all CTa (50%, 40%, 30%, 20% and 
10%) and EPIC-μCT datasets were registered using the dataset that was acquired at the 
maximum dose as reference. Registration of the datasets enabled comparison of cor-
responding cartilage regions (femoral condyles, tibial plateaus and patellar cartilage) in 
all CTa scans per knee.
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To study the capability of CTa to analyze the spatial distribution of high and low sGAG 
content in cartilage and the influence of radiation dose reduction on this capability, 
we used the EPIC-µCT as reference standard for spatial sGAG distribution in cartilage 
(Figure  2A) 78, 79, 203. Using Skyscan analysis software, we defined an area of high and 
low sGAG content in the cartilage within a central slice through the medial and lateral 
tibiofemoral joint and on a central slice of the mid-potion of the patellar cartilage in all 
CTa datasets (maximum dose, 50%, 40%, etc.) (Figure 2B-D). To define these areas (which 
we will refer to as masks from now on), we used 150 HU as cut-off point between high 
and low sGAG content of cartilage. We used this number based on the point where 
the cumulative histogram of all cartilage ROIs used in the spatial analysis of cartilage 
reaches 50% (Figure 3). Next, both masks for sGAG distribution were used as an overlay 
for cartilage on the registered corresponding EPIC-µCT images (Figure 2E-F). Within the 
masked EPIC-µCT images, we calculated the number of pixels defined as having high 
Figure 2: EPIC-µCT datasets are used as reference for the spatial sGAG distribution of cartilage (A). Using a fixed X-ray 
attenuation threshold of 150 Hounsfield Units in all CTa datasets (B, only maximum radiation dose shown), a mask for 
high and low sGAG content was created (C-D). The masks were used as an overlay of EPIC-µCT cartilage (E-F). Within 
the masked EPIC-µCT images, the number of pixels correctly and incorrectly predicted as having a high and low sGAG 
content by CTa was calculated (G-H). #: high sGAG content. *: low sGAG content.
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or low sGAG content by CTa, using a threshold of 70 gray values for EPIC-µCT. This was 
again based on the cumulative histogram of all cartilage ROIs on the EPIC-µCT images 
(Figure 3). Finally, we calculated the number of pixels which were incorrectly defined 
as high or low quality by CTa by adding the number of incorrectly defined pixels in 
both masks, dividing them by the total number of pixels in both masks together and 
then multiplying them by 100 to obtain the percentage of incorrectly defined pixels 
(Figure 2G-H).
statistical analysis
In this study we used ten knees from eight individuals. The use of two knees from one 
individual could potentially lead to an overestimation of the correlation between μCT 
and CTa measurements 214, 215. Exclusion of either one of the knees in the two patients 
that were scanned bilaterally did not influence the results of our study. Therefore, we 
decided to exclude the bilaterally scanned knees from the analysis.
The correlation between the mean X-ray attenuation values of CTa and the mean 
X-ray attenuation values of EPIC-μCT was calculated per radiation dose for all cartilage 
ROIs pooled. Because of the fact that we analyzed seven cartilage ROIs per knee joint 
and the potential correlation which might already exist within all knee joints itself, 
we used a linear mixed model to analyze if the correlation coefficients between, CTa 
outcomes and EPIC-μCT outcomes were statistically significant.
All analyses were performed using GraphPad (GraphPad Software Inc., San Diego, 
USA) and SPSS version 17.0 (SPSS Inc., Chicago, USA). All p-values < 0.05 were consid-
ered to be statistically significant.
Figure 3: Cumulative histograms of both CT arthrography (A) and EPIC-µCT (B). On the x-axis the attenuation values 
in Hounsfield Units (CT arthrography) and gray values (EPIC-µCT), the y-axis indicates the percentage of pixels within 
the histogram with a certain attenuation value and all attenuation values below that value. With the black line, we 
have visualized the level of our selected thresholds (50% of the cumulative histogram) per technique as cut-of point 
between high and low sGAG content of cartilage (CT arthrography 150 Hounsfield Units, EPIC-µCT 70 gray values).




After CT scanning, four knees were excluded from the study due to clearly visible calci-
fications in the cartilage and due to the fact that from two individuals two knees were 
scanned. Thus, a total of six cadaveric knee joints from six individuals were included in 
the analysis (three female, three male; mean age at death 72 years; age range at death 
30 – 94 years). Furthermore, 12 cartilage ROIs were not included in our data analysis 
because of motion artifacts during µCT scanning and segmentation errors due to 
severe cartilage loss 81.
Figure 4: Correlation plots of mean attenuation from EPIC-μCT and CT arthrography acquired using six different ra-
diation doses. A: maximum radiation dose (n=33); B: 50% of the maximum radiation dose (n=33); C: 40% of the maxi-
mum radiation dose (n=33); D: 30% of the maximum radiation dose (n=33); E: 20% of the maximum radiation dose 
(n=33); F: 10% of the maximum radiation dose (n=33). The dashed lines indicate the 95% confidence interval of the 
best fit regression line. wbMP: weight-bearing medial plateau; wbMC: weight-bearing medial condyle; pMC: posterior 
medial condyle; mpP: mid-portion patella; wbLP: weight-bearing lateral plateau; wbLC: weight-bearing lateral con-
dyle; pLC: posterior lateral condyle.
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Correlation of CTa with sGaG content in large anatomical roIs
Mean X-ray attenuation values of the CTa scans acquired with maximum radiation cor-
related strongly with the sGAG content of cartilage expressed by EPIC-μCT attenuation 
values (n=33; R=0.81; R2=0.66; p<0.0001) (Figure  4A). In the analysis of the additional 
CTa scans with reduced radiation dose, this correlation remained strong when radia-
tion dose was reduced; 50% of the maximum radiation dose (n=33; R=0.78; R2=0.60; 
p<0.0001), 40% of the maximum radiation dose (n=33; R=0.76; R2=0.58; p<0.0001), 30% 
of the maximum radiation dose (n=33; R=0.76; R2=0.59; p<0.0001), 20% of the maximum 
radiation dose (n=33; R=0.77; R2=0.59; p<0.0001), and 10% of the maximum radiation 
dose (n=33; R=0.78; R2=0.61; p<0.0001) radiation dose per scan was used (Figure 4B-F).
spatial analysis of cartilage quality
The number of pixels that were incorrectly defined as having high or low sGAG content 
by CTa was lowest in the CTa scan acquired using the maximum radiation dose (35% ± 
9%) (Figure 5). When less radiation was used to obtain CTa, the number of pixels which 
were incorrectly defined as high and low quality cartilage increased (50% radiation: 
37% ± 9%, 40% radiation: 38% ± 9%, 30% radiation: 38% ± 9%, 20% radiation: 39% ± 
9%, 10% radiation: 40% ± 9%) (Figure 5). The effect of this increase in incorrectly defined 
pixels on the capability of CTa to distinguish between the spatial distribution of high 
and low sGAG content of cartilage within a single slice is clearly visible in Figure 6.
Figure 5: Bar graphs showing the percentage of pixels incorrectly predicted as high and low sGAG content by the dif-
ferent radiation doses (maximum, 50%, 40%, 30%, 20% and 10% of the maximum dose) used in this study. Whiskers 
show the 95% confidence interval of the mean.
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Figure 6: Registered images of both EPIC-μCT and CT arthrography acquired using different radiation doses (maxi-
mum radiation dose, 50%, 40%, 30%, 20% and 10% of the maximum radiation dose) per scan. The attenuation of 
cartilage regions is visualized in color and representative for the sGAG content of the cartilage. High attenuation values 
represent low sGAG content and low attenuation values represent high sGAG content.




Recently, CTa was introduced as a non-destructive method to measure cartilage quality 
in human cadaveric knees 200 . The main aim of the present cadaver study was to assess 
whether radiation dose reduction influences the ability of CTa to measure cartilage 
quality. Lowering the ionizing radiation dose of the acquisition protocol is necessary 
to make CTa suitable and acceptable for use in clinical research in humans. The results 
of this study demonstrate that mean attenuation values in large anatomical ROIs in 
CTa acquired with different radiation doses are strongly correlated with the sGAG 
content of articular cartilage measured with EPIC-μCT. This correlation was similar to 
previous reported results in cadavers 200 and also similar to previously published in vitro 
results 78, 208, 216. When the radiation dose used to acquire CT scans was decreased, the 
correlation between CTa X-ray attenuation values and the sGAG content of cartilage 
only slightly decreased, but remained good, even if the radiation dose was reduced to 
approximately 10% of the original dose. The correlation between X-ray attenuation and 
the reference test for sGAG content remains relatively good because of the fact that 
the noise in the CT images averages out when calculating the mean X-ray attenuation 
values in relatively large cartilage ROIs.
The second aim of this study was to assess the capability of CTa to detect local differ-
ences in the sGAG content of articular cartilage and to study the effect of radiation dose 
reduction on this differentiation of cartilage quality within a single slice. The ability to 
detect local differences in cartilage sGAG content could make CTa applicable as a diag-
nostic tool for focal cartilage damage instead of a diagnostic arthroscopy. Additionally, 
it would enable the use of CTa as an imaging tool to measure the effect of cartilage 
repair therapies (e.g. microfracturing and autologous chondrocyte implantation 14, 
126 similar to MRI based techniques like dGEMRIC 111, 114. Our results demonstrate that, 
using CTa acquired using the maximum radiation dose, high and low sGAG distribu-
tion can be clearly distinguished. An important remark is that the choice of the used 
thresholds for defining high and low sGAG content within the cartilage based on the 
pooled cumulative histograms has an arbitrary component. This might introduce an 
over or underestimation of the capability of CTa to determine local sGAG differences. 
The increase of noise in the CT image obtained using lowered radiation doses, however, 
causes an increased percentage of incorrectly defined pixels with high and low sGAG 
content. In the lowest radiation dose used to obtain CTa, the increased noise even 
makes it impossible to distinguish differences in sGAG distribution from noise in the 
CT images.
Based on the results of this study, we suggest using a CTa protocol with a low radia-
tion dose if overall cartilage quality is of interest in clinical research. The lowest radiation 
dose we used (CTDIvol of 8.13 mGy per scan) is comparable to the dose of a regular CT 
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scan of the knee (CTDIvol of approximately 8 mGy 220). In addition to cartilage quality, 
morphological abnormalities can also be diagnosed using CTa with accuracy compa-
rable to conventional MRI sequences. This was demonstrated in previous research by 
De Filippo et al. and Vande Berg et al. 82, 229, however, we did not investigate this in 
the present study. If the spatial distribution of sGAG on a single slice is of interest, we 
recommend using a higher radiation dose than for overall cartilage quality measure-
ments since decrease in CNR increases the number of incorrectly predicted quality 
pixels and makes it hard or impossible to differentiate high from low quality cartilage 
at low radiation dose scans.
Despite the promising results, a limitation of CTa will remain the use of ionizing radia-
tion, because of the risk of predisposing patients to the development of certain cancers 
by using (repetitive) CT scans 220. Therefore, MRI based techniques which quantitatively 
measure cartilage quality (e.g. dGEMRIC, Na23 mapping, T2 mapping, and T1rho 154, 155) 
remain favorable in a clinical research setting in large cohorts in humans. However, we 
think that by using a relatively low radiation dose protocol, subgroups of patients in 
which CTa is favorable of MRI can be identified (e.g. patients with contra-indications to 
undergo MRI). In addition, CT has also some advantages over MRI (e.g., relative short 
acquisition time and low costs). Therefore, we expect that low radiation dose CTa 
can become a complementary technique to MRI based techniques to quantitatively 
measure cartilage quality in clinical research. In addition to ionizing radiation, other 
potential limitations of CTa when applied in humans are: the risk of infection and pain 
due to the intra-articular injection with contrast agent, and the risk of an (allergic) reac-
tion to the contrast agent.
Future research using CTa should focus on implementing and validating CTa in a 
clinical research setting in humans in vivo using a low radiation dose protocol. Filtering 
the CT data using a low-pass image processing filter will diminish the amount of noise 
in CT images and might enable the use of even less radiation than suggested in our 
study. A drawback of using such a filter is, however, the decrease in spatial resolution 
of the CT images. Another method to lower the radiation dose is the use of an iterative 
reconstruction algorithm 230, 231 instead of the standard filtered back projection image 
reconstruction algorithm as used in this study. Because of the high in plane resolution 
of CT images acquired with multidetector CT scanners, future research could also focus 
on investigating the potential of CTa to detect subchondral bone changes and changes 
in cartilage quality simultaneously. Recently, the feasibility of contrast-enhanced pe-
ripheral quantitative CT to analyze cartilage and subchondral bone status on a single 
scan in vitro was described 232 and therefore it is of interest to test this as well as in vivo 
using CTa.
In conclusion, CTa acquired using a low radiation dose is able to measure overall 
articular cartilage quality throughout the whole human knee with a radiation dose 
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comparable to a regular CT scan of the knee. Spatial sGAG distribution assessment is 
also possible using CTa, however for this purpose a higher radiation dose is necessary. 
Nevertheless, due to the reduction in radiation dose, CTa might be implemented as a 
non-destructive tool to quantitatively measure articular cartilage in clinical research.
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validation of CT arthrography 
as imaging biomarker in human 
osteoarthritis research
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Recently, computed tomography arthrography (CTa) was introduced as quantitative 
imaging biomarker to estimate cartilage sulphated glycosaminoglycan (sGAG) content 
in human cadaveric knees. The aim of the present study was to assess the correlation 
between in vivo CTa in human knees with osteoarthritis (OA) and ex vivo reference 
standards for sGAG and collagen content.
materials and methods
In this prospective observational study 11 knee OA patients underwent CTa before 
total knee replacement (TKR). Cartilage CTa X-ray attenuation was determined in 6 
anatomical regions of interest. Femoral and tibial cartilage specimens harvested during 
TKR were scanned using equilibrium partitioning of an ionic contrast agent with micro-
CT (EPIC-μCT), which served as reference standard for sGAG. Next, cartilage sGAG 
and collagen content were determined using dimethylmethylene blue (DMMB) and 
hydroxyproline assays. The correlation between CTa X-ray attenuation, EPIC-μCT X-ray 
attenuation, sGAG content and collagen content was assessed.
results
CTa X-ray attenuation correlated well with EPIC-μCT (r=0.76, 95% confidence interval 
(95%CI) 0.64 to 0.85). CTa correlated moderately with the DMMB assay for sGAG content 
(r=-0.66, 95%CI -0.87 to -0.49) and to lesser extent with the hydroxyproline assay for 
collagen content (r=-0.56, 95%CI -0.70 to -0.36).
Conclusion
Outcomes of CTa applied in vivo in human OA knees correlates well with sGAG content. 
Outcomes of CTa also slightly correlate with cartilage collagen content. However, since 
outcomes of CTa are mainly sGAG dependent, CTa may be suitable as quantitative 
imaging biomarker to estimate cartilage sGAG content in future clinical OA research.




Knee osteoarthritis (OA) is the most common joint disease in middle-aged and elderly, 
causing serious morbidity and large socio-economic impact 8, 9. Since no definitive 
treatment options other than joint replacement surgery in end stage OA are available, 
research focuses on development of disease-modifying osteoarthritis drugs (DMOADs) 
which may be effective in early OA, for example by improving cartilage biochemical 
composition 13, 128.
To non-invasively monitor effectiveness of these novel interventions on cartilage 
biochemical composition, imaging techniques are essential. Therefore, quantitative 
imaging assessing important cartilage composites i.e. sulphated glycosaminoglycan 
(sGAG) and collagen, became of interest 129 .
Most imaging techniques applied in clinical research are magnetic resonance imag-
ing (MRI) based, e.g. delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) for ana-
lyzing sGAG content 93 and T2-mapping for analyzing collagen content 233. Computed 
tomography (CT) based techniques have also been developed, but are mainly applied 
in in vitro or animal research. Examples are: equilibrium partitioning of an ionic contrast 
agent using micro-CT (EPIC-μCT) and μCT arthrography estimate sGAG content 78-81, 203, 
234, 235.
Recently, a clinically applicable protocol for CT arthrography (CTa) was introduced 
as a potential alternative technique to MRI based estimate of cartilage biochemical 
composition 200. Ex vivo CTa in human cadaveric knee joints was shown to be a quan-
titative imaging biomarker cartilage sGAG content by exploiting its inverse relation 
with an ionic contrast agent similar to dGEMRIC 200. However, outcomes of CTa were 
also dependent on integrity of the collagen network of cartilage, which influences 
the speed of contrast influx into cartilage 200. Although CTa was already applied in vivo 
by comparing its outcomes to dGEMRIC and cartilage morphology observed during 
arthroscopy 236, 237, these studies did not assess the correlation between CTa and refer-
ence standards for cartilage biochemical composition and were not performed in knee 
OA patients which constitute an important target population for quantitative imaging 
techniques for cartilage composition.
The aim of this study was to assess the correlation between in vivo CTa in human 
knees with OA and ex vivo reference standards for sGAG and collagen content.
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maTerIals and meThods
study design and participants
For this prospective observational study, conducted between October 2012 and De-
cember 2013, all consecutive patients scheduled for total knee replacement (TKR) at 
our institution were approached.
The inclusion criteria were: age ≥ 18 years and radiographic knee OA with asymmetric 
distribution and a maximum of grade 1-2 (doubtful or definite osteophyte formation 
without definite joint space narrowing) according to the Kellgren & Lawrence (KL) grad-
ing system 28 in the least affected tibiofemoral compartment. We chose to include only 
these patients to be sure that we captured a relatively wide range of cartilage quality and 
therefore also sGAG content of the articular cartilage. Exclusion criteria were: glomerular 
filtration rate < 60 ml/min, previous reactions to CT contrast agent and co-morbidities 
in the ipsilateral lower extremity precluding exercise after contrast administration.
We performed a power analysis in which we used the Fisher transformation 238 to 
assess the number of measurements needed to establish a correlation coefficient of at 
least 0.7 (considered a good correlation 239) with a predefined 95% confidence interval 
(95%CI) width of 0.5 - 0.9, and found that 25 measurements would be needed. Since six 
measurements are performed per participant, three participants would be enough for 
our study. Because we considered this number very low, we decided to include at least 
10 participants (60 measurements for the correlation analyses) until the end date of the 
study (December 2013).
The study was approved by the institutional review board of our institution (MEC-
2012-218) and written informed consent was obtained from all participants.
acquisition of CT arthrography
CTa was performed four weeks before TKR. This time window was chosen to allow detec-
tion of infection caused by the intra-articular injection well before surgery. Patients were 
positioned in a supine position and after disinfection, 15 ml 30% ioxaglate (Hexabrix 320, 
Mallinckrodt, Hazelwood, USA) and 70% 1% phosphate buffered saline (PBS) solution 
was injected intra-articularly using a 21 gauge needle 200 and a superolateral approach 
160. We first aspirated synovial fluid from the knee in order to confirm that the needle 
was positioned in the knee joint and to ensure that we could inject the 15 ml of contrast 
dilution while minimizing further dilution due to extensive joint effusion. To promote 
contrast distribution throughout the joint, participants actively exercised their knee for 
two minutes over the full possible range of motion immediately after the injection.
Ten minutes post-injection, CT in the axial plane was acquired using a dual-source 
multidetector spiral CT scanner (SOMATOM Definition Flash, Siemens Healthcare AG, 
Germany). We used a tube voltage of 80 kV, units of current of 3140 mAs, pitch of 0.35 
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and collimation of 32 x 0.6 mm 200. Scan time was approximately 30 seconds. These 
parameters resulted in an effective radiation dose of 0.4 millisievert (mSv) and an ef-
fective skin dose of 120 milligray (mGy) which is well below the threshold of 1000 mGy 
above which deterministic effects on the skin are expected 240.
All scans were reconstructed in the sagittal plane with an effective slice thickness of 
0.75 mm and a sharp reconstruction kernel. Multiplanar reconstruction was performed 
resulting in an image voxel size of 0.265 by 0.265 mm, e.g. an in-plane resolution of 512 
x 512 voxels.
analysis of CT arthrography
Reconstructed datasets were segmented into binary datasets using a local attenuation 
threshold algorithm (3D-Calc, Skyscan, Kontich, Belgium) (Figure 1A-D) 81, 241 . These bi-
nary datasets (Figure 1C-D) were used to manually draw six cartilage regions of interest 
Figure 1: Regions of interest in CTa and EPIC-μCT datasets. Representative sagittally reconstructed images of a me-
dial and lateral compartment of a knee joint which underwent CTa (A-B). After segmentation into a binary datasets, 
the different regions of interest are shown in 2D (C-D) and in a 3D representation: the posterior non-weight-bearing 
cartilage of the femoral condyles (pFC) (E), the weight-bearing cartilage of the femoral condyles (wbFC) (F) and the 
weight-bearing cartilage of the tibial plateaus (wbTP) (G). After image registration, the same ROIs were analyzed in 
EPIC-μCT datasets.
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(ROIs): posterior non-weight-bearing femoral cartilage (pFC) (Figure 1E), weight-bearing 
femoral cartilage (wbFC) (Figure 1F) and weight-bearing tibial cartilage (wbTP) of the 
medial and lateral tibiofemoral compartment (Figure 1G). Each ROI consisted of 40 con-
tiguous slices and was manually drawn by a researcher with four years of experience in 
musculoskeletal imaging (JvT) using CT Analyser software (Skyscan, Kontich, Belgium). 
In each ROI, mean cartilage X-ray attenuation was calculated using CT Analyser.
harvesting of cartilage and acquisition of ePIC-μCT
During TKR, weight-bearing and non-weight-bearing femoral cartilage and weight-
bearing tibial cartilage with adjacent subchondral bone were harvested, stored in 
saline and transported directly to the laboratory.
We used EPIC-μCT as reference standard for cartilage sGAG content since its out-
comes have a good correlation with cartilage sGAG content 78, 79, 203. Similar to CTa, EPIC-
μCT provides information on sGAG distribution of cartilage within the entire cartilage 
volume, allowing analysis of articular cartilage regions exactly matching the cartilage 
ROIs analyzed with CTa.
Between 30 minutes and 1 hour after surgery, all specimens were removed from the 
saline and incubated in ioxaglate solution for 24 hours at room temperature 207-209. A 
20% ioxaglate with 80% PBS 1% solution was used since this results in optimal cartilage 
segmentation at the air/cartilage and bone/cartilage interfaces 200. The contrast solu-
tion also contained Ethylenediaminetetraacetic acid (EDTA) (Sigma Aldrich, St Louis, 
USA) and protease inhibitors (Roche, Basel, Switzerland) to prevent sGAG removal from 
the specimen during incubation.
EPIC-μCT was performed using a Skyscan 1076 (Skyscan, Kontich, Belgium) with the 
following scan settings: isotropic voxel size of 35 μm; voltage of 95 kV; current of 100 
mA; field of view 68 mm with a 1.0 mm aluminum / 0.25 mm copper filter over 198o 
with a 0.36 degree rotation step. Plastic foil was wrapped around the specimen to avoid 
dehydration during scanning. Depending on the size of the specimen, scan time was 
0.5  –  1.5 hours. The datasets were reconstructed identically using NRecon software 
(Skyscan, Kontich, Belgium).
analysis of ePIC-μCT
To enable comparison of corresponding cartilage regions, EPIC-μCT datasets were 
registered to CTa datasets with Multimodality Image Registration using Information 
Theory (MIRIT, University of Leuven) 228. This automated registration algorithm uses a 
rigid transformation model (translations and rotations) and uses mutual information 
as a similarity measure for the registration of the μCT datasets to the CT datasets. Next, 
using CT Analyser software, datasets were segmented into binary datasets using a 
previously determined fixed attenuation threshold (25 gray values for air and 120 gray 
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values for subchondral bone) 200. In the segmented μCT datasets, cartilage ROIs cor-
responding with ROIs of CTa were drawn and mean X-ray attenuation was calculated.
Biochemical cartilage analyses
After acquisition of EPIC-μCT, four (posterior femoral cartilage), six or eight (weight-
bearing femoral and plateau cartilage based on the size) full thickness cartilage ex-
plants of 6 mm diameter were taken using a biopsy punch from standardized locations 
corresponding with cartilage of the ROIs analyzed with CTa and EPIC-μCT. Location and 
number of cartilage explants were chosen to ensure representative cartilage samples 
in each ROI.
Since ioxaglate used for EPIC-μCT might interact with biochemical assays (pilot tests, 
data not shown), explants were washed at room temperature for 24 hours in 1% PBS. 
During washing, EDTA and protease inhibitors were added to prevent sGAG loss from 
cartilage. Next, explants were cut in halves and stored separately in airtight tubes at -20 
°C together with the washing solution.
Before biochemical analyses were performed, explants were thawed at room tem-
perature. One half of each explant was digested in papain solution containing 250 µg/
ml papain and 5 MM l-cytein HCl overnight at 60 ºC. sGAG content in cartilage and 
in the washing solution of the matching explant was quantified with the 1,9dimeth-
ylmethylene blue (DMMB) dye binding assay at pH 3 described by Farndale et al. 138. 
Absorption ratios at 540nm and 595 nm were used to calculate sGAG content using 
chondroitin sulphate (Sigma Aldrich, St Louis, USA) as standard. Total sGAG content in 
explant and washing solution was calculated to correct for possible loss of sGAG during 
washing.
The other half of each explant was used to quantify collagen content based on the 
hydroxyproline content according to Bank et al. 139. Samples were digested with alpha-
chymotrypsin followed by a papain solution and digests were hydrolyzed with equal 
volumes 12M HCl at 95 ºC overnight. Samples were then dried and re-dissolved in water. 
Hydroxyproline content was measured using a colorimetric method with chloramine-T 
and dimethylaminobenzaldehyde as reagents and hydroxyproline as standard (Merck, 
Darmstadt, Germany) at extinction 570 nm. Values of degraded and intact collagen 
content were summed, resulting in total collagen content per explant.
Next, for each ROI four to eight explants were used to calculate the mean sGAG and 
collagen content by averaging the content of the explants taken from that specific ROI. 
The mean sGAG and the mean collagen content of a specific cartilage ROI could then 
be correlated with the mean CT and μCT attenuation in the matching ROI.
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statistical analysis
To assess the correlation between CTa and reference tests (EPIC-μCT, sGAG content and 
collagen content), a four-dimensional multivariate mixed-effects model was applied. In 
this model, it is assumed that the CTa and the reference tests are multivariately normally 
distributed (i.e. Y~N4(μ,Σ), where Y = (CTa, EPIC-μCT, sGAG content, collagen content); μ 
and Σ are the mean vector (i.e. μ = (μ1 = CTa, μ2 = EPIC-μCT, μ3 = sGAG content, μ4 = col-
lagen content)) and covariance matrix of these variables, respectively. To take into 
account potential intrinsic correlation between outcomes of different ROIs within one 
participant, a random intercept was included in the model (e.g. μ1,i.j. = β1 + b1,I ; i = 1, … 
, 11, j; j= 1, …, 62).
Pearson’s correlation coefficients of CTa and each reference test were extracted from 
the results of this model. For each Pearson’s correlation coefficient the 95%CI was calcu-
lated. To assess goodness-of-fit, we used an omnibus posterior predictive check (PPC) 
242. We computed a Bayesian p-value with extreme values of this p-value (e.g., < 0:05 
or > 0:95) indicating a poor fit of the model to the data 242.
To assess if the correlation coefficients calculated within the model were significant-
ly different, we calculated the contour probability of the correlations. For these values, 
similar to the Bayesian p-value, extreme values, i.e. <0.05 or >0.95, indicate that there 
is a statistically significant difference between two correlation coefficients 243. These 
analyses were performed using a Bayesian approach with Markov chain Monte Carlo 
(McMC) sampling using WinBugs 140.
resulTs
Participants
Fourteen patients were included. Two participants were excluded because their TKR was 
postponed after inclusion, in one participant ioxaglate was injected extra-articularly and 
four cartilage specimens (two weight-bearing cartilage specimens of the medial tibial 
plateau, one posterior non-weight-bearing cartilage specimen of the lateral femoral con-
dyle and one weight-bearing cartilage specimen of the medial femoral condyle) were se-
verely damaged during surgery and were therefore excluded from the analysis. Therefore, 
results are based on data of 11 participants (5 women and 6 men, 7 left and 4 right knees).
The mean age with standard deviation was 64 ± 7 years and their mean body mass 
index with standard deviation was 33 ± 6 kg/m2. The KL grades in the medial tibio-
femoral compartments were 3 or 4 in seven participants and 1 or 2 in four participants. 
KL grades in the lateral tibiofemoral compartments were 1 or 2 in nine participants 
and 3 in two participants. We did not observe any adverse reactions related to the 
intra-articular contrast injections.
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Correlation of CTa, ePIC-µCT and biochemical cartilage analyses
For the applied four-dimensional mixed-effects model, the Bayesian p-value of the PPC 
was 0.52, which indicates that the model assumptions appear to be satisfied.
Mean CTa X-ray attenuation in all femoral and tibial cartilage ROIs correlated well 
with attenuation of EPIC-μCT (r=0.76, 95%CI 0.64 to 0.85; Figure 2A). When each ROI was 
analyzed separately, the range of correlation coefficients between outcomes of CTa 
and EPIC-μCT was 0.75 to 0.80.
The correlation between CTa and sGAG content measured using the DMMB assay 
was moderate (r=-0.66, 95%CI -0.87 to -0.49; Figure 2B). A range of -0.75 to -0.60 was 
observed for the correlation coefficients between X-ray attenuation of CTa and sGAG 
content in all separate cartilage ROIs.
The correlation between outcomes of CTa and collagen content measured using the 
hydroxyproline assay was also moderate (r=-0.56, 95%CI -0.70 to -0.36; Figure 2C). Here, a 
range of correlation coefficients from -0.56 to -0.51 was obtained for each separate ROI.
Figure 2: Correlation plots of CTa, EPIC-μCT and ex vivo reference standards for sGAG and collagen content of articular 
cartilage. Correlation plots of mean attenuation of CTa in all anatomical ROIs with EPIC-μCT attenuation (A), sGAG 
content of the cartilage measured with DMMB assay (B), collagen content of the cartilage measured with hydroxypro-
line assay (C) and mean attenuation of EPIC-μCT and sGAG content measured with DMMB assay (D). The dashed lines 
indicate the 95% confidence interval of the Pearson’s correlation coefficient.
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Mean EPIC-μCT outcomes and sGAG content measured using the DMMB assay corre-
lated well (r=-0.81, 95%CI -0.87 to -0.69; Figure 2D). The range of correlation coefficients 
for each separate ROI was -0.82 to -0.75.
Figure 3: Cartilage sGAG content estimated using CTa, EPIC-μCT and histology. Representative images of matching 
sagittal slides of CTa, EPIC-μCT and histology (see appendix 1 below this figure caption fot the methods used for prepa-
ration and staining of the bone-cartilage specimen with safranin-O). The attenuation of cartilage is visualized in color: 
A high attenuation represents a low sGAG content of cartilage and a low attenuation represents a high sGAG content. 
A high intensity of safranin-O staining on histology represents a high sGAG content and a low intensity or discoloration 
represents a low or absent sGAG content. The top row shows visual agreement in high cartilage sGAG content and the 
bottom row shows visual agreement for low cartilage sGAG content.
Appendix 1: After acquiring all cartilage biopsies for the EPIC-μCT specimen, the bone-cartilage specimens were fixed 
using a paraformaldehyde solution for one week. Next, the specimens were decalcified using formic acid for four weeks 
and embedded in paraffin. After embedding, sagittal sections of 5 μm were acquired in the central (non)-weight-bear-
ing area of the specimen which was determined visually. Those slices were stained with safranin-O to image the sGAG 
distribution. All specimens were stained in one batch. After staining the images we visually selected two slices, which 
matched with the imaging outcomes on approximately the same sagittal slice through the central (non)-weight-
bearing area of the particular specimen.
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By calculating the p-values of the contour probability of the different correlations we 
observed that the correlation between CTa and EPIC-μCT was significantly different from 
the correlation between CTa and sGAG or collagen content (contour probability > 0.99). 
The correlation between EPIC-μCT and sGAG content was significantly different from 
the correlation between EPIC-μCT and collagen content (contour probability = 0.002). 
The other correlation coefficients did not differ significantly from each other.
The matched images of CTa, EPIC-μCT and histology (visual representation of sGAG 
content using Safranin-O staining) representing cartilage with relatively high and low 
sGAG content shown in figure 3 confirmed the good correlation between CTa and EPIC-
μCT and cartilage sGAG content.
dIsCussIon
Quantitative imaging biomarkers that non-invasively estimate cartilage biochemical 
composition are essential for development and monitoring of DMOADs in OA. This 
study was performed to assess the correlation between in vivo CTa in human OA knees 
and ex vivo reference standards for sGAG and collagen content.
Our results show a good correlation between X-ray attenuation of CTa and EPIC-
μCT and a somewhat less pronounced correlation between CTa and cartilage sGAG 
content determined by the DMMB assay. These results are in agreement with previous 
research showing a good correlation between outcomes of CTa acquired in ex vivo hu-
man cadaveric knee joints and EPIC-μCT 200. The results are also consistent with several 
previous in vitro studies examining the correlation between contrast-enhanced (micro)
CT and the sGAG content of articular cartilage 78, 79, 203. Therefore, we believe that CTa 
X-ray attenuation may be used as a quantitative estimate for sGAG content of articular 
cartilage in future clinical OA research.
The difference in strength of correlation between CTa and sGAG content measured 
using EPIC-μCT versus DMMB assay might be caused by the fact that the attenuation 
of EPIC-μCT and cartilage sGAG content are well correlated, but not by a linear relation-
ship. This indicates that, although not fully specific, EPIC-μCT is good reference test 
for cartilage sGAG content. Due to the aforementioned, we think that we observed 
a difference in strength of the correlation between CTa and EPIC-μCT compared to 
CTa and sGAG content as measured using the DMMB assay. Another explanation for 
the difference in strength of correlation may be that the ROIs in CTa and EPIC-μCT 
were matched exactly by image registration while the DMMB assay was limited to as-
sessment of sGAG content in representative cartilage explants that did not correspond 
exactly with the cartilage volume of the imaging ROIs. We chose this approach since 
we considered it to be reliable to analyze representative focal cartilage explants taken 
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from standardized locations out of the cartilage ROIs analyzed using CTa and EPIC-μCT. 
Since there were no large spatial differences in sGAG distribution within cartilage ROIs 
in EPIC-μCT (data not shown), we are convinced that this did not influence our results 
compared to analyzing total cartilage ROIs using the DMMB assay.
We found a moderate correlation between outcomes of CTa and collagen content 
of cartilage measured using the hydroxyproline assay. This result could potentially be 
explained by a strong relation between collagen and sGAG content of cartilage and a 
concomitant loss of sGAG and collagen in the OA process. Cartilage sGAG and collagen 
content were, however, only weakly correlated in our study (r=0.40, data not shown). 
This indicates that, in addition to sGAG content, the integrity of the collagen network 
also influences contrast influx into cartilage as suggested in previous ex vivo research 
200. It is important to note that in CTa, there is no equilibrium between cartilage sGAG 
content and the contrast agent because CTa images are acquired already 10 minutes 
after contrast administration. This is unlike EPIC-μCT in which cartilage is incubated 
in contrast agent for 24 hours 78, 79, 203. Therefore, measurements from non-equilibrium 
CTa are also influenced by other factors than sGAG content alone 207-209. In particular, 
the collagen network of the extracellular matrix of the cartilage, which determines 
the permeability of the cartilage, influences the diffusion rate of contrast agent into 
the cartilage besides its sGAG content 210, 211. Contrast diffusion goes slowly in healthy 
cartilage, in which an intact collagen network and densely packed collagen parallel 
to the cartilage surface result a relative low permeability of the cartilage 212, 213. When 
the collagen network is impaired, e.g. in case of loss of collagen content, cartilage 
permeability increases, resulting in higher diffusion rate of contrast into the cartilage. 
The influence of collagen content of cartilage on CTa outcomes, however, is less pro-
nounced compared to the influence of cartilage sGAG content since the correlations 
were significantly different. This suggests that, although not totally sGAG specific, CTa 
may be considered a useful imaging biomarker to estimate cartilage sGAG content in 
future human OA research.
CTa might be a worthwhile quantitative biochemical cartilage imaging technique 
in future clinical research additional to contrast-enhanced MRI based techniques used 
for the same purpose. CTa has a relatively fast acquisition time and can be acquired 
already ten minutes after contrast administration, while the delay between intravenous 
contrast administration in knee dGEMRIC is at least 1.5 hours 95. This makes CTa more 
patient friendly and clinically feasible than MRI. Moreover, in the generally middle-aged 
or elderly OA population, the relative long acquisition time of MRI compared to CT 
(minutes versus seconds) and the number of patients with possible contra-indication 
for MRI (for example non MRI compatible implants) may favor CTa as an alternative to 
MRI in clinical OA research 244. CTa might also be applicable as imaging biomarker for 
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cartilage biochemical composition in large cohort studies since it is relatively cheap 
and widely available 245.
Potential limitations of CTa include concerns of ionizing radiation. The effective radia-
tion dose used for CTa as presented in this paper (0.4 mSv) is four times higher than 
a regular CT of the knee 220. However, it has been shown that CTa acquired using only 
10% of this dose also has a good correlation with cartilage sGAG content ex vivo in 
cadaveric knees 246. Besides, active knee flexion and extension may be impossible for 
the full range of motion for OA patients, resulting in variations in contrast concentra-
tion across the knee joint. Recent research by Silvast et al., however, shows that dif-
ferences in contrast concentration do not influence the speed of contrast influx into 
cartilage and would therefore not influence the reliability of CTa outcomes 198. Finally, 
although not observed in our study and also not reported in other studies applying CTa 
in vivo in humans 236, 237, 247, the intra-articular injection introduces the risk of infection 
and increases the risk of knee pain after injection. It may be worthwhile to perform 
fluoroscopic-guided intra-articular injections in future research with CTa since this may 
overcome the problem of extra-articular contrast agent deposition, which happened in 
one of our study participants, however against increased costs and logistic complexity 
of the procedure.
Based on our results and despite the potential drawbacks we propose that CTa may 
be applicable in future clinical OA research. Of course, more research is needed, par-
ticularly to assess reproducibility in OA patients before CTa could be applied in cross-
sectional and longitudinal studies. Such a reproducibility study might also benefit from 
including more participants and different delays between contrast administration and 
CT acquisition to assess if this influences the correlation between CTa and cartilage 
composition in full thickness ROIs. In addition, a depth-wise analysis to assess the ef-
fect of different concentrations of cartilage composites throughout the extracellular 
matrix and across the cartilage layer would be interesting. For such a study it would be 
interesting to include patellar cartilage, which is thicker and has been shown to have 
a different composition than femoral and tibial cartilage 248. In addition, nowadays OA 
is considered a whole joint disease in which not only cartilage, but also subchondral 
bone, menisci and synovium play important roles in disease development and progres-
sion 22. The simultaneous analysis of cartilage and subchondral bone was also described 
previously in in vitro studies using contrast-enhanced μCT 232, 249. It would also be 
worthwhile to assess the ability of CTa to evaluate cartilage and meniscus composition 
within one examination. Simultaneous analysis of cartilage and meniscus composition 
has recently been described for contrast-enhanced MRI 143, 250 and contrast-enhanced 
CT in vitro 251, 252. Finally, future research might assess the possibility of injecting the 
contrast agent intravenously instead of intra-articularly to make the technique more 
patient friendly. This dGEMRIC like approach will, however, be challenging because the 
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intra-articular contrast is also used for the purpose of cartilage segmentation. Moreover, 
an intravenous approach requires a longer delay between contrast administration and 
acquisition of the CT scan.
In conclusion, our study shows that when applied in vivo in human OA knees, X-ray 
attenuation of CTa correlates well with sGAG content. Outcomes of CTa also slightly 
correlate with cartilage collagen content. However, since outcomes of CTa are mainly 
sGAG dependent, CTa may be suitable as quantitative imaging biomarker to estimate 
cartilage sGAG content in future clinical OA research.
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QuanTITaTIve ImaGInG BIomarKers of CarTIlaGe 
ComPosITIon In osTeoarThrITIs researCh
For a long time, radiography and subsequently conventional magnetic resonance 
imaging (MRI) were used as imaging biomarkers for evaluating cartilage morphological 
disease state in osteoarthritis (OA) research 253. Because research is switching its focus 
towards disease-modifying OA drugs (DMOADs) in order to target OA at an early stage 
of disease, quantitative imaging biomarkers for cartilage composition became of in-
terest during the last decade 128, 129, 254, 255. Therefore, several MRI based techniques to 
(indirectly) measure the sulphated glycosaminoglycan (sGAG) content of the extracel-
lular matrix of articular cartilage were or are being translated to clinical OA research. 
Examples of such techniques are delayed gadolinium-enhanced MRI of cartilage 
(dGEMRIC) 93, 95, T1rho-mapping 131, 132, sodium imaging 74, 75 and sGAG specific chemical 
exchange saturation transfer (gagCEST) 76, 256.
Despite all efforts with regard to translation, validation and application of these 
techniques in clinical research, until now, only dGEMRIC has been shown to be a robust 
and valid imaging biomarker for cartilage sGAG content in human OA subjects 88, 91, 
chapters 3 and 4. Contrary to what was suggested in vitro or ex vivo 134, T1rho-mapping seems 
not suitable as an imaging biomarker for sGAG content in human OA cartilage 69, 90, chapter 
4. Sodium imaging and gagCEST are both validated and reproducible in vivo as sGAG 
biomarkers 72, 76, 77, 257 and are therefore promising techniques. However, both are best 
applied at ultra-high field MRI systems, e.g. 7 Tesla 256, which are not widely available for 
human application yet.
An alternative to MRI based biomarkers could be computed tomography (CT) based 
quantitative sGAG imaging. Similar to dGEMRIC, contrast-enhanced CT utilizes the 
inverse relation between a contrast agent and the sGAG distribution throughout the 
articular cartilage 78, 79. Although CT arthrography (CTa) was already an established tech-
nique for the assessment of knee pathology 82, 83, it has only recently been implemented 
and used to evaluate OA cartilage composition 236, 237, chapters 7,8 and 9. However, CTa has yet 
to be assessed clinically with regard to its reproducibility and to the willingness of pa-
tients to undergo an intra-articular injection with contrast agent. Future developments 
in CT scanner technology and image post processing, for example novel dual energy 
CT scanners and iterative reconstruction algorithms, might lead to imaging protocols 
which need less or even no contrast agent and less radiation dose 230, 231, 258, 259, which 
would be favorable for the application of CTa in clinical research. However, to date, CTa 
is a more invasive technique compared to dGEMRIC and the use of potentially harmful 
ionizing radiation is a drawback of the technique with regard to implementation on a 
large scale in OA research.
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Despite the aforementioned lack of availability of thoroughly tested quantitative im-
aging biomarkers for cartilage in human OA subjects, recent consensus driven guide-
lines for OA research encourage the implementation of imaging biomarkers in general 
in OA intervention trials and cohort studies 260. This is surprising since besides dGEMRIC, 
until now, no other imaging biomarker for cartilage composition has been shown to be 
valid and robust in humans OA. Furthermore, only some small size therapeutic OA stud-
ies using dGEMRIC as an outcome have been reported 156, 261-263, chapter 5, while large scale 
OA intervention trials have not yet been performed due to the lack of potent DMOADs.
One may question what the exact place of imaging biomarkers for cartilage composi-
tion is in the current OA research field? When the first quantitative imaging biomarker, 
e.g. dGEMRIC, was introduced in 1996 64, the expectations were high. Quantitative 
imaging biomarkers could be used to assess the efficacy of DMOADs or to predict OA 
progression in the future 264. Rather than a diagnostic or prognostic tool, by the year 
2015, imaging OA biomarkers are only used in small size trials as outcome for carti-
lage sGAG content. Furthermore, imaging biomarkers might be used select subjects 
for studies targeting cartilage with differences in disease stage within the joint at a 
compositional level in terms of its sGAG content.
To assess if imaging biomarkers are capable of being used as primary endpoint in 
OA trials, a lot of future research needs to be performed. This research should focus 
on further validation, implementation and comparison of potential and already estab-
lished quantitative imaging biomarkers, for example the potential of gagCEST versus 
dGEMRIC. In addition, compositional imaging biomarker for cartilage collagen content, 
e.g. T2- of T2*-mapping 233, 265, may be of additional value to sGAG biomarkers. When 
this research is performed, attention should be paid that these sequences are widely 
available, such that they can be feasibly applied on a large scale in order to compare the 
results of different researchers.
To assess the potential of imaging biomarkers to serve as a predictor of cartilage 
degeneration within disease course and outcome, imaging biomarkers should be 
included in large scale cohort studies like the OsteoArthritis Initiative (OAI) in the USA 
(http://www.oai.ucsf.edu/) or the Cohort Hip and Cohort Knee in The Netherlands 
(http://www.check-onderzoek.nl/) in which OA progression or clinical outcome mea-
sures of OA, like pain can be correlated to outcomes of imaging biomarkers. A potential 
alternative to compositional imaging biomarkers are quantitative thickness measure-
ments of articular cartilage thickness to determine and follow articular cartilage in OA 
45, 46. Despite the fact that the segmentation is time consuming and that a relative long 
follow-up period of several years is required 266, it has been shown that quantitative 
morphometric measurements of cartilage may predict progression of knee OA 267, 268. 
Therefore, it could be of interest to compare its outcomes to those of imaging bio-
markers for cartilage composition in cross-sectional and longitudinal cohort studies. In 
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addition, it may be of interest to also look at other tissues in the knee for prediction of 
OA progression. For example, it has recently been shown that specific bone shapes are 
predictors of end stage knee 269-271. Moreover, the European League Against Rheuma-
tism (EULAR) has recently recommended to also focus on non-cartilaginous tissues in 
OA research 272.
ImaGInG BIomarKers To ImaGe The whole osTeoarThrITIC 
joInT
Nowadays, OA is considered to be a whole joint disease in which, besides cartilage, also 
(subchondral) bone, menisci, synovium, and Hoffa’s fat pad in the knee, play an import 
role in disease development and progression 22, 273. Therefore, MRI based whole organ 
scoring systems which assess morphological changes of all these tissues have been 
proposed. Examples are the Knee Osteoarthritis Scoring System (KOSS) 40, the Whole-
Organ MRI Score (WORMS) 41, the Boston Leeds Osteoarthritis Knee Score (BLOKS) 42 
and MRI Osteoarthritis Knee Score (MOAKS) 43, 44. These scoring systems are increas-
ingly used in OA research 25. A drawback of those scoring systems is that they rely on 
morphological tissue changes, which may not always be present in early stage disease.
Quantitative imaging biomarkers may be used to image composition of multiple key 
tissues other than articular cartilage in any stage of knee OA. Using this information, the 
complex and simultaneous mechanisms in different tissues in OA development and 
progression might be further analyzed. This information might eventually lead to the 
identification of new disease pathways which may lead to the development of novel 
treatment options for OA. Until now, however, only a few studies have been performed 
to assess the capability of imaging biomarkers to assess other tissues in the knee joint 
other than cartilage.
Using MRI, cartilage and meniscal tissue can be assessed within one examination 186, 
250, 274, 275, chapter 6, ultra short echo time imaging might be used to assess the calcified car-
tilage and subchondral bone 276, 277 and several contrast-enhanced and non-contrast-
enhanced options to quantitatively assess synovitis have been proposed 278-280. CTa 
might also be a very usefully technique for the purpose of imaging cartilage, meniscus 
and also subchondral bone changes in OA 249, 252, 281, 282.
Future research with the purpose of assessing multiple tissues within the OA joint 
might benefit from using a multimodality approach, e.g. combining CT and MRI bio-
markers, like already performed in animal research 283. CT or MRI could also be combined 
with other emerging techniques for quantitative assessment of bone metabolism, mac-
rophage activity within the synovium, but also meniscal and anterior cruciate ligament 
tears. These techniques use single photon emission CT (SPECT) and positron emission 
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tomography (PET) and have recently been validated in vivo in animal research 245, 254, 284, 
285 and are already also applied for bone metabolism and meniscal and anterior cruciate 
ligament tears in human research 286-290. Combing these datasets with high resolution 
CT or MRI scans enables accurate localization of bone or macrophage activity or menis-
cal and ligamentous injuries throughout the joint.
In addition to assessing OA pathophysiology and progression, imaging of multiple 
OA affected tissues might be helpful to different subtypes of OA which have recently 
been identified in the OAI 291. Since different subtypes of OA have been shown to have 
their own etiology, speed of progression and clinical characteristics, a combination 
of specific imaging biomarkers and clinical tests may be developed to identify these 
subgroups that might benefit from specific treatment or even preventive strategies in 
future studies 292, 293.
ImaGe PosT ProCessInG of QuanTITaTIve mrI Based ImaGInG 
BIomarKers
Taking into account that future research will include quantitative analyses of multiple 
tissues, the need for accurate and reliable image post processing algorithms will be of 
utmost importance. This is especially the case in MRI based biomarkers since quantita-
tive analysis of OA tissues needs multiple acquisitions during which patient motion can 
cause inaccurate quantitative outcomes. This has been reported for dGEMRIC 84, 85, chapter 
2, but may also be the case for other quantitative MRI biomarkers. Image registration 
is also helpful in longitudinal studies since it makes the analysis of the data less time 
consuming because region of interest (ROI) drawing is only needed once.
An imaging post processing tool should also include the quantification of other, 
non-motion related, inaccuracies. Such inaccuracies could be caused by partial volume 
effects, low signal to noise ratios throughout datasets, or B0 or B1 inhomogeneity. In 
present imaging biomarker research, the accuracy of quantitative MRI measures is 
usually presented using the coefficient of determination for all analyzed images. This in-
formation may be used to evaluate the overall accuracies and reliability of quantitative 
MRI datasets for a specific patient or group of study patients. However, it may be better 
to use a measure for inaccuracy which is calculated per voxel in the analyzed images 
instead of all images of one or more patients together. This voxel based information 
on accuracy can be used to calculate a weighted outcome of quantitative MRI data 
in which voxels with a high inaccuracy contribute less to the outcome of the analysis 
compared to accurate voxels. This way, inaccurate voxels throughout a specific patient 
or even multiple patients have less influence on the calculated outcomes of quantita-
tive imaging biomarkers chapter 2.
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Currently, not much research is performed related to the development, validation 
and implementation of image post processing tools for quantitative imaging biomark-
ers. This is striking because of the potential large impact these biomarkers can have in 
OA research. Therefore, more research with regard to image registration and assess-
ment of accuracy in data analyses is necessary. Implementation of semi-automated or 
automated ROI segmentation algorithms may also be beneficial for biomarker image 
processing. Such segmentation was recently proposed for hip and knee cartilage 294-297 
and may result in relative fast image post processing tools. This is especially of interest 
if imaging biomarkers are being included as an outcome measure in large OA trials or 
cohort studies in the future.
ConClusIons
The research on which this thesis is based forms a contribution towards the application 
of quantitative imaging biomarkers of cartilage composition in OA. The most important 
results can be summarized as follows:
• Until now, dGEMRIC is the only validated and robust imaging biomarker for quanti-
fying cartilage sGAG content in human OA subjects in clinical research. 
• dGEMRIC and dGEMRIM may be capable of assessing cartilage and meniscus sGAG 
content within one contrast-enhanced MRI examination.
• T1rho-mapping appears not suitable as an alternative to dGEMRIC for quantifying 
cartilage sGAG content in articular cartilage and seems therefore not applicable as 
an imaging biomarker for OA research.
• CT arthrography may be suitable as an imaging biomarker for quantitative mea-
surement of cartilage sGAG content in clinical OA research and therefore could be 
considered an alternative to MRI.
• Sophisticated imaging post processing tools are of utmost importance to generate 
reliable outcomes of quantitative MRI biomarkers of cartilage composition.
fuTure PersPeCTIves
Quantitative imaging biomarkers in OA research have not yet held to the high initial 
expectations. Despite the fact that quantitative imaging biomarkers for cartilage 
composition are therefore not yet applicable at a large scale in clinical OA research for 
reasons discussed before, a lot of interesting and important research is to be carried 
out within the coming years. This research should focus on implementing promising 
new imaging biomarkers, e.g. gagCEST, in clinical research and compare its outcomes 
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to dGEMRIC. In addition, the relation between imaging biomarkers and clinically im-
portant outcome measure for OA, like pain should be assessed, as well as the ability to 
predict OA development or progression by using these imaging biomarkers in large 
cohort studies. Based on this research, the OA community must reach consensus about 
the role of quantitative imaging biomarkers as an outcome measure or predictor of 
disease in OA research.
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For a long time, radiography and subsequently conventional magnetic resonance 
imaging (MRI) were used as imaging biomarkers for evaluating cartilage morphological 
disease state in osteoarthritis (OA). Because research is switching its focus towards dis-
ease modification or even prevention to target OA at an early stage, imaging techniques 
that measure cartilage composition rather than its morphology became of interest. 
Several MRI and computed tomography (CT) based quantitative imaging biomarkers 
for cartilage composition were developed. These techniques were advocated to allow 
a quantitative measure of the sulphated glycosaminoglycan (sGAG) content, an impor-
tant composite of the cartilage extracellular matrix. The main aims of this thesis is based 
have been divided between MRI and CT based quantitative imaging biomarkers since 
their different stage of application in research. MRI has already been applied in human 
OA research, whereas CT was still to be translated and implemented in clinical research.
ParT 1: mrI Based QuanTITaTIve ImaGInG BIomarKers of 
CarTIlaGe sulPhaTed GlyCosamInoGlyCan ConTenT
The first part of this thesis focused on MRI based techniques and aimed at optimiza-
tion of image post processing, assessing reproducibility, comparison of different MRI 
sequences and application in clinical OA research.
1.1 optimization of image processing and reproducibility of dGemrIC
Since accurate image post processing is of utmost importance to generate reliable and 
robust quantitative MRI outcomes, an imaging post processing tool was developed 
and described in chapter 2. This tool corrects for intra-sequence patient motion during 
acquisition of quantitative MR images, by applying image registration reducing errors 
and incorrect outcomes. This resulted in 6-14% improvement in accuracy of delayed 
gadolinium-enhanced MRI of cartilage (dGEMRIC) T1 relaxation time. Using image 
registration, the tool also allows assessment of the same cartilage region throughout 
multiple MRI acquisitions, which makes analyses less time consuming. Finally, the al-
gorithm also involves a fitting technique which corrects for unreliable quantitative MRI 
biomarker data by calculating a weighted mean outcome for all voxels in a specific car-
tilage region based on the inaccuracy of each voxel. Because of these abilities and the 
fact that this tool could be used in any quantitative MRI biomarker, e.g. T1rho-mapping 
or T2-mapping, the image post processing tool was used in all chapters in this thesis 
where MRI based measures were used for cartilage sGAG content.
Along with robust image processing tools, the outcomes of the MRI exam itself should 
also be reproducible in order to be able to apply the particular technique in cross-
sectional or longitudinal study designs. Therefore, chapter 3 described a reproducibility 
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study of dGEMRIC acquired at 3 Tesla in early stage knee OA patient. It was shown that 
dGEMRIC is highly reproducible in terms of results in large cartilage regions, as well 
as for differentiating between spatial distributions of diverse cartilage quality within a 
single slice. dGEMRIC can therefore be used as an imaging biomarker in cross-sectional 
and longitudinal study designs. In addition, a threshold for defining significant changes 
in dGEMRIC results for longitudinal follow-up was determined.
1.2 validation and comparison of dGemrIC and T1rho-mapping as 
imaging biomarker in human osteoarthritis research
T1rho-mapping has been proposed as a non-contrast-enhanced alternative to dGEMRIC 
for sGAG quantification in clinical studies. However, no thorough validation has been 
performed comparing both techniques within the same OA patients using a reference 
standard for cartilage sGAG. Therefore, in chapter 4 an in vivo comparison and valida-
tion study assessing the capability of dGEMRIC and T1rho-mapping was performed. 
In knee OA patients, dGEMRIC results strongly correlate with cartilage sGAG content, 
whereas T1rho-mapping did not. Therefore, it appears that T1rho-mapping cannot be 
regarded as an alternative for dGEMRIC to measure cartilage sGAG content in clinical 
OA research. It was also shown that results of dGEMRIC are also partially influenced by 
the collagen content of cartilage. Despite the fact that dGEMRIC cannot be regarded 
as entirely sGAG specific, the difference in strength in correlation between dGEMRIC 
and sGAG (r=0.73) and collagen content (r=0.40) suggests that dGEMRIC may be used 
as an imaging biomarker for sGAG content. The outcomes of T1rho-mapping did also 
not correlate with cartilage collagen content. Therefore, the use of T1rho-mapping as 
imaging biomarker in OA is questionable.
1.3 application of dGemrIC in clinical osteoarthritis research
Since dGEMRIC has been shown to be a robust and valid sGAG imaging biomarker in 
longitudinal studies, in Chapter 5 we used dGEMRIC to assess the effects of a potential 
disease-modifying OA drug, i.e. intra-articular injections with hyaluronic acid, in patients 
with early stage knee. This therapy has been advocated to improve cartilage composi-
tion by increasing the cartilage sGAG content. There was, however, no effect of the 
injections on cartilage sGAG content measured with dGEMRIC and using the threshold 
for change as defined in chapter 3. Although promising results were and are still being 
generated in in vitro and in vivo animal research with regard to improving cartilage 
composition using disease-modifying therapies, large human OA treatment trials have 
yet to be set up. The use of quantitative image biomarkers for cartilage composition is, 
in addition to clinical examination and questionnaires, a desirable outcome measure in 
such studies.
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OA is nowadays regarded as a whole joint disease rather than a disease of only 
cartilage, therefore protocols imaging several relevant tissues within the knee joint 
became of interest in clinical research. Since articular cartilage and the meniscus are 
both partially composed of sGAG, the ability of dGEMRIC to serve as imaging biomarker 
for both tissues in one MR examination was assessed in chapter 6. It was shown that 
T1 relaxation times of degenerated menisci on conventional MRI were borderline 
significantly lower compared to healthy menisci. These differences in outcomes of 
morphologically healthy and degenerated menisci were highly reproducible inde-
pendent of the anatomical location of the assessed menisci, showing the potential of 
contrast-enhanced MRI as a quantitative imaging biomarker for assessment of cartilage 
and meniscal composition. However, future research is needed to assess the role of 
contrast-enhanced MRI for multiple OA tissues within one examination.
ParT 2: CT Based QuanTITaTIve ImaGInG BIomarKers of 
CarTIlaGe sulPhaTed GlyCosamInoGlyCan ConTenT
The second part of this thesis focused on CT based techniques and aimed at translating 
CT arthrography from a microscopic to a macroscopic setup and making suitable to be 
used in clinical OA research.
2.1 Translation of μCT arthrography to clinically applicable CT 
arthrography
Similar to dGEMRIC, contrast-enhanced CT can be used as a quantitative imaging 
biomarker for cartilage composition. Previously, microCT arthrography (μCTa) was suc-
cessfully used as sGAG biomarker in in vivo animal OA research. Chapter 7 describes 
an ex vivo study in human cadaveric knee joints in which results of CT arthrography 
(CTa) are shown to be strongly correlated with cartilage sGAG content measured using 
a reference standard for sGAG. This study shows the potential of CTa as an imaging 
biomarker in human OA research.
Compared to MRI, CT has the disadvantage of using ionizing radiation. In chapter 8 
it was shown that when only 10% of the radiation dose used in chapter 7 was used, 
it is still possible to measure cartilage sGAG content in cadaveric human knee joints. 
Using such a low radiation dose could be of interest especially if CTa would be used 
in longitudinal study designs or if the technique would be used in relatively young 
patients. Moreover, chapter 8 showed that CTa can determine spatial differences in 
sGAG content in adjacent cartilage regions. However, this capability is reduced at lower 
radiation dose and the amount of radiation used to acquire CTa should therefore be 
adjusted to the research question.
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2.2 validation of CT arthrography as imaging biomarker in human 
osteoarthritis research
After translating μCTa to a clinically applicable CTa protocol, chapter 9 describes an 
in vivo validation study for CTa to measure cartilage sGAG content in humans with 
knee OA. It was shown that outcomes of CTa have a strong correlation with cartilage 
sGAG content in human OA tibial and femoral cartilage. In agreement with chapter 4, 
it was again shown that contrast distribution throughout the cartilage is also partially 
influenced by its collagen content. The correlation of CTa with the collagen content of 
cartilage (r=0.56), however, less strong compared to the correlation between CTa and 
its sGAG content (r=76). Because of its high relative high resolution, low coasts and 
speed of acquisition, CTa may be used as an alternative to dGEMRIC in future human 
OA research. This is also true for patients with relative or absolute contra-indications for 
MRI.
ConClusIons
The research on which this thesis is based forms a contribution towards the application 
of quantitative imaging biomarkers of cartilage composition in OA. The most important 
results can be summarized as follows:
• Until now, dGEMRIC is the only validated and robust imaging biomarker for quanti-
fying cartilage sGAG content in human OA subjects in clinical research. 
• dGEMRIC and dGEMRIM may be capable of assessing cartilage and meniscus sGAG 
content within one contrast-enhanced MRI examination.
• T1rho-mapping appears not suitable as an alternative to dGEMRIC for quantifying 
cartilage sGAG content in articular cartilage and seems therefore not applicable as 
an imaging biomarker for OA research.
• CT arthrography may be suitable as an imaging biomarker for quantitative mea-
surement of cartilage sGAG content in clinical OA research and therefore could be 
considered an alternative to MRI.
• Sophisticated imaging post processing tools are of utmost importance to generate 
reliable outcomes of quantitative MRI biomarkers of cartilage composition.
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Röntgenfoto’s en later ook magnetic resonance imaging (MRI) werden lange tijd ge-
bruikt als beeldvormende technieken om de ernst van slijtage van een gewricht, ook 
wel artrose genoemd, te bepalen. Dit werd gedaan aan de hand van de kraakbeendikte 
of vormafwijkingen van het kraakbeen welke gedurende de loop van de ziekte ontstaan 
en in ernst toenemen. Wetenschappelijk onderzoek naar artrose richt zich tegenwoordig 
op behandelingen welke toepasbaar zijn in een vroeg stadium van de ziekte, wanneer 
er nog geen verlies van dikte of vorm van kraakbeen zichtbaar is. In dit stadium is het 
namelijk wellicht mogelijk het ziekteproces te vertragen of zelfs ongedaan te maken. 
Om het effect van dergelijke behandelingen te kunnen meten is er de laatste jaren 
een aantal geavanceerde beeldvormende technieken ontwikkeld die niet de vorm of 
dikte van kraakbeen, maar de samenstelling van kraakbeen in maat en getal bepalen. 
Voorbeelden hiervan zijn MRI en computed tomography (CT) technieken welke, al dan 
niet met gebruik van een contrastmiddel, bepaalde bestanddelen van het kraakbeen 
zouden kunnen bepalen. Een belangrijk bestanddeel van kraakbeen dat bepaald kan 
worden is een schakeling van lange suikerketens welke ervoor zorgt dat kraakbeen 
water opzuigt als een spons om vervolgens op te zwellen, zoals een binnenband van 
een fiets met lucht wordt gevuld. Een ander belangrijk bestanddeel welke voor stevig-
heid van het kraakbeen is een netwerk van collageenvezels dat als een soort rubber 
van een opgeblazen binnenband een stevig, maar ook in zekere mate flexibel, loopvlak 
geeft. In dit proefschrift werden een aantal op MRI en CT gebaseerde, geavanceerde 
beeldvormende technieken voor kraakbeensamenstelling grondig bestudeerd. De on-
derzoeksdoelstellingen waren verschillend voor geavanceerde MRI en CT technieken, 
omdat deze niet dezelfde manier worden toegepast in wetenschappelijk onderzoek 
naar artrose. MRI wordt namelijk al gebruikt voor artroseonderzoek bij mensen, terwijl 
CT tot op heden vooral wordt gebruikt in dierexperimenteel onderzoek.
deel 1: GeavanCeerde mrI TeChnIeKen om 
KraaKBeensamensTellInG In maaT en GeTal Te BePalen
Het eerste deel van dit proefschrift richtte zich op het verbeteren en nauwkeuriger 
maken van het berekenen van de uitkomsten van geavanceerde MRI technieken en het 
onderzoeken van de meetfout van deze technieken. Daarnaast werd van verschillende 
MRI technieken hun verband met kraakbeensamenstelling bekeken en vergeleken en 
werden deze technieken toegepast in artroseonderzoek bij mensen.
Jasper Tiel - Binnenwerk cp7.indd   171 30-09-15   10:35
172
1.1 verbeteren en nauwkeuriger maken van het berekenen van 
uitkomsten van geavanceerde mrI technieken en het onderzoeken van de 
meetfout van deze technieken
Om betrouwbare en nauwkeurige uitkomsten van geavanceerde MRI technieken te 
verkrijgen is het belangrijk om over goede beeldverwerkingssoftware te beschikken. In 
hoofdstuk 2 is dergelijke software ontwikkeld en getest voor een bepaalde geavanceer-
de MRI techniek, namelijk delayed gadolinium-enhanced MRI of cartilage (dGEMRIC). 
De software corrigeert voor bewegingen van de patiënt tussen de verschillende beel-
den die worden gemaakt bij een dGEMRIC scan. Door de beelden, die door beweging 
zijn verschoven, op een specifieke manier te bewerken en weer op de goede plek te 
zetten worden de uitkomsten van dGEMRIC 6-14% meer nauwkeurig. Dit bewegen en 
bewerken wordt beeldregistratie genoemd en kan ook worden toegepast om exact 
hetzelfde stuk kraakbeen op verschillende scans in de loop van de tijd met elkaar te 
vergelijken. Dit is veel nauwkeuriger en tijdsefficiënter dan iedere keer hetzelfde stukje 
op te zoeken en handmatig aan te geven. Daarnaast zorgt de software ervoor dat uit-
komsten van dGEMRIC in een stuk kraakbeen die, ondanks beeldregistratie, nog erg on-
nauwkeurig zijn minder zwaar wegen bij het berekenen van de gemiddelde uitkomst 
van een geanalyseerd deel van het kraakbeen. De software is getest op dGEMRIC scans, 
maar kan ook worden gebruikt om uitkomsten van andere geavanceerde MRI technie-
ken nauwkeurig te berekenen. De beeldverwerkingssoftware is daarom toegepast in 
elk hoofdstuk van dit proefschrift waar geavanceerde MRI technieken worden gebruikt.
Naast goede beeldverwerkingssoftware om nauwkeurig de uitkomsten van dGEMRIC 
te bepalen is het van belang dat de uitkomsten van de techniek geen grote meetfout 
hebben en dat uitkomsten vergelijkbaar zijn als de techniek meerdere malen binnen 
korte tijd wordt herhaald. Het onderzoeken van deze meetfout wordt ook wel het 
onderzoeken van de reproduceerbaarheid van de meting genoemd. Wanneer zowel 
de uitkomsten nauwkeurig zijn als de meting zelf goed reproduceerbaar is, kan een 
techniek als robuust worden beschouwd en worden ingezet in artroseonderzoek. In 
hoofdstuk 3 is gekeken of dGEMRIC reproduceerbare uitkomsten geeft in patiënten 
met een vroeg stadium van artrose. Het bleek dat de uitkomsten van dGEMRIC goed 
reproduceerbaar waren als het gaat om grote gebieden van kraakbeen en ook als 
werd gekeken naar verschillen binnen kraakbeen in een gebied op een bepaald beeld 
van de gehele scan. Dit laatste is van belang wanneer er gekeken wordt naar lokale 
afwijkingen van kraakbeen zoals het verlies van lange suikerketens. Daarnaast werd er 
een drempelwaarde berekend die gebruikt kan worden om te zien of de uitkomst van 
de dGEMRIC scan in de loop van de tijd is verbeterd of verslechterd.
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1.2 verband tussen uitkomsten van geavanceerde mrI technieken met 
kraakbeensamenstelling en onderlinge vergelijking van verschillende mrI 
technieken
Een nadeel van dGEMRIC is dat er voor het maken van deze MRI scan contrastmiddel 
moet worden ingespoten in een ader van de patiënt. Dit contrastmiddel verdeelt zich 
in het kraakbeen naargelang de hoeveelheid eiwitketens die het bevat. De hoeveelheid 
contrastmiddel in een bepaald gebied kan worden gemeten met behulp van de MRI 
scan. Aan het gebruik van het contrastmiddel kleven een aantal risico’s en daarom werd 
gezocht naar een alternatieve geavanceerde MRI techniek om de samenstelling van 
gewichtskraakbeen in maat en getal te bepalen zonder dat daarvoor contrastmiddel 
noodzakelijk zou zijn. Een techniek waarmee dit mogelijk zou kunnen is T1rho-map-
ping. Tot op heden waren echter nog geen onderzoeken gedaan waarin uitkomsten 
van dGEMRIC en T1rho-mapping vergeleken werden met zogenaamde gouden stan-
daard metingen in het laboratorium. Daarnaast werden ook de uitkomsten van beide 
technieken nog niet eerder met elkaar vergeleken. Een dergelijk validatie- en vergelij-
kingsonderzoek is daarom uitgevoerd en beschreven in hoofdstuk 4. De uitkomsten 
van dGEMRIC lieten een goed verband zien met de hoeveelheid suikerketens in het 
kraakbeen. Voor T1rho-mapping bleek dit echter niet het geval te zijn. De uitkomsten 
van dGEMRIC bleken ook deels te worden beïnvloed door de hoeveelheid collageen in 
het kraakbeen, al was dit verband minder sterk dan het verband met de suikerketens. 
dGEMRIC lijkt daarom geschikt om in toekomstig onderzoek in mensen met artrose te 
worden gebruikt als maat voor de hoeveelheid suikerketens. Uitkomsten van T1rho-
mapping hadden, net als met de suikerketens, geen verband met de hoeveelheid 
collageen in kraakbeen. T1rho-mapping lijkt daarom ongeschikt om in toekomstig 
onderzoek gebruikt te worden om kraakbeensamenstelling te meten bij mensen met 
artrose.
1.3 Toepassing van geavanceerde mrI technieken in onderzoek bij 
mensen met knieartrose
In hoofdstuk 3 en 4 is aangetoond dat dGEMRIC een reproduceerbare meting is 
welke een goed verband heeft met de hoeveelheid suikerketens in het kraakbeen. In 
hoofdstuk 5 is dGEMRIC daarom gebruikt om het effect van een potentieel artrose-
vertragend middel, namelijk hyaluronzuur, dat in de knie wordt geïnjecteerd op de 
hoeveelheid suikerketens in gewrichtskraakbeen te bepalen. Dit effect werd in eerder 
laboratoriumonderzoek al waargenomen. In het kraakbeen van de patiënten werd er 
echter geen toename van de hoeveelheid suikerketens gemeten met dGEMRIC, terwijl 
de injecties met hyaluronzuur wel een positief effect hadden op pijnklachten, stijfheid 
en de functie van de knie. Deze positieve effecten kunnen dus zeer waarschijnlijk niet 
worden toegeschreven aan een toename van suikerketens in het kraakbeen. Mogelijk 
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komen uit laboratorium- en dierexperimenteel onderzoek in de toekomst nieuwe 
mogelijk artrose-vertragende of -beïnvloedende therapieën voort. Als het effect van 
deze therapieën wordt bestudeerd is het aan te raden om ook gebruik te maken van 
geavanceerde beeldvormende technieken om kraakbeensamenstelling te meten, 
naast scorelijsten en functie-onderzoek. Op deze manier kan dan worden gekeken of 
bepaalde effecten daadwerkelijk verklaard kunnen worden door een verandering in de 
samenstelling van gewrichtskraakbeen.
Tegenwoordig wordt artrose niet alleen gezien als een ziekte waarbij het kraakbeen 
in het gewricht slijt en uiteindelijk te gronde gaat. Namelijk, ook andere weefsels 
van het gewricht slijten of raken aangedaan. Voorbeelden van dergelijke weefsels 
zijn het bot dat net onder het gewrichtsoppervlak ligt, de binnenbekleding van het 
gewrichtskapsel welke verantwoordelijk is voor de aanmaak van gewrichtsvloeistof 
(het synovium) en ook de meniscus van de knie. De meniscus is een structuur die qua 
samenstelling lijkt op kraakbeen met suikerketens en collageen en die ervoor zorgt dat 
de knie goed kan bewegen, stabiel is en dat de kracht van het bovenbeen naar het 
onderbeen wordt verplaatst op een gelijkwaardige manier. In hoofdstuk 6 is gekeken 
of met een dGEMRIC scan, naast de hoeveelheid suikerketens in het kraakbeen, ook de 
hoeveelheid suikerketens in de meniscus kan worden gemeten. De resultaten van dit 
onderzoek toonden aan dat dit waarschijnlijk het geval is als gekeken wordt naar het 
verschil in uitkomst van de scan in menisci die intact waren vergeleken met menisci 
die slijtage toonden in het kader van artrose. Ondanks dit veelbelovende resultaat zal 
toekomstig onderzoek met een zelfde studieopzet als in hoofdstuk 4 (uitkomsten ver-
gelijken met gouden standaard metingen in het laboratorium) nog moeten uitwijzen 
of dit daadwerkelijk het geval is.
deel 2: GeavanCeerde CT TeChnIeKen om 
KraaKBeensamensTellInG In maaT en GeTal Te BePalen
Het tweede deel van dit proefschrift richtte zich op het toepasbaar maken van een ge-
avanceerde CT scan met contrastmiddel in wetenschappelijk onderzoek met mensen. 
Deze techniek werd tot op heden alleen nog gebruikt in dierexperimenteel onderzoek.
2.1 het toepasbaar maken van een geavanceerde CT scan met 
contrastmiddel in knieën van mensen
Net als bij dGEMRIC wordt bij een geavanceerde CT scan met contrastmiddel gebruik 
gemaakt van de verdeling van het contrastmiddel naargelang de hoeveelheid suiker-
ketens van het gewrichtskraakbeen. Het contrastmiddel wordt echter niet in de aderen, 
maar direct in het kniegewricht geïnjecteerd. Deze techniek werd tot nu toe voorna-
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melijk gebruikt bij dierexperimenteel onderzoek en wordt een CT artrografie genoemd. 
In hoofdstuk 7 werd, in een onderzoek met knieën van patiënten die hun lichaam ter 
beschikking aan de wetenschap hadden gesteld, gekeken of het CT artrogram ook bij 
menselijke knieën kan worden gebruikt om suikerketens te meten. Er bleek een sterk 
verband te bestaan tussen de uitkomsten van de CT scan en de hoeveelheid suikerke-
tens die werden gemeten met een gouden standaard meting in het laboratorium. Het 
CT artrogram zou dus waarschijnlijk kunnen worden toegepast om gewichtskraakbeen 
samenstelling te kunnen meten in menselijke knieën.
Een nadeel van CT ten opzichte van MRI is dat voor het maken van een CT scan 
röntgenstraling wordt gebruikt welke, bij veelvuldige toepassing, mogelijk een scha-
delijk effect op de weefsels zou kunnen hebben. Om te kijken of het ook mogelijk is 
om suikerketens te meten met een lage dosis röntgenstraling is in hoofdstuk 8 een 
onderzoek beschreven waarbij CT scans met verschillende hoeveelheden straling 
werden vergeleken met de uitkomst van een gouden standaard meting. Het bleek dat 
als 10% van de hoeveelheid straling in hoofdstuk 7 werd gebruikt, er door middel van 
een CT artrogram alsnog suikerketens in gewrichtskraakbeen kunnen worden geme-
ten. Dit maakt deze geavanceerde techniek ook geschikt en veilig om te gebruiken 
om patiënten in de loop van de tijd te vervolgen met meerdere CT scans. Ook werd 
gekeken naar de mogelijkheid om met een CT artrogram verschillen in de hoeveelheid 
suikerketens te meten binnen een bepaald gebied binnen het kraakbeen op een beeld 
van de gehele scan. Dit bleek, net als bij dGEMRIC, mogelijk. Echter de mogelijkheid om 
onderscheid te maken tussen verschillen in suikerketens op een bepaald beeld werd 
minder goed mogelijk bij het gebruik van een lage röntgenstralingsdosis. De hoeveel-
heid röntgenstraling die gebruikt wordt voor een CT artrogram moet dus worden aan-
gepast aan het doel van de CT scan wanneer deze in het kader van wetenschappelijk 
onderzoek wordt gemaakt.
2.2 validatie van het CT artrogram om kraakbeen samenstelling te meten 
in mensen met knieartrose
Nadat in hoofdstuk 7 en 8 de toepassing van het CT artrogram in knieën van overleden 
mensen werd onderzocht, is in hoofdstuk 9 gekeken naar het verband tussen uitkom-
sten van een CT artrogram en de hoeveelheid suikerketens in levende menselijke 
knieën. De uitkomsten van de CT scan hadden ook in levende knieën een sterk verband 
met de hoeveelheid suikerketens in het kraakbeen, maar waren, net als bij dGEMRIC, 
ook deels gerelateerd aan de hoeveelheid collageen van het gewrichtskraakbeen. CT 
heeft een relatief hoge resolutie, een lagere prijs en is sneller vergeleken met MRI. Het 
CT artrogram zou daarom een uitstekend alternatief kunnen zijn voor dGEMRIC om, 
in toekomstig wetenschappelijk onderzoek, de hoeveelheid suikerketens in gewrichts-
kraakbeen van levende mensen kunnen meten.
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ConClusIes
Het onderzoek waarop dit proefschrift is gebaseerd vormt een bijdrage aan de mo-
gelijke toepassing van geavanceerde beeldvormende technieken om kraakbeensa-
menstelling in maat en getal te bepalen bij onderzoek naar artrose. De belangrijkste 
resultaten kunnen als volgt worden samengevat:
• Tot op heden is dGEMRIC de enige goed gevalideerde en robuuste geavanceerde 
beeldvormende techniek waarmee kraakbeensamenstelling in de vorm van suiker-
ketens kan worden gemeten bij patiënten met knieartrose.
• dGEMRIC kan, naast kraakbeensamenstelling, mogelijk ook in dezelfde scan de 
hoeveelheid suikerketens in de meniscus meten.
• T1rho-mapping lijkt niet geschikt als geavanceerde beeldvormende techniek om 
kraakbeensamenstelling te meten bij mensen met knieartrose.
• CT artrografie is mogelijk geschikt als geavanceerde beeldvormende techniek om 
de hoeveelheid suikerketens in gewrichtskraakbeen te meten bij mensen met 
knieartrose en is daarom een mogelijk alternatief voor MRI.
• Geavanceerde beeldverwerkingssoftware verbetert de nauwkeurigheid van uit-
komsten van geavanceerde beeldvormende MRI technieken.
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90%-CRLBσ: 90% percentile of the CRLBσ in a region of interest
95%CI: 95% confidence interval
ACLT: anterior cruciate ligament tear
ADL: activities of daily living
aMEN: anterior horn of the meniscus
BLOKS: Boston Leeds osteoarthritis knee score
BMI: body mass index
CEST: chemical exchange saturation transfer
CI: 95% confidence interval
CRLB: Cramér–Rao lower bound
CRLBσ: square root of the Cramér–Rao lower bound
CT: computed tomography
CTa: using CT arthrography
CTDIvol: CT-Dose Index
CV: coefficient of variation
dGEMRIC: delayed gadolinium-enhanced MRI of cartilage
dGEMRIM: delayed gadolinium-enhanced MRI of the meniscus
DMMB assay: dimethylmethylene blue assay
DMOADs: disease-modifying osteoarthritis drugs
ECM: extracellular matrix
EDTA: ethylenediaminetetraacetic acid
EPIC- µCT: equilibrium partitioning of an ionic contrast agent using micro-CT
EULAR: European league against rheumatism
FCD: fixed-charge density
FOV: field of view
FSE: fast spin echo
FSPGR: fast spoiled gradient-recalled echo
gagCEST: glycosaminoglycan specific chemical exchange saturation transfer
HA: hyaluronic acid
ICC: intraclass correlation coefficient
ICC(2,1): two-way random intraclass correlation coefficient
IRB: Institutional Review Board
IR: inversion recovery
IR SPGR: inversion recovery spoiled gradient-echo
KL: Kellgren & Lawrence grading system
KOOS: knee injury and osteoarthritis outcome score
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KOSS: knee osteoarthritis scoring system
LMI: localized mutual information
McMC: Markov chain Monte Carlo
MIRIT: multimodality image registration using information theory
MOAKS: MRI Osteoarthritis Knee Score
mpP: mid-portion of patellar cartilage
MRI: magnetic resonance imaging
ncCT: non-contrast CT
NRS: numeric rating scale
OA: osteoarthritis
OAI: OsteoArthritis Imitative
PBS: phosphate buffered saline
PCC: posterior predictive check
PET: positron emission tomography
pFC: posterior non weight-bearing cartilage of the femoral condyle
PG: proteoglycans
pLC: posterior non-weight bearing area of the lateral femoral condyle
pMC: posterior non-weight bearing area of the medial femoral condyle
pMEN: posterior horn of the meniscus
QoL: knee-related quality of life
r: Pearson’s correlation coefficient
ROIs: regions of interest
sGAG: sulphated glycosaminoglycan
SNR: signal-to-noise ratio
SPARCK: software for post processing and registration of cartilage of the knee
SPECT: single photon emission computed tomography
SPGR: spoiled gradient-echo
T: Tesla
T1GD: post contrast T1 relaxation time
TI: inversion time
TKR: total knee replacement
TR: repetition time
TSL: spin lock time
μCT: micro computed tomography
μCTa: micro computed tomography arthrography
VGA: visual grading analysis
wbFC: weight-bearing cartilage of the femoral condyle
wbFCa: anterior weight-bearing cartilage of the femoral condyle
wbFCp: posterior weight-bearing cartilage of the femoral condyle
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wbLC: lateral femoral condyle
wbLP: weight-bearing lateral tibial plateau
wbMC: medial femoral condyle
wbMP: weight-bearing medial tibial plateau
wbTP: weight-bearing cartilage of the tibial plateau
WORMS: whole-Organ MRI Score
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Research School: Molmed / NIHES
PhD period: 15-03-2010 – 31-12-2013
Promotors: Prof.dr.ir. H.H. Weinans and Prof.dr. G.P. Krestin
Daily supervisor: Dr. E.H.G. Oei
General courses / workshops year
workload 
(eCTs)
MRI Safety and Scanning Course (Department of Radiology, Erasmus MC) 2010 2
Introduction to Data Analysis (NIHES) 2010 2
Biomedical Scientific English writing course (Molmed) 2011 4
Translational Imaging Workshop by AMIE “‘From mouse to man” (Molmed) 2011 1
Basiscursus Regelgeving en Organisatie van Klinische trials / Good Clinical 
Practice (Molmed)
2011 1
Diagnostic Research (NIHES) 2012 1
Writing a successful grant proposal (Molmed) 2012 1
(Inter)national podium presentations year
workload 
(eCTs)
Clinical application of CT-arthrography as a measure for cartilage quality, 
validated by in-vitro contrast-enhanced μCT.
European congress of Radiology, Vienna, Austria
2011 1
CT arthrography to measure cartilage quality: influence of sulphated 
glycosaminoglycan content and structural composition of extracellular 
matrix on contrast agent diffusion into cartilage.
5th OARSI imaging workshop, Salzburg, Austria
2011 1
CT-arthrography to measure cartilage quality: influence of sulphated 
glycosaminoglycan content and structural composition of extracellular 
matrix on contrast agent diffusion into cartilage.
Radiologendagen, Maastricht, The Netherlands
2011 1
Reproducibility of 3D delayed Gadolinium Enhanced MRI of Cartilage of the 
knee at 3.0 Tesla in patients with early stage osteoarthritis.
Radiologendagen, Maastricht, The Netherlands
2011 1
Reproducibility of 3D delayed Gadolinium Enhanced MRI of Cartilage 
(dGEMRIC) of the knee at 3.0 Tesla in patients with early stage osteoarthritis.
European society of skeletal radiology, Innsbruck, Austria
2012 1
3D Delayed Gadolinium-Enhanced MRI of Cartilage at 3.0 Tesla used 
to evaluate the effect of hyaluronic acid on cartilage quality in knee 
osteoarthritis patients.
Radiologendagen, ‘s Hertogenbosch, The Netherlands
Awarded with Best Scientific Paper Award
2012 1
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Effectiviteit van hyaluronzuur injecties bij knieartrose geëvalueerd met 
dGEMRIC.
Najaarscongres Nederlandse Orthopaedische Vereniging, Veldhoven, The 
Netherlands
2012 1
Reproducibility of 3D delayed Gadolinium Enhanced MRI of Cartilage of the 
knee at 3.0 Tesla in patients with early stage osteoarthritis.
Annual Meeting of the Radiological Society of North America, Chicago, United 
States of America
2012 1
3D Delayed Gadolinium-Enhanced MRI of Cartilage at 3.0 Tesla used 
to evaluate the effect of hyaluronic acid on cartilage quality in knee 
osteoarthritis patients.
European congress of Radiology, Vienna, Austria
2013 1
Correlation between quantitative delayed contrast-enhancement in 
meniscus and cartilage in knee osteoarthritis.
Annual meeting of the International Society for Magnetic Resonance in Medicine, 
Salt Lake City, United States of America
2013 1
CT arthrography of the human knee to quantitatively measure cartilage 
biochemical composition: preliminary results of an in-vivo validation study
European congress of Radiology, Vienna, Austria
2014 1
Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) is superior to 
T1rho-mapping in measuring cartilage sulphated glycosaminoglycan 
content: preliminary results of an in vivo validation study
European congress of Radiology, Vienna, Austria
2014 1
Delayed gadolinium-enhanced MRI of the Meniscus (dGEMRIM) in 
patients with knee osteoarthritis: relation with meniscal degeneration on 
conventional MRI, reproducibility, and correlation with dGEMRIC
European congress of Radiology, Vienna, Austria
2014 1
Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) is superior to 
T1rho-mapping in measuring cartilage sulphated glycosaminoglycan 
content: preliminary results of an in-vivo validation study using an ex-vivo 
reference standard for cartilage sulphated glycosaminoglycan content
Annual meeting of the International Society for Magnetic Resonance in Medicine, 
Milano, Italia
2014 1
Quantitative CT arthrography of the human knee to measure cartilage 
biochemical composition: results of an in-vivo validation study against ex-vivo 
reference standards
Radiologendagen, ‘s Hertogenbosch, The Netherlands
Nominated for Best Scientific Paper Award
2014 1
Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) is superior to 
T1rho-mapping in measuring cartilage glycosaminoglycan content: results 
of an in-vivo validation study against ex-vivo reference standards for cartilage 
composition
Radiologendagen, ‘s Hertogenbosch, The Netherlands
Nominated for RSNA travel grant
2014 1
Quantitative CT arthrography of the human knee to measure cartilage 
biochemical composition: results of an in-vivo validation study against ex-vivo 
reference standards
Annual Meeting of the Radiological Society of North America, Chicago, United 
States of America
2014 1
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(Inter)national poster presentations year
workload 
(eCTs)
CT arthrography of the knee to measure cartilage quality with low radiation 
exposure.
OARSI World Congress on Osteoarthritis. San Diego, United States of America
2011 1
CT arthrography of the knee to measure cartilage quality with low radiation 
exposure.
Annual Meeting of the Orthopedic Research Society, San Francisco, United States 
of America
2012 1
CT arthrography of the knee to measure cartilage quality with low radiation 
exposure.
European congress of Radiology, Vienna, Austria
2012 1
Reproducibility of 3D delayed Gadolinium Enhanced MRI of Cartilage 
(dGEMRIC) of the knee at 3.0 Tesla in patients with early stage osteoarthritis.
OARSI World Congress on Osteoarthritis. Barcelona, Spain
2012 1
Effectiveness of hyaluronic acid in knee osteoarthritis patients evaluated 
using delayed gadolinium-enhanced MRI of cartilage.
6th OARSI imaging workshop, Hilton Head Island, United States of America
2012 1
The relation between quantitative delayed contrast-enhancement in 
meniscus and cartilage in knee osteoarthritis.
OARSI World Congress on Osteoarthritis, 2013, Philadelphia, United States of 
America
2013 1
CT arthrography of the human knee to quantitatively measure cartilage 
biochemical composition: preliminary results of an in-vivo validation study 
using ex-vivo reference standards for cartilage composition.
OARSI World Congress on Osteoarthritis. Paris, France
2014 1
Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) is superior to 
T1rho-mapping in measuring cartilage sulphated glycosaminoglycan 
content: preliminary results of an in-vivo validation study using an ex-vivo 
reference standard for cartilage sulphated glycosaminoglycan content





Co-supervising Masters project of Esther E. Bron: “Optimization of registration 
in assessment of human knee cartilage T1 mapping with dGEMRIC”
2011 4
Co-supervising Internship of Vincent Dahi: “Implementation of T1rho- and 
T2-mapping into SPARCK”
2012 1
Co-supervising Masters Internship of Koen Dijkstra: “dGEMRIM, T2- and 




“Quantitative MRI techniques to measure knee cartilage quality: Clinical 
validation and evaluation”
Anna foundation | NOREF
Main applicant: € 10.000,00
2013 4
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Peer reviewing for International journals on regular basis
European Radiology, Arthritis Care and Research, Arthritis and Rheumatology, 
PLoS One, Cartilage
2012-2015 5




1. J. van Tiel, M. Siebelt, J.H. Waarsing, T.M. Piscaer, M. van Straten, R. Booij, M.L. Dijkshoorn, G.J. 
Kleinrensink, J.A. Verhaar, G.P. Krestin, H. Weinans, E.H. Oei. 
 Clinically applied CT arthrography to measure the sulphated glycosaminoglycan content of 
cartilage.
 Osteoarthritis Cartilage. 2011 Oct;19(10):1183-9.
2. J. van Tiel, M. Siebelt, J.H. Waarsing, T.M. Piscaer, M. van Straten, R. Booij, M.L. Dijkshoorn, G.J. 
Kleinrensink, J.A. Verhaar, G.P. Krestin, H. Weinans, E.H. Oei.
 CT arthrography of the human knee to measure cartilage quality with low radiation dose.
 Osteoarthritis Cartilage. 2012 Jul;20(7):678-85.
3. E.E. Bron, J. van Tiel, H. Smit, D.H.J. Poot, W.J. Niessen, G.P. Krestin, H. Weinans, E.H. Oei, G. 
Kotek, S. Klein.
 Image registration improves human knee cartilage T1 mapping with delayed -enhanced 
MRI of cartilage (dGEMRIC).
 Eur Radiol. 2013 Jan;23(1):246-52.
4. J. van Tiel, E.E. Bron, C.J. Tiderius, P.K. Bos, M. Reijman, S. Klein, J.A. Verhaar, G.P. Krestin, H. 
Weinans, G. Kotek, E.H. Oei.
 Reproducibility of 3D delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) of the 
knee at 3.0 T in patients with early stage osteoarthritis.
 Eur Radiol. 2013 Feb;23(2):496-504.
5. S. Matzat, J. van Tiel, G.E. Gold, E.H. Oei.
 Quantitative MRI Techniques of Cartilage Composition.
 Quant Imaging Med Surg. 2013 Jun;3(3):162-74.
6. J. van Tiel, E.H. Oei.
 Quantitative measurement of articular cartilage quality using MRI.
 Ned Tijdschr Geneeskd. 2013;157:A6340.
7. A.C. Kok, G.J.M. Tuijthof, S. den Dunnen, J. van Tiel, M. Siebelt, V. Everts, C.N. van Dijk, G.M. 
Kerkhoffs.
 Hole geometry of bone marrow stimulation does not influence cartilage repair in talar 
osteochondral defects in the goat.
 Clin Orthop Relat Res. 2013 Nov;471(11):3653-3662.
8. J. van Tiel, M. Reijman, P.K. Bos, J. Hermans, G.M. van Buul, E.E. Bron, S. Klein, J.A. Verhaar, G.P. 
Krestin, S.M. Bierma-Zeinstra, H. Weinans, G. Kotek, E.H. Oei. 
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 Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) shows no change in cartilage 
structural composition after viscosupplementation in patients with early stage knee osteo-
arthritis.
 PLoS One. 2013 Nov;8(11):e79785
9. E.H. Oei, J. van Tiel, W.H. Robinson, G.E. Gold.
 Quantitative Radiological Imaging Techniques for Articular Cartilage Composition: Towards 
Early Diagnosis and Development of Disease-Modifying Therapeutics for Osteoarthritis.
 Arthritis Care Res (Hoboken). 2014 Aug;66(8):1129-41.
10. J. van Tiel, G. Kotek, M. Reijman, P.K. Bos, E.E. Bron, S. Klein, J.A. Verhaar, G.P. Krestin, H. Wein-
ans, E.H. Oei.
 Delayed Gadolinium-Enhanced MRI of the Meniscus (dGEMRIM) in patients with knee os-
teoarthritis: relation with meniscal degeneration on conventional MRI, reproducibility and 
correlation with dGEMRIC.
 Eur Radiol. 2014 Sep;24(9):2261-70.
11. J. van Tiel, G. Kotek, M. Reijman, P.K. Bos, E.E. Bron, S. Klein, K. Nasserinejad, G.J. van Osch, J.A. 
Verhaar, G.P. Krestin, H. Weinans, E.H. Oei.
 Is T1rho-mapping an alternative to delayed gadolinium-enhanced MRI of
 Cartilage (dGEMRIC) in assessing sulphated glycosaminoglycan content in human osteoar-
thritic knees? An in vivo validation study
 Radiology. 2015. Accepted for publication
12. J van Tiel, M. Siebelt, M. Reijman, P.K. Bos, J.H. Waarsing, A.M. Zuurmond, K. Nasserinejad, G.J. 
van Osch, J.A. Verhaar, G.P. Krestin, H. Weinans, E.H. Oei.
 Quantitative in vivo CT arthrography of the human osteoarthritic knee to estimate cartilage 
sulphated glycosaminoglycan content: correlation with ex-vivo reference standards
 Osteoarthritis Cartilage. 2015. Revision submitted
13. R.A. van der Heijden, E.H. Oei, E.E. Bron, J. van Tiel, P.L. van Veldhoven, S. Klein,
 J.A. Verhaar, G.P. Krestin, S.M. Bierma-Zeinstra, M. van Middelkoop.
 Quantitative MRI shows no difference in patellofemoral cartilage composition between 
patients with patellofemoral pain and healthy control subjects.
 Am J Sport Med. 2015. Submited
14. P.R. Moshtagh, B. Pouran, J. van Tiel, J.Rauker, M.R. Zuiddam, F.W. Dirne, V. Arbabi, N.M. 
Korthagen, H. Weinans,  A.A. Zadpoor.
 Micro- and nano-mechanics of osteoarthritic cartilage: the effects of tonicity and disease 
severity.
 Osteoarthritis Cartilage. 2015. Submitted.




Iemand die mij zeer dierbaar is schreef eens: “promoveren is als topsport”. Toen ik dit vijf 
jaar geleden las had ik nog geen goed idee waar zij het over had. Nu ik inmiddels zelf 
alle frustratie, teleurstellingen, maar natuurlijk vooral de mooie en leuke momenten 
van het doen van promotieonderzoek mee heb gemaakt kan ik alleen maar stellen dat 
ik het met haar eens ben. Onderzoek doen is inderdaad als topsport en er is een sterk 
team voor nodig om dit tot een goed einde te brengen.
Allereerst wil ik de patiënten bedanken die het voor mij mogelijk hebben gemaakt om 
mijn onderzoek te kunnen uitvoeren. Doordat deze mensen hun tijd of hun lichaam 
aan de wetenschap hebben besteed heb ik dit proefschrift kunnen realiseren. Hartelijk 
dank hiervoor!
En dan wil ik nu de mensen uit mijn onderzoeksteam bedanken.
Prof.dr.ir. Weinans, beste Harrie, bedankt dat je me de mogelijkheid hebt gegeven om 
onderzoek te komen doen in Rotterdam. Achteraf ben ik ontzettend blij met jouw 
keuze mij niet in eerste instantie, maar in tweede instantie aan te nemen op een ander 
project dan waar ik aanvankelijk op solliciteerde. Jouw bevlogenheid en enthousiaste 
kijk op de wereld van de wetenschap hebben mij erg geïnspireerd en gemotiveerd 
gedurende de afgelopen jaren. Ik hoop, ondanks dat jij nu in het UMC Utrecht werkt, 
dat wij in de toekomst nog veel samen zullen werken.
Prof.dr. Krestin, beste professor, ook u wil ik bedanken dat u mij de mogelijkheid heeft 
gegeven een belangrijk deel van mijn onderzoek op de afdeling radiologie uit te voe-
ren. Bedankt voor uw altijd snelle, kritische en opbouwende commentaren op mijn 
manuscripten en ander werk. Ondanks dat ik geen radioloog word hoop ik toch in de 
toekomst zowel op klinisch, als op onderzoeksgebied met u samen te mogen werken.
Dr. Oei, beste Edwin, ik was jouw eerste promovendus, maar daar was niets van te 
merken. Je was en bent nog steeds een fantastische begeleider en een prettig mens 
om mee samen te werken. Ondanks een drukke baan als radioloog en je vele extra 
taken daarnaast was je altijd benaderbaar voor een korte of lange vraag en heb je een 
zeer waardevolle input geleverd aan mijn proefschrift, op zowel wetenschappelijk als 
tekstueel gebied. Ik hoop dat er de komende jaren nog veel onderzoek zal volgen op 
wat wij tot nu toe hebben gedaan en ik hoop dat wij hier een gezamenlijke bijdrage 
aan kunnen blijven leveren.
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Leden van de leescommissie en promotiecomissie: prof.dr. Bierma - Zeinstra, prof.dr. 
Maas, prof.dr. Niessen, prof.dr. Stam en prof.dr. Verhaar, hartelijk dank voor het lezen en 
het beoordelen van dit manuscript en het als opponent zitting nemen in de promotie-
commissie. Prof.dr. Trattnig, thank you for reading my thesis and for your willingness to 
serve as an opponent on the thesis committee.
Naast bovengenoemde mensen wil ik nog een aantal mensen in het bijzonder be-
danken voor hun hulp, input en niet onderzoek gebonden tijdverdrijf tijdens mijn 
onderzoeksperiode.
Prof.dr. Verhaar, beste professor, ondanks dat u niet in de vorm van promotor bij mijn 
onderzoek betrokken was wil ik u hartelijk danken voor uw input en het met een zeer 
klinisch gerichte blik meedenken over mijn onderzoek en manuscripten. Ik heb het 
altijd gewaardeerd met u over mijn onderzoek te praten en zo tot nieuwe (klinische) 
inzichten te komen waar ik weer mee verder kon. Ik hoop de komende jaren nog veel 
van u te leren tijdens mijn opleiding tot orthopedisch chirurg.
Dr. Reijman en dr. Bos, beste Max en Koen, dank voor jullie hulp en input tijdens het 
opzetten van mijn klinische studies en het opschrijven van de resultaten hiervan. Koen, 
als opleider hoop ik de komende jaren nog veel van jou te leren, al hoop ik dat we het 
naast vakinhoudelijke zaken toch ook nog over wetenschap kunnen hebben, bijvoor-
beeld op een mooi congres.
Beste Dirk Poot, Esther Bron, Gavin Houston, Gyula Kotek, Mika Vogel en Stefan Klein, 
dank voor jullie hulp bij het opzetten van alle MRI protocollen en het analyseren hier-
van. Zonder jullie hulp was dit nooit gelukt!
Hetzelfde geldt voor Marcel Dijkshoorn, Marcel van Straten, Ronald Booij en Wim 
Vermeule. Dank voor jullie hulp en flexibiliteit als het gaat om het opzetten, testen en 
maken van de CT artrogrammen.
Our international collaborators, dear prof.dr. Garry Gold, prof.dr. Jukka Jurvelin, dr. Eve-
liina Lammentausta, prof.dr. Miika Nieminen, dr. Carl Johan Tiderius and prof.dr. Juha 
Töyräs, thank you for collaborating with us during the implementation phase, protocol 
setup and clinical application of our translational and clinical MRI and CT studies in 
humans. I hope we can expand our collaboration in the future, which may eventually 
lead towards the application of quantitative imaging biomarkers of cartilage compo-
sition as a primary outcome measure for future clinical trials in osteoarthritis research 
in humans.
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Beste staf, arts-assistenten, onderzoekers en andere medewerkers van de afdeling 
orthopedie en het orthopedisch research laboratorium van het Erasmus MC, dank 
voor jullie medewerking en meedenken als het gaat om mijn onderzoek. Natuurlijk 
ook bedankt voor de gezelligheid de afgelopen jaren. Vooral voor mijn ex-collegae op 
het lab, ik hoop dat ik jullie niet teveel heb geïrriteerd met mijn immer flauwe grappen, 
mijn gefluit, mijn getik, of enigerlei andere dingen die anderen altijd lijken te storen…
Beste onderzoekers, laboranten en andere medewerkers van de afdeling radiologie van 
het Erasmus MC, ook aan jullie mijn dank voor jullie hulp en gezelligheid tijdens alle 
borrels, etentjes en andere activiteiten gedurende de afgelopen jaren.
Beste chirurgen en arts-assistenten chirurgie uit het Reinier de Graaf Gasthuis in Delft, 
bedankt voor de enorm leerzame en leuke vooropleiding die ik bij jullie heb gehad! 
Ook dank voor het geven van voldoende tijd en support om mijn promotie af te ronden 
tijdens mijn tijd bij jullie.
Beste Rintje en Michiel, mijn paranimfen, samen werden wij de afgelopen jaren ook wel 
“de drie musketiers” genoemd. Ik vind het fantastisch dat ik met jullie aan mijn zijde mijn 
proefschrift mag verdedigen!
Beste Rintje, ik weet nog goed dat toen ik begon op EE16:18 ik mij af vroeg van wie 
die stapels papier toch waren die het gehele bureau tegenover mij in beslag namen. 
Toen er vervolgens een goedlachse, met een tulband gesierde, Friesche jongeman 
achter kwam zitten was het al gauw over met de rust daar. 538 Party en Fresh FM Friday, 
met ons gefluit maakten we iedereen gek! Gelukkig liet jij je vooral door Michiel en 
een beetje door mij overtuigen je studentenonderzoek door te zetten tot een pro-
motieonderzoek; de rest is natuurlijk geschiedenis…! Naast collega en vriend, want 
vrienden schijn je pas te zijn als je samen dronken bent geweest heb ik weleens iemand 
horen zeggen, werden we ook stadsgenoten. Dus samen in de trein naar Roffa en ook 
’s avonds op de racefiets een rondje doen. Dat laatste en bier drinken hebben we de 
laatste tijd te weinig gedaan, dus daar moeten we wat aan gaan doen! Op naar een 
mooie opleidingstijd met veel borrels op de NOV, cursus en wie weet wat nog meer!
Beste Michiel, tijdens onze eerste kennismaking werd ik door jou doorgezaagd over wat 
ik nu precies met de MRI en die magnetron ging doen. Toen beide projecten vervolgens 
om totaal verschillende redenen vertraging opliepen, hebben wij samen een middag 
zitten brainstormen met als resultaat in ieder geval 3 papers! Daarnaast zijn er natuurlijk 
ook voldoende memorabele tripjes uit deze middagsessie koffie drinken voort geko-
men. Ik denk dan bijvoorbeeld aan ons tripje naar Oulu, de congressen, maar natuurlijk 
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ook de borrels in Boudewijn. Ook wij zijn na al dit drankgelach gelukkig vrienden en ik 
hoop dat nog lang te zijn! Wat dat betreft dezelfde wens als voor Rintje, op naar een 
mooie tijd met zoveel mogelijke leuke uitstapjes de komende jaren!
Boys van JC Kopstuk, veel dank voor alle leuke, mooie, brakke en minder brakke din-
gen die we samen hebben gedaan gedurende de afgelopen 10 jaar. Ik hoop dat we, 
ondanks dat iedereen zijn eigen weg zoekt, al dan niet met of zonder vriendin/vrouw/
kind(eren), de komende jaren nog veel mooie dingen samen zullen doen. Op naar ons 
Lustrum-Lustrum!
Lieve familie en schoonfamilie, bedankt voor jullie interesse. Lieve Sofie, Koen, Léon, 
Alexandra, Diger, Marieke en natuurlijk Thijn, ook jullie bedankt voor jullie interesse. 
Ik ben trots en blij dat jullie mijn (schoon)zussen, (schoon)broers en neefje zijn. Lieve 
Grad en Hetty, bedankt voor jullie gastvrijheid, waardering, gezelligheid en natuurlijk 
het oppassen op de kinderen waardoor ik soms nog wat extra tijd had om naast mijn 
opleiding dit werk af te ronden.
Lieve papa en mama, fijn dat jullie mij altijd hebben gesteund! Bedankt voor het ver-
trouwen en jullie liefde, ondanks dat ik wellicht niet altijd jullie makkelijkste kind was. 
Ook aan jullie veel dank voor het oppassen op onze kleintjes waardoor Wen en ik soms 
ook nog wat leuke tijd samen konden doorbrengen.
Lieve Wen en kids, wat is het altijd heerlijk om na een dag hard werken thuis te komen 
en jullie weer te zien en te kunnen knuffelen. Ik zal beloven dat ik de komende tijd niet 
al mijn vrije uren aan het afronden van mijn onderzoek en het voorbereiden van poli’s 
en operaties zal besteden, maar vooral aan jullie! Bedankt voor alle leuke, grappige en 
ontroerende momenten de afgelopen maand, ruim 2 jaar en meer dan afgelopen 10 
jaar. Jullie zijn mijn toppers waar ik het meest van hou, voor altijd!




Jasper van Tiel was born in Utrecht, the Netherlands on the 7th of December 1984. He 
attended secondary school at ‘College Blaucapel’ in Utrecht from which he graduated 
in 2003. In that same year he started his medical study at Utrecht University. From the 
beginning of his study onwards, Jasper was fascinated by the musculoskeletal system 
and its pathophysiology. During his study he also became interested in medical re-
search. Therefore, after graduating as a medical doctor, in March 2010, he started his 
research project on quantitative cartilage imaging as a joint project of the Department 
of Orthopedic Surgery and the Department of Radiology of the Erasmus MC Rotterdam. 
He worked as a full time PhD student for almost four years under supervision of prof.
dr.ir. H.H. Weinans, prof.dr. G.P. Krestin and dr. E.H.G. Oei. The research carried out dur-
ing this period was rewarded with the Best Scientific Abstract Award in 2012 by the 
Radiological Society of the Netherlands and resulted in the current thesis. After finish-
ing this research project, Jasper started his training to become an orthopedic surgeon 
in January 2014. He worked at the Department of General Surgery at the Reinier de 
Graaf Gasthuis in Delft (supervisor dr. M. van der Elst) and continued his training at the 
Department of Orthopedic Surgery at the Erasmus MC in July 2015 (supervisor dr. P.K. 
Bos). Jasper lives together with his girlfriend Wendy and their son and daughter.
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